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Literature Review: Overgeneral autobiographical memory and depressive 
symptoms in older adults: An evaluative review 
Objectives: Overgeneral autobiographical memory (OGM) is a well-researched 
phenomenon in adults with clinical depression. However, the nature and mechanisms of 
OGM have not been well established in older adults. The aim of this review was to 
synthesise existing literature on OGM and depressive symptoms in older adults under 
the framework of the Capture and Rumination, Functional Avoidance and Impaired 
Executive Control (CaR-FA-X) model (Williams, 2006; Williams et al., 2007). Method: 
Literature searches were conducted using PsychINFO, PubMed and Web of 
Knowledge, with search terms 1) older adults, 2) depression, and 3) overgeneral 
memory. Eighteen articles were reviewed. Articles were grouped into four categories by 
design: studies comparing healthy older and younger adults; studies comparing older 
adults with and without depression; longitudinal research; and intervention studies. 
Results: The literature suggests that OGM is elevated in healthy older adults compared 
to younger adults, and further elevated in older adults with depression. Evidence 
supports the role of impaired executive function as a mechanism for OGM in older 
adults with depression, but no studies had measured other factors implicated by the 
CaR-FA-X model (i.e. functional avoidance and rumination). Some support was found 
for the use of Life Review interventions to increase memory specificity and improve 
wellbeing. Conclusion: OGM appears prevalent in older adults with depression, 
however we do not yet have a clear understanding of the mechanisms through which 
this occurs. It is recommended that future research looks at the role of functional 
avoidance and rumination, and at the use of memory specificity interventions being 
developed in the working age adult literature.  
 
Service Improvement Project: An evaluation of psychological service provision in 
a palliative care setting 
 
Objectives: Current UK guidelines recommend a four-level model of psychological 
service provision in oncology settings. This model gives responsibilities to non-
psychologist professionals to provide psychological support, and places Clinical 
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Psychologists in a central role to provide supervision, consultation and training to other 
staff as well as direct clinical work. The aims of this project were: 1) to evaluate 
psychological service provision at a palliative care service from the perspective of staff 
members, and 2) to explore staff perceptions of the role of Clinical Psychology in 
palliative care. Method:  Hospice staff members (n=28) completed a survey about their 
confidence in providing psychological support and perceived barriers to this, and 
providing feedback on the Clinical Psychology service. Follow-up interviews (n=2) and 
a focus group (n=5) were conducted to further explore staff confidence, responsibilities, 
and the role of Clinical Psychology. Results: The survey data indicated generally high 
levels of confidence in providing psychological support. A lack of access to 
recommended training, a lack of information about psychological support, and 
competing pressures were identified as barriers. Staff gave positive feedback on the 
supervision, consultation and training provided by the Clinical Psychologist, but 
highlighted a need for more Clinical Psychology hours. Thematic analysis on the 
interview and focus group data identified themes related to staff confidence, collective 
responsibilities, the importance of multiple perspectives, and the role and presence of 
Clinical Psychology. Outcome: The findings suggested areas for improvement and 
potential barriers to providing psychological support at the palliative care service. A 
report and recommendations were fed back to the service and plans were made to act on 
these. Wider implications are discussed in relation to implementing the recommended 
model of psychological service provision, and regarding the role of Clinical Psychology 
in palliative care settings.  
 
Main Research Project: Psychological factors associated with self-reported sleep 
disturbance in Chronic Fatigue Syndrome and Insomnia 
Objectives: Reports of tiredness and poor quality sleep are common to both Chronic 
Fatigue Syndrome (CFS) and insomnia, despite evidence that sleep structure is not 
objectively impaired in these groups. Similar vulnerability and maintenance factors 
have been identified in both conditions, such as perfectionism, unhelpful beliefs and 
misattributions about symptoms. The aim of this study was to compare CFS and 
insomnia groups in terms of subjective sleep and fatigue symptoms and associated 
cognitive factors. Method: Using a cross-sectional design, CFS patients (n=18), 
community insomnia participants (n=18) and healthy community controls (n=19) were 
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compared on a range of self-report questionnaires, including measures of psychological 
wellbeing (depression, anxiety, worry), insomnia, sleepiness and fatigue severity, 
cognitions about sleep and fatigue, and other cognitive variables associated with CFS 
and insomnia. Results: Between-group analyses identified that CFS and Insomnia 
participants did not differ significantly on the majority of variables. Compared to 
controls, both groups reported poorer psychological wellbeing and higher levels of 
insomnia, sleepiness, and sleep-related cognitions. Both groups also reported elevated 
perfectionism and unhelpful beliefs about emotions. Compared to the Insomnia group, 
CFS participants reported higher levels of fatigue, fatigue-related cognitions, and pre-
sleep somatic experiences. Conclusions: This study found similarities between CFS and 
insomnia participants in terms of cognitive processes known to maintain insomnia. This 
indicates that it may be appropriate to use a transdiagnostic cognitive-behavioural 
approach to treating sleep disturbance in CFS. The results also indicate the importance 
of assessing for unhelpful fatigue-related beliefs and pre-sleep somatic complaints when 







University of Bath 





Overgeneral autobiographical memory and 












Internal Supervisor: Dr James Gregory 
 
Word Count: 7,849 
 
 
Intended Journal: Aging and Mental Health. This peer-reviewed journal 
accepts submissions of review articles that summarize emerging trends, or 








Autobiographical memory is the sub-system of episodic memory that relates to personal 
experiences. The ‘self-memory system’ model, proposed by Conway and Pleydell-
Pearce (2000), describes autobiographical memories as transitory mental constructions 
of autobiographical knowledge, which are formed either as a response to cues from the 
environment or as a result of conscious retrieval. The ability to ‘look back’ at one’s life 
history using autobiographical memory is thought to serve various functions in relation 
to well-being, including: forming  a sense of identity and growth over time; maintaining 
social relationships; and learning from past experiences to guide present behaviour (see 
Bluck, Alea, & Ali, 2014). As noted by Bluck et al. (2014), reflecting on past events is 
seen as particularly important and meaningful in later stages of life. 
 
1.1. Autobiographical Memory and Depression 
Depression affects around 11% of people aged 16 to 74 at any one time in the UK 
(Singleton, Bumpstead, O'Brien, Lee, & Meltzer, 2001). There is strong evidence that 
the ability to recall events from one’s past is compromised in people with depression 
and that this impairment can maintain depressive symptoms. Dalgleish and Werner-
Seidler (2014) summarise four ways in which autobiographic memory problems 
contribute to depression. First, there is evidence of a bias towards recalling negative 
events, which reinforces a pervasive negative view of the self, other people and the 
world. Correspondingly, the second feature is a diminished ability to access positive 
memories, and a tendency to recall positive events in less detail. Third, people with 
depression are found to recall personal events in an ‘overgeneral’ way; memories are 
grouped into themes and ‘chapters’ rather than being recalled as individual events. This 
‘overgeneral memory’ (OGM) effect is the main focus of the current review and is 
described further below. Finally, there are differences in the way people with depression 
relate to their autobiographical memories. For example, distressing memories may be 
avoided through suppression, which can lead to intrusive recall. Alternatively, negative 
events may be ruminated upon, reinforcing negative ideas about the self and lowered 
mood.  
 
1.2. Overgeneral Memory 
Autobiographical memory is thought to have different degrees of specificity. Conway 
and Pleydell-Pearce (2000) propose a three-level hierarchical structure to the 
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organisation of autobiographical memories. At the broadest level, memories contain 
general knowledge about extended lifetime periods, for example “when I was at 
primary school”. They then contain knowledge relating to a general category of events, 
for example “on school sports days”. Finally, specific autobiographical memories 
contain event-specific knowledge about a single incident, for example “winning the 
100-metre race when I was eleven”. In order to consciously retrieve a specific memory, 
the relevant lifetime period must first be accessed, which provides cues to access the 
category of events, which in turn cues retrieval of specific incidents (Conway & 
Pleydell-Pearce, 2000).  
First described by Williams and Broadbent (1986), OGM is the tendency to retrieve 
autobiographical information at the general, rather than specific level. Using their 
Autobiographical Memory Test (AMT), Williams and Broadbent (1986) asked 
participants to retrieve specific autobiographical memories in response to ‘positive’ (e.g. 
happy, successful) and ‘negative’ (e.g. angry, lonely) cue words. They found that, 
compared to controls, participants who had recently attempted suicide had difficulty 
retrieving specific memories. The OGM phenomenon has been extensively researched 
since this discovery and is associated strongly with depression, as well as trauma-related 
disorders (for reviews, see: Sumner, 2012; Williams, 2006; Williams et al., 2007).  
 
1.3. Overgeneral Memory and Depression 
The relationship between depression and OGM is well established; adults with clinical 
depression have difficulty generating specific memories as compared to non-depressed 
controls (e.g. Kuyken & Dalgleish, 1995). The effect of depressed mood on specificity 
has been found even when controlling for potential mediating factors, such as impaired 
executive function (Dalgleish et al., 2007). OGM has been identified as a trait marker 
for depression, as it is found to remain stable on remission and to indicate vulnerability 
to ongoing depression (Brittlebank, Scott, Williams, & Ferrier, 1993). A meta-analysis 
of studies looking at OGM as a predictor of the course of depression found that high 
OGM at baseline predicts higher depression symptoms at follow up; this effect occurs 
over and above the predictive value of baseline symptom severity (Sumner, Griffith, & 






1.4. CaR-FA-X Model 
The most comprehensive theory of the mechanisms underlying OGM is the Capture 
and Rumination, Functional Avoidance and Impaired Executive Control, or CaR-FA-X, 
model (Williams, 2006; Williams et al., 2007). This suggests there are three processes 
that contribute, on their own or in combination, to the occurrence of OGM. First, if a 
memory cue is associated with negative meanings about the self, the individual may get 
‘captured’ by this negative self-relevant idea and begin to ruminate, disrupting the 
memory search. Second, OGM may represent a functional avoidance of specific 
memories as a way of regulating emotions; this may start as avoidance of the negative 
affect associated with particular (e.g. trauma-related) memories, then become a 
generalised retrieval style. Finally, reduced executive function capacity may contribute 
to OGM by making it difficult to maintain attention and inhibit inappropriate responses. 
Any of these mechanisms may result in the memory search being truncated at the 
general level, before a specific event has been identified (Williams et al., 2007).  
In a comprehensive review, Sumner (2012) synthesised the evidence for the three 
mechanisms of the CaR-FA-X model. Strong support was found for the link between 
rumination and OGM, in people with depression (Crane, Barnhofer, Visser, 
Nightingale, & Williams, 2007) and non-clinical populations (e.g. Raes, Watkins, 
Williams, & Hermans, 2008; Sutherland & Bryant, 2007). Rumination is a form of 
‘repetitive thinking’, which can be either constructive or unconstructive, depending on: 
1) the emotional valence of the thoughts; 2) the context and situation; and 3) whether 
the thinking is abstract or concrete (Watkins, 2008). Rumination is hypothesised to lead 
to distress when the valence is negative, the context is negative, and the level of 
processing is abstract. In line with this model, ruminating on negatively-valenced 
information and thinking in an abstract, analytical way have been identified as related to 
OGM (Sumner, 2012). Evidence for the ‘capture’ mechanism appears more mixed. Self-
relevant cues have been found to trigger OGM in individuals with a history of 
depression (e.g. Crane, Barnhofer, Mark, & Williams, 2007; Spinhoven et al., 2007); 
however the opposite effect – increased memory specificity -  has been found in a non-
clinical population (Sumner, Griffith, & Mineka, 2011). Sumner therefore suggests that 
‘capture’ may only occur in the presence of negative self-schemas.    
Reasonable evidence has been found for OGM as a functional avoidance strategy, 
particularly in Post-Traumatic Stress Disorder (PTSD), although Sumner (2012) 
highlights a need for longitudinal research into how this mechanism develops. The 
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functional avoidance aspect may depend on whether OGM is defined as high memory 
generality, or low memory specificity. Retrieving low numbers of specific memories 
appears to protect against negative emotions following an aversive experience, whereas 
retrieving high numbers of overgeneral memories appears to increase distress (Raes, 
Hermans, Williams, & Eelen, 2006). This suggests it may be avoidance of negative 
specific memories that serves an affect regulation function, as opposed to OGM per se 
(Sumner, 2012). 
 In further support of the CaR-FA-X model, there is robust evidence for the relationship 
between impaired executive control and OGM (Sumner, 2012). Various aspects of 
executive functioning have been implicated in OGM, including impaired inhibition and 
updating abilities (Piolino et al., 2010) and reduced working memory capacity (e.g. 
Neshat-Doost, Dalgleish, & Golden, 2008). Impaired executive control has been found 
to influence OGM in adults with depression independently of the effect of depressed 
mood (Dalgleish et al., 2007).  
The CaR-FA-X model is well supported, however it is not proposed as a “one size fits 
all” model (Crane, Barnhofer, Visser, et al., 2007; Sumner, 2012). The different 
mechanisms operate independently and may make different contributions to OGM in 
different populations. Understanding the particular mechanisms underlying OGM in 
different populations is important in order to develop tailored methods of intervention 
as research in this field progresses (Sumner, 2012).   
 
1.5. Older Adults 
Older people are particularly vulnerable to depression, with around one in four people 
over 65 experiencing depression at any one time (Craig & Mindell, 2005). 
Understanding and addressing factors associated with depression is therefore an 
important priority in this population. There are a number of reasons to assert that the 
nature of the relationship between OGM and depression may be different in older adults 
compared to adults of working age. Firstly, even in healthy aging, there are known 
declines in executive functions such as working memory, filtering information, and 
metacognitive control (MacPherson, Phillips, & Della Sala, 2002; Salthouse, Atkinson, 
& Berish, 2003; Souchay & Isingrini, 2004; Zanto, Hennigan, Östberg, Clapp, & 
Gazzaley, 2010). Older adults with depression have more significant executive function 
impairments than non-depressed older adults (Lockwood, Alexopoulos, & van Gorp, 
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2002). Given the established relationship between executive function and OGM, this is 
likely to be significant.  
Secondly, research indicates there are differences in the nature of autobiographical 
memory in healthy older adults compared to younger adults. When asked to recall 
different life periods, older adults show a bias towards semantic descriptions (of 
meanings and knowledge) that are not linked to a particular place or time, whereas 
younger adults provide more episodic details (Levine, Svoboda, Hay, Winocur, & 
Moscovitch, 2002). When asked to freely recall life events, older adults tend to retrieve 
more memories from adolescence and early adulthood than later life periods, and show 
more positive associations with this time period; this phenomenon is known as the 
‘reminiscence bump’ and is hypothesised to be due to the high frequency of formative 
events occurring during early life (Rubin, Rahhal, & Poon, 1998). It has been suggested 
that over time, autobiographical memories become more integrated into a personal life 
narrative with an emphasis on meaning, rather than episodic details (Levine, 2004). 
These effects of aging on autobiographical memory may result in older adults naturally 
retrieving more memories at the ‘general’ level on tasks such as the AMT. It could also 
be hypothesised that OGM would be less prominent in older adults when asked to recall 
events from the ‘reminiscence bump’, due to the salience and meaning of events in 
younger life.  
Finally, there are frequent findings of a ‘positivity bias’ in older adults (see Carstensen 
et al., 2011). Despite the prevalence of depression in this group, aging is commonly 
associated with more positive emotional well-being and stability. It has been suggested 
that this occurs due to attentional and memory biases towards positively-valenced 
information as a means of emotion regulation (Mather & Carstensen, 2005). Older 
adults also retrieve more positive autobiographical memories compared to younger 
adults (Kennedy, Mather, & Carstensen, 2004), although this effect is diminished in 
older adults with depression (Yang & Rehm, 1993). The positivity bias may have an 




It is becoming important to establish the nature of OGM in older adults with depression 
so that they can benefit from advances in treatment that are being developed in the 
OGM literature (see Dalgleish & Werner-Seidler, 2014). Interventions aimed at 
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increasing autobiographical recall and specificity, such as Method-of-Loci and Memory 
Specificity Training (MEST), are showing promising outcomes in working age adults 
with depression. Method-of-Loci involves asking individuals to rehearse retrieval of 
positive memories using a mnemonic technique that links the memories with locations 
on familiar journeys. This technique has been found to improve access to specific 
positive memories in people with depression (Dalgleish et al., 2013). Trials of MEST, a 
group-based programme in which participants practice retrieving specific memories, 
have demonstrated positive outcomes in individuals with depression in terms of 
improving memory specificity and reducing depressive symptoms (Neshat-Doost et al., 
2013; Raes, Williams, & Hermans, 2009).  
To know whether the above techniques and interventions can be equally applied to 
helping older adults with depression, we first need to understand OGM in older adults. 
 
1.7. Current Review 
There has been increasing research into OGM in older adults. This has included studies 
looking at differences between healthy older and younger adults, specific clinical groups 
(e.g. people with depression or dementia) and interventions for increasing memory 
specificity. The purpose of this evaluative review is to establish what is currently known 
about OGM in relation to depression in older adults, as a synthesis and to guide future 
research. Key questions that the review aims to address are: whether there are 
differences in OGM between older and younger adults in the absence of depression; 
whether OGM is a characteristic feature and relapse marker of depression in older 
adults as it is in working age adults; and whether interventions targeted at increasing 
memory specificity can be effective for treating depression in older adults. The existing 
research findings are considered under the theoretical framework of the CaR-Fa-X 
model, and the potential clinical implications are discussed.  
 
2. Method  
Literature searches were conducted in January 2015 using PsychNET, PubMed and 
Web of Knowledge (Science Citation Index and Social Science Citation Index). Three 
search terms and possible synonyms were used: 1. Older Adults (old age, elderly, 
geriatric, gerontology), 2. Depression (depressive, mood disorder, low mood, 
dysthymia, anhedonia), and 3. Overgeneral Memory (autobiographical memory, OGM). 
The date was restricted to articles published from 1986 onwards, following Williams 
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and Broadbent’s (1986) original article describing OGM. Book chapters and 
unpublished dissertations were not included. 
The search returned 253 references after removal of duplicates. Titles and abstracts 
were then reviewed to screen against the following inclusion criteria: 1. Published in the 
English language (9 excluded), 2. Described peer-reviewed, original research (24 
excluded), 3. Focused on an older adult population, defined broadly for the purpose of 
this review as aged 50 and above (133 excluded), 4. Did not focus on older adults with 
cognitive impairment or medical/psychiatric diagnoses apart from depression (25 
excluded), 5. Employed a standardised measure of depression, which was not used 
solely for the purpose of screening out participants (20 excluded), and 6. Employed a 
quantitative measure of OGM or autobiographical memory specificity (24 excluded). If 
any criteria were unclear from the title and abstract, articles were accessed in full to 
assess eligibility. References from included articles were examined for relevant papers, 
which resulted in a further 5 articles being screened for eligibility; these were all 
excluded due to an absence of depression measures. Eighteen articles were included for 
full review and broadly categorised into four groups based on design: 
 Non-clinical cross-sectional studies comparing older adults (OA) and younger 
adults (YA) 
 Cross-sectional studies comparing OA with and without depression symptoms 
(non-clinical samples), or clinical depression (clinical samples). 
 Longitudinal studies 
 Intervention studies  
The design, sample and measures used in the included studies are summarised in Tables 
1-5. In addition to reviewing the content, the quality of each study was considered using 
the checklist in Appendix A. This checklist was taken from one used by the journal 
Behavioural and Cognitive Psychotherapy as part of their peer-review process, and was 
used as a guide for critically appraising the design, methodology and clarity of each 






3.1. Non-Clinical Cross-Sectional Studies comparing Older Adults with Younger 
Adults (see Table 1) 
A number of studies compared OGM in healthy OA and YA, while effectively 
controlling for depression symptoms. These are included in the current review as they 
provide relevant information about differences in OGM between older and younger 
adults in the absence of depression.  
Two studies examined the relationship between OGM and executive function. Ros et al. 
(2010) found that OA perfomed worse than YA on tasks of working memory and 
sustained attention, and retrieved fewer specific and more categoric memories on the 
AMT. Structural equation modelling using data from both age groups showed that better 
working memory contributed to improved memory specificity. The authors therefore 
conclude that the cognitive changes associated with aging account for OGM in OA (Ros 
et al., 2010). However, many of the executive function tasks employed in this study 
were not well-recognised or validated measures. The description of the administration 
of the AMT also suggests that these authors did not provide participants with prompts 
when they retrieved a general memory, which would have negatively impacted on 
scores and limits comparison with other studies. Findings from Holland et al. (2012) 
were not as conclusive. These authors looked at the relationship between memory 
specificity on the AMT and two aspects of executive control: updating (altering 
responses based on working memory of previous responses) and inhibition (inhibiting 
inappropriate responses). OA showed poorer executive functioning than YA and 
recalled fewer specific memories in response to neutrally-valenced cues. Across both 
groups, better updating predicted greater memory specificity. These findings support the 
role of executive functioning in OGM, specifically the ‘updating’ aspect of working 
memory. However, OGM was only found in OA in response to neutral cues: no 
difference in memory specificity was found between age groups for positive or negative 
cues. This suggests a preserved ability to retrieve specific memories with stronger 
emotional associations. Holland et al. (2012) suggest that such memories require less 
cognitive effort to retrieve, compensating for age-related declines in executive function.  
 
Executive control has also been looked at in relation to the ability to follow task 
instructions. Ford et al. (2014) used a musical-cued version of the AMT to examine the 
16 
  
Table 1: Non-Clinical Cross-Sectional Studies- Older Adults vs Younger Adults 
Study Location Sample Gender Ages Depression 
Measure 
OGM Measure Other Measures 
Ford, Rubin, and 
Giovanello (2014) 
USA 1. YA (N=25) 
  
 
2. OA (N=21), 
within subjects  
 
1. 10 male, 
15 female 
 
2. 10 male, 
11 female 
 
1. M= 18.7, SD= 
0.76,  
 











































Used to compare 
groups and 
controlled for in 
analyses 
 









France 1. YA (N=18) 
 
 
2. OA (N=16) 
 
 
3. OA with dementia 
(N=10) 
1. 8 male, 10 
female 
 
2. 6 male, 10 
female 
 
3. 1 male, 9 
female 
 
1. M= 22.16, 
SD= 1.92  
 
2. M= 75.18, 
SD= 4.61 
 
3. M= 76.30, 
SD= 4.01 
 
BDI: Used to 
exclude if score 
14+, and entered 
as covariate in 
analyses. 
 














Study Location Sample Gender Ages Depression 
Measure 
OGM Measure Other Measures 
Ros and Latorre 
(2010) 




2. OA (N=46) 
1. 21 male, 
29 female  
 
 






















Ros, Latorre, and 
Serrano (2010) 









impact of manipulating task instructions on OGM. Their OA and YA groups were 
equivalent in depression symptoms and executive function performance. Task 
instructions were varied so that participants were asked to recall 1) specific, 2) general, 
or 3) any memory. Across all conditions, OA retrieved fewer memories, a smaller 
proportion of specific memories and less memory detail compared to YA. Notably, OA 
recalled the same proportion of specific memories regardless of task instruction, 
whereas YA modified their responses, recalling more specific memories in the ‘specific’ 
condition. This suggests that OA have difficulty implementing task instructions, even in 
the absence of observable executive function deficits or depression. Ford et al. (2014) 
also suggest that OA have a natural bias towards OGM due to an age-related tendency 
to incorporate events into an overall life narrative, as proposed by Levine (2004). The 
novel musical-cued AMT used in this study was selected due to evidence that music is 
particularly effective for the retrieval of salient memories. However, this limits the 
generalisability of Ford et al.’s (2014) findings, as it is not clear whether the same 
retrieval processes are involved in response to visual or verbal cues. Replication with 
the standard verbal AMT would enable firmer conclusions and comparison with other 
studies.  
 
In a study stemming from literature on self-concept, Martinelli et al. (2013) compared 
YA with healthy OA and OA with dementia on a novel word-cue memory task. 
‘Autobiographical episodes’ (specific memories), ‘personal semantics’ (general 
knowledge about the self) and ‘self-defining memories’ (episodic memories related to 
self-concept) were recorded. Healthy OA recalled fewer specific memories than YA, 
however retrieval of specific 'self-defining' memories did not differ. This suggests that, 
despite deterioration in memory specificity, healthy OA have a preserved ability to 
retrieve memories  at the specific episodic level when they are highly self-relevant. 
Consistent with the ‘positivity bias’, Martinelli et al. (2013) also found that healthy OA 
produced more positive 'personal semantics' than YA, and that having a positive self-
concept was associated with more positive 'personal semantics' and 'self-defining' 
memories. In further support of the ‘positivity bias’, Ros and Latorre (2010) found that 
healthy OA retrieved fewer negative memories in response to negative cues than YA. 
These findings support the idea that reduced memory specificity for negative events 




3.2. Cross-Sectional Studies comparing Older Adults with and without Depression 
Symptoms 
 
To address the question of whether OGM is a characteristic feature of depression in 
older adults as it is in younger adults, cross-sectional studies comparing older adults 
with and without depression symptoms were reviewed. These included studies that 
employed non-clinical samples (i.e. older adults with high scores on depression 
measures but without a clinical diagnosis), as well as clinical samples.  
 
3.2.1. Non-Clinical Samples (see Table 2) 
Two studies (Latorre et al., 2013; Serrano et al., 2007) were conducted by the same 
research group. Serrano et al. (2007) found that OA with depression symptoms recalled 
more general memories than those without, but only for negative cues. There was no 
difference in specific memory recall. This indicates that the presence of OGM in OA 
with depression symptoms may be specific to negative memories, and occur due to 
increased generality rather than reduced specificity. The authors attribute this to 
rumination truncating the memory search at the general level. This is in line with 
findings that increased memory generality is associated with distress (Raes et al., 2006). 
Both groups showed a bias towards positive memories. However, those with depression 
symptoms retrieved signficantly more negative memories than those without, 
suggesting that depression is associated with a less pronounced ‘positivity bias’. 
Consistent with Serrano et al. (2007), Latorre et al. (2013) found that OA with high and 
low depression symptoms recalled more positive than negative memories. Both their 
groups were also slower to recall negative than positive memories. This further supports 
the ‘positivity bias’ and may indicate functional avoidance of specific negative 
memories. In contrast to Serrano et al. (2007), Latorre et al. (2013)’s high depression 
group produced fewer specific memories than the low depression group, with no 
signficant difference in general memory retrieval, indicating OGM through reduced 
specificity rather than increased generality. Although no relationship was found 
between depression scores and OGM, higher life satisfaction was associated with higher 
memory specificity. The authors therefore propose that high memory specificity may be 
protective against depression. A limitation of both Serrano et al. (2007) and Latorre et 
al. (2013), as well as other studies conducted by this research group, is that they altered 




Table 2: Cross-Sectional Studies- Older Adults with/without Depression Symptoms (Non-Clinical Populations) 
Study Location Sample Gender Ages Depression 
Measure 
OGM Measure Other Measures 
 
Gidron and Alon 
(2007) 



















and van der Leeden 
(2010) 




2. OA with no 
history of 






1. 15 male, 
48 female,  
 
 
















AMT Visual Analogue 
Mood Scale 
Latorre et al. (2013) Spain 1. OA with high 
depression 
symptoms (N= 33) 
 
2. OA with low 
depression 
symptoms (N= 33) 
 
 




 2. 12 male, 
21 female 
 













16 for group 
allocation 
 





Study Location Sample Gender Ages Depression 
Measure 
OGM Measure Other Measures 
 
Serrano, Latorre, and 
Gatz (2007) 








77 male, 108 
female 
 










general memory. This would be likely to reduce the scores obtained and limits the 
ability to compare the findings with other studies.  
 
To explore whether OGM is a ‘state’ or ‘trait’ marker for depression in OA, Haringsma 
et al. (2010) compared the AMT performance of OA with remitted depression 
symptoms to matched healthy OA. Participants were assessed pre and post a negative 
mood induction. No difference was found between groups in terms of memory 
specificity, and although the induction successfully induced a sad mood for both groups, 
the sad mood state did not influence OGM in either group. This suggests that OGM is 
not sensitive to current mood state in OA, nor is it a ‘trait’ marker of past depression. 
Haringsma et al. (2010) propose that the effects of normal ageing on OGM may 
override the detrimental effect of past depression, resulting in no observable difference 
between never-depressed and remitted-depressed OA. It is worth noting, however, that 
the ‘remitted depressed’ group were not a clinical sample initially, and prior to 
participating they had undergone an intervention for depression symptoms that included 
addressing rumination. Given the relationship between OGM and rumination proposed 
by the CaR-FA-X model, this intervention may have reduced OGM in Haringsma et al. 
(2010)’s  sample.  
 
In a study examining the ‘reminiscence bump’, Gidron and Alon (2007) used an 
adapted version of the AMT to cue for memories from different life periods. They found 
that specificity for memories from adolescence was negatively correlated with 
depression scores. OA who scored above cut-off for depression symptoms showed 
reduced specificity for childhood and adolescent memories compared to those below 
cut-off. This suggests that depression is associated with OGM for the ‘reminiscence 
bump’, which is commony found to have positively-biased recall. The authors are 
inconclusive about reasons for this: depression may make it harder to retrieve memories 
from adolescence, or difficulty retrieving memories from this period may be a risk 
factor for depression. Alternatively, both could be associated with a common factor 
such as adolescent hormone levels (Gidron & Alon, 2007). 
 
3.2.2. Clinical Samples (see Table 3) 
In the earliest study identified in this review, Fromholt et al. (1995) compared OA with 
first episode clinical depression, OA with dementia and healthy controls, in 
performance on a novel memory task. Participants were asked to talk freely for 15
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 Table 3: Cross-Sectional Studies- Older Adults with/without Depression (Clinical Populations) 
Study Location Sample Gender Ages Depression 
Measure 
OGM Measure Other Measures 
Birch and Davidson 
(2007) 
UK 1. OA with 
depression (N=17) 
 
2. OA without 
depression (N=17)  
 
1. 4 male, 13 
female 
 
2. 6 male, 11 
female 
 
1. 65+, M=71.5, 
SD=4.7 
 
2. 65+, M=73.9, 
SD= 5.1 
 














and Larsen (1995) 




2. OA with dementia 
(N=30) 
 
3. Healthy OA 
(N=30) 
 




2. 5 male, 25 
female  
 
3. 12 male, 
18 female 
 
1. 72-90, M= 
80.2, SD= 5.27 
 
 
2. 73-89, M= 
80.5, SD= 4.36 
 





















Ricarte et al. (2011) Spain 1. OA with 
depression (N=34) 
 
2. OA without 
depression (N=34) 
1. 5 male, 29 
female 
 
2. 7 male, 27 
female 
 
1. 65+, M= 74.59, 
SD=5.48  
 













minutes about “events that have been important in your life”. The number of memories, 
valence and level of detail was scored, along with the distribution across the lifespan. 
OA with depression recalled fewer, less detailed memories than controls, and performed 
no better than OA with dementia, suggesting that depression can be as detrimental to 
autobiographical recall as organic cognitive impairment. The group with depression also 
produced signficantly more memories from the recent past (during the episode of 
depression), and a larger proportion of negative memories for this time period than the 
other groups. The authors suggest that having depression may make it more difficult to 
retrieve earlier memories due to rumination on recent negative events. However, 
rumination was not measured in this study. Although interesting in terms of the effects 
of depressed mood on memory chronology and valence, the use of free recall and 
memory ‘detail’ as the only measure of specificity makes these findings difficult to 
compare with those from studies employing the AMT. 
Two studies (Birch & Davidson, 2007; Ricarte et al., 2011) have compared AMT 
performance between OA with clinical depression and healthy OA controls. Birch and 
Davidson (2007) looked at executive function in relation to OGM. OA with depression 
in Secondary Care recalled fewer specific memories than controls, but there were no 
significant differences in the number of general memories. This suggests that there is 
more pronounced OGM in depressed compared to non-depressed OA, due to reduced 
specificity rather than increased generality. For both groups combined, a positive 
relationship was found between specific memories and working memory, and a negative 
relationship between categoric memories and working memory. However, neither age 
nor depression score was related to OGM. These findings support the significant role of 
executive functioning in OGM, over and above the influences of age and depression. 
Interestingly however, no difference was found between groups in terms of cognitive 
functioning: depressed OA recalled fewer specific memories than controls despite 
having preserved working memory. The authors therefore propose an added role of self-
referrent rumination in depression that interrupts the memory search, although 
rumination was not explicitly measured. Ricarte et al. (2011) found that OA with 
depression in Primary Care recalled fewer specific memories and more extended 
memories than controls. In contrast with Birch and Davidson (2007), this suggests that 
OGM occurs due to both reduced specificity and increased generality. OA with 
depression also showed greater OGM in response to negative than positive cues, 
potentially indicating a functional avoidance of specific negative memories. Finally, 
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Ricarte et al. (2011) found that higher memory specificity was associated with increased 
life satisfaction and reduced hopelessness in their control group, suggesting that 
memory specificity could be protective  against depression. 
 
3.3. Longitudinal Studies(see Table 4) 
Two of the above studies additionally included longitudinal elements to their design, 
which can help to address the question as to whether OGM is a marker for vulnerability 
to depression in OA. To establish whether OGM was predictive of depressive relapse, 
Haringsma et al. (2010) followed up their OA with remitted depression at 14-17 
months. They found that baseline scores and responsiveness to mood induction on the 
AMT did not predict new depressive episodes or depression scores at follow-up. This 
suggests that OGM does not act as a marker for depression or predict relapse in OA, as 
it does in working age adults (e.g. Brittlebank et al., 1993).  However, as noted above, 
the sample of remitted depressed OA in this study was from a non-clinical population 
and had previously received an intervention that may have altered OGM.  
Fromholt et al. (1995) followed up their group with first episode depression at 6 months 
to re-assess depression and performance on the free narrative memory task. At follow 
up, those who had recovered from their depressive episode still tended to recall more 
memories from the recent past, however there was no longer a bias towards negative 
memories. This supports ‘state’ rather than ‘trait’ theories of the effects of depression on 
memory, as the negativity bias was lost on recovery. However, there was no change in 
the detail of the memories retrieved between baseline and follow-up, indicating that 
remission did not improve memory specificity and OGM could potentially be a ‘trait’ 
marker of depression in OA. It must be noted that the memory task administered in this 
study did not prompt participants for specific memories as in the AMT, therefore only 
limited conclusions can be made regarding OGM.  
 
3.4. Intervention Studies (see Table 5) 
In order to address the question as to whether improving memory specificity can 
effectively treat depression in OA, studies looking at OGM in the context of 
interventions for depression were reviewed. The majority of these studies focused on 
the use of therapeutic group interventions. However, one study measured memory 
specificity in the context of a medication trial. Gallassi et al. (2006) assigned OA with 
depression to receive one of two antidepressant therapies, and compared with matched
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Study Location Sample Gender Ages Depression 
Measure 
OGM Measure Other Measures 
Fromholt et al. 
(1995) 
Denmark OA with first episode 
depression (N=15) 
 
T1. Baseline (as 
above) 
T2. 6m follow-up 
 
2 male, 13 
female 















Haringsma et al. 
(2010) 
Netherlands OA with remitted 
depression (N=61) 
 












Table 5: Intervention Studies 
Study Location Sample Gender Ages Depression 
Measure 
OGM Measure Other Measures 
de Medeiros, Mosby, 
Hanley, Pedraza, and 
Brandt (2011) 
USA OA (non-clinical) 
 
1. Autobiographical 
Writing Group (N=18) 
 
2. Oral Reminiscence 
Group (N=18) 
 
3. Control Group 
(N=15) 
 
T1. Baseline  
T2. Post-intervention 





1. 7 male, 
11 female  
 
2. 6 male, 
12 female  
 





1. 67-88, M79.6, 
SD=6.1  
 
2. 71-96, M=81.5, 
SD=5.9 
 





























Gallassi, Di Sarro, 
Morreale, and 
Amore (2006) 
Italy 1. OA with depression 
(N=48), assigned to 
either  
a. Fluoxetine (N=24)  
b.Reboxetine (N=24)  
 
2. Matched Healthy 
OA (N=15).  
 
T1. Baseline  
T2. 6m of treatment 
 
 






 2. 6 male, 
9 female. 
 



































Study Location Sample Gender Ages Depression 
Measure 




Portugal OA with depression 
symptoms  
 

















4 for study 
inclusion 
 






Spain OA  
 
















1. 10 male, 
16 female  
 
 




















Study Location Sample Gender Ages Depression 
Measure 
OGM Measure Other Measures 
Serrano, Latorre, 
Gatz, and Montanes 
(2004) 
Spain OA with depression 
symptoms  
 





























Serrano Selva et al. 
(2012) 
Spain OA with depression  
 




2. Placebo Group 
(N=19) 
 
T1. Baseline  
T2. Post-intervention 
T3. 6 week follow-up 
T4. 6m follow-up. 
 




















controls. Participants were assessed for depression symptoms and cognitive 
performance at baseline and at 6 months post treatment. Measures included an 
autobiographical memory task in which participants were asked to recall memories from 
different life periods. Memories were scored for content and level of detail. At baseline, 
OA with depression showed poorer performance on the autobiographical memory task 
and on working memory tasks. Following treatment, those in remission from depression 
showed improvements in autobiographical memory and working memory. These 
findings suggest that depression in OA affects various aspects of memory, including the 
specificity of autobiographical memory, and that much of this impairment is related to 
the depressed state and improves on remission. However, performance of the remitted 
participants remained signficantly worse than controls, suggesting residual 
autobiographical memory problems that might indicate a depressive ‘trait’.  It must be 
noted that OGM was not the primary focus of this trial, which looked at various 
cognitive factors. As such, the autobiographical memory task is only briefly described 
and it is difficult to ascertain to what extent this provides a comparable measure of 
OGM. 
de Medeiros et al. (2011) randomly assigned their community sample to either an 
autobiographical writing intervention, an oral reminiscence intervention, or an inactive 
control group. Paticipants were assessed pre and post-intervention and at 6 month 
follow-up using measures of autobiographical memory, depression and wellbeing. 
Compared to the control group, neither intervention led to significant improvements in 
recall for specific autobiographical incidents, memory detail, or depression score. 
However, while the interventions involved recalling autobiographical memories, they 
did not explicitly target memory specificity. Additonally, the authors note that the 
autobiographical memory tasks they used are usually used with people with cognitive 
impairment, therefore may not have been sensitive enough to detect change in a non-
clinical sample (de Medeiros et al., 2011).  
In a study using the AMT, Ramirez et al. (2014) allocated their OA community sample 
to either a Life Review intervention focused on memory specificity, gratitude and 
forgiveness, or a placebo group which focused on more general early life memories. 
Participants were assessed pre and post intervention and 4 month follow-up using the 
AMT, measures of depression and wellbeing. A significant reduction in depression and 
an increase in life satisfaction and happiness was found following the Life Review 
intervention, but not in the placebo group. There was also a significant increase in 
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specific memory retrieval in the intervention group, but not placebo group. This 
suggests that a Life review intervention explicitly focused on memory specificity can 
improve OGM and mood in OA post-intervention. However, the gains found following 
the intervention were not maintained at follow-up. The authors also did not explicitly 
look at the relationship between change in depression score and change in OGM, 
therefore it cannot be inferred whether the increased memory specificity led to 
improvements in mood. As the intervention targeted 'gratitude' and 'forgiveness' as well 
as memory specificity, it is not possible to separate which part was helpful. 
 
Goncalves et al. (2009) allocated OA with depressive symptoms to either a Life Review 
intervention, or inactive control group. Participants were assessed pre and post 
intervention using the AMT and measures of depression and life satisfaction. They 
found that both the intervention and control groups demonstrated an increase in specific 
and positive memories on the AMT, however this was only significant in the 
intervention group. There were also greater improvements in depression & life 
satisfaction scores in the intervention group. This supports the use of Life Review to 
increase memory specificity and improve depression symptoms. However, the 
conclusions that can be drawn are limited due to the lack of an active control group and 
follow-up period. This study also employed a very small sample and does not report the 
demographics of the two groups separately. Further, the results section of this article 
was appraised as being particularly poor in quality. Only the data for significant 
findings are provided, meaning that the reader cannot draw conclusions regarding the 
magnitude of the differences between the Life Review and control groups.  
 
The final two studies were conducted by the same research group, Serrano and 
colleagues. Serrano et al. (2004) allocated OA with depression symptoms to a Life 
Review intervention or inactive control group. Participants were assessed pre and post 
intervention using the AMT, depression, hopelessness and life satisfaction measures. 
Consistent with Goncalves et al. (2009), a significant reduction in depression and 
hopelessness and an increase in life satisfaction was found following intervention, but 
not in the control group. A significant increase in specific memories was found in the 
intervention group, and Serrano et al. (2004) also looked at the relationship between 
changes in OGM and depression scores. They found that change in memory specificity 
was a significant predictor of post-intervention hopelessness and life-satisfaction (and 
nearly significant for depression), when controlling for baseline scores. Although the 
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direction of the relationship cannot be concluded, this finding supports the relationship 
between improved memory specificty and improved mood. Serrano Selva et al. (2012) 
addressed methodological limitations of the group’s earlier trial by employing a clinical 
sample, an active control of supportive therapy, and follow-ups at 6 weeks and 6 
months. Participants randomised to receive the Life Review intervention did not 
improve any more than the control group in terms of depression score, hopeless or life 
satisfaction. However, in the intervention group, there was an increase over time in 
specific memories and this was associated with improved depression scores. These 
changes were maintained on follow up. Those who produced more specific memories 
decreased depression scores at a faster rate, suggesting that increased memory 
specificity may be a mechanism for improvement in depression. Overall, the findings of 
Serrano and colleagues indicate that Life Review can successfully increase memory 
specificity and that this is associated with improvements in mood and wellbeing. 
However, Life Review may not be more successful than other forms of therapy at 
improving depression symptoms.  
 
3.5. Methodological Limitations 
Some general limitations of the reviewed literature are important to note. The majority 
of the studies employed small sample sizes, limiting their statistical power and 
generalisability. The studies were variable as to whether clinical populations were used 
and how these were defined. In some instances, the demographics of the sample, or 
groups within the sample, were not fully described. Additionally, many of the studies 
did not state whether the mental health history of the participants was screened, 
therefore it cannot be known whether the sample included individuals with difficulties 
apart from depression (e.g. PTSD), which might influence OGM. The inclusion or 
exclusion of participants on antidepressant medications also varied between studies, 
which could contribute to variability in the findings. 
 
It was notable that seven of the eighteen reviewed studies were published by the same 
Spanish research group (Serrano, Latorre, Ricarte, Ros and colleagues). Again, this 
limits the generalisability of the conclusions drawn as it is not clear to what extent these 
findings will replicate by different researchers and in different cultural groups.  
 
Although the AMT was used to assess OGM in the majority of studies, some used other 
methods that limit the ability to compare findings. Among those that did use the AMT, 
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the exact procedure was not always clearly described, and the descriptions indicated 
variations in task administration. For example, some researchers did not prompt 
participants if they initially retrieved a general memory (e.g. Serrano and colleagues) 
which would likely lower memory specificity score, whereas others provided prompts 
and scored participants’ final responses (e.g. Holland et al., 2012) which would likely 
increase specificity score.  This variability means that it is not feasible to directly 
compare the data from different studies. 
 
4. Discussion 
The current review aimed to establish what is currently known about OGM in relation 
to depression in older adults, and to identify potential clinical and research implications 
emerging from this field of research.  
 
4.1. Older Adults and OGM 
The findings from studies comparing healthy older and younger adults provide evidence 
that, in the absence of depression, older adults have increased OGM compared to 
younger adults. The evidence also indicates that at least part of this effect is due to age-
related declines in executive functioning, with both working memory (Ros et al., 2010) 
and ‘updating’ of the memory search (Holland et al., 2012) identified as possible 
mechanisms. This further supports the role of reduced executive function capacity in 
OGM, as proposed by the CaR-FA-X model (Williams, 2006; Williams et al., 2007), 
and suggests this element of the model is especially relevant to older adults.  
Executive function problems alone cannot account for the OGM effect in older adults, 
however, as there are findings that OGM occurs in the absence of working memory 
deficits (or depression; Ford et al., 2014) and that memory specificity to emotional cues 
is preserved in the presence of reduced working memory (Holland et al., 2012). To 
account for this, Ford et al. (2014) point to a possible age-related tendency to 
incorporate memories into a single life narrative, leading to overgeneral recall. The 
retrieval of specific memories that are emotionally-valenced (Holland et al., 2012) and 
self-referrent (Martinelli et al., 2013) appears relatively preserved in healthy older 
adults. Therefore, it may be that memories that are highly related to older adults’ 
integrated self-concept are retrieved more automatically than less self-referrent 
memories, overcoming age-related declines in executive function.  
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The evidence reviewed in healthy older adults is consistent with the concept of a  
‘positivity bias’ in autobiographical memory, with findings that older adults retrieve 
fewer specific negative memories than younger adults (Ros & Latorre, 2010) and that a 
positive self-concept improves retrieval for specific positive memories (Martinelli et al., 
2013). This also supports the idea that OGM in the form of reduced memory specificity 
to negative events might be beneficial to wellbeing (Raes et al., 2006). 
 
4.2. Older Adults, Depression and OGM 
The findings from studies comparing healthy older adults to those with clinical or non-
clinical depression suggest, with one exception (Haringsma et al., 2010), that depression 
is associated with increased OGM in older adults as it is in working age adults. 
However, the literature does not agree as to whether this occurs due to increased 
memory generality (Serrano et al., 2007), reduced specificity (Birch & Davidson, 2007; 
Latorre et al., 2013), or a combination of both (Ricarte et al., 2011). In line with the 
association between OGM and depression, there is evidence that having higher memory 
specificity is associated with increased well-being in older adults (Latorre et al., 2013; 
Ricarte et al., 2011) and may therefore be protective against depression.  
As well as contributing to OGM, depression appears to slow down older adults’ 
memory search (Latorre et al., 2013; Serrano et al., 2007), which could be a result of 
reduced working memory capacity. The evidence from Birch and Davidson (2007) 
further supports the importance of working memory in relation to OGM suggested by 
the CaR-FA-X model, and indicates that this has an effect on OGM that is independent 
of depression or age. However, increased OGM was found to occur in older adults with 
depression in the absence of signficant working memory impairment (Birch & 
Davidson, 2007), suggesting that OGM in this client group cannot be solely attributed to 
mood-related impairments in executive functioning. OGM has been found to be most 
pronounced in response to negative memory cues, (Ricarte et al., 2011; Serrano et al., 
2007). In line with the CaR-FA-X model (Williams, 2006; Williams et al., 2007) , it is 
possible that older adults with depression ruminate on negative self-referent 
information, disrupting specific memory retrieval, or that there is avoidance of specific 
negative memories as an emotional regulation strategy. However, as none of the studies 
reviewed have formally assessed rumination or emotional regulation, the role that these 




In contrast to findings in working age adults that suggest OGM is a stable ‘trait’ marker 
for depression (e.g. Brittlebank et al., 1993), OGM does not appear to remain stable on 
remission from depression, to respond to negative mood states, or predict depressive 
relapse in older adults (Haringsma et al., 2010). However, these factors have been 
investigated by only one study, which had notable limitations in terms of sample 
recruitment. By comparison, Fromholt et al. (1995) found that recalling low levels of 
memory detail remained stable on remission from depression. Further longitudinal 
research in clinical samples would be needed to further investigate the stability of OGM 
over time in older adults with depression. 
In terms of older adult memory phenomena, there is evidence that older adults with 
depression lose the ‘reminiscence bump’ of enhanced recall for adolescent events 
(Gidron & Alon, 2007), and that the ‘positivity bias’ usually observed in memory 
retrieval is diminished (Latorre et al., 2013; Serrano et al., 2007). Older adults with 
depression may instead demonstrate a bias towards recalling more recent, negative 
events (Fromholt et al., 1995). Whether these apparent differences are a cause of, or a 
consequence of, depression in older adults cannot be determined from the existing 
findings and would require further longitudinal research.  
 
4.3. Clinical Implications 
Studies of Life Review interventions support the use of this approach as a way to 
improve memory specificity, depression symptoms and wellbeing in older adults. 
However, the only adequately controlled trial in a clinical sample (Serrano Selva et al., 
2012) did not find any significant benefit of Life Review over supportive therapy in 
terms of depression outcome. Additionally, the finding that autobiographical memory 
improves on remission of depression through antidepressant treatment (Gallassi et al., 
2006) suggests that OGM may improve as a consequence of reduced depressive 
symptoms, rather than improvements in OGM leading to reductions in depression. 
Intervening by targeting OGM in older adults therefore does not appear necessary to 
reduce depression. However, the limited evidence to date suggests that increasing 
memory specificity may be one mechanism through which depression can be improved 
in this client group. This is in line with findings in the general adult literature that 
interventions targeting memory specificity, such as MEST, can improve both memory 




4.4.  Limitations 
The inclusion criteria for this review were kept broad due to the relatively low numbers 
of available articles. As a result, there was great heterogeneity in the studies reviewed in 
terms of the methodology, quality and samples. Although the literature searches were 
conducted using a systematic procedure, the current review does not claim to be 
exhaustive and due to resources available it did not include a search of the grey 
literature. The definition of the ‘older adult’ population as 50 years and over is a 
particular limitation. It was initially intended to define the population as 65 years and 
over, in line with the commonly accepted criteria for older adult mental health services. 
However from an initial screen of the search results, it was clear that this would leave 
few articles and exclude many of theoretical interest.  
 
4.5. Recommendations for Future Research 
This review has highlighted some limitations and gaps in the existing literature on OGM 
in older adults, which suggest directions for future research. 
In terms of methodological issues, researchers looking at OGM in older adults need to 
adopt standardised procedures for administering the AMT to allow comparison between 
studies. This would also faciliate future systematic and meta-analytic review. When 
isolating the relationship between depression and OGM, it is also important to ensure 
that other problems that might influence OGM (e.g. cognitive impairment, PTSD and 
antidepressant medications) are adequately screened and controlled for.  
It was notable that few of the reviewed papers (Ford et al., 2014; Ricarte et al., 2011; 
Ros et al., 2010) cited the CaR-FA-X model, despite the dominance of this theoretical 
framework in the wider OGM literature. Research is needed to look more explicitly at 
different factors of the CaR-FA-X model, especially rumination and functional 
avoidance, to establish the contributions these make to OGM in this client group. There 
is a substantial line of research into rumination and repetitive thinking (see Watkins, 
2008), and this is leading to the development of interventions for depression such as 
Rumination-focused Cognitive Behavioural Therapy (RF-CBT; Watkins et al., 2011) 
and Competitive Memory Training (COMET), which has shown positive outcomes in 
older adults (Ekkers, 2011). Establishing the relationship between rumination and OGM 
in older adults would enable more joined-up thinking around clinical approaches. 
Further longitudinal research would also be beneficial in order to establish whether 
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OGM is a stable ‘trait’ marker of depression in older adults, and whether OGM can 
predict depressive relapse in this group. 
Finally, there is a need for further clinical trials to help draw firmer conclusions 
regarding the efficacy and mechanisms of action of Life Review interventions. Ideally, 
trials are needed on a larger scale and with more in-depth analysis of mediating factors. 
In progressing this research, it would also seem beneficial to draw on the literature on 
memory specificity interventions being developed in the wider research, such as MEST. 
Although the two lines of research appear to have evolved separately, they have 
converged on similar conclusions around the potential benefits of increasing memory 
specificity as an intervention for depression.   
 
4.6. Summary and Conclusion 
This evaluative review provides a synthesis of what is currently known about OGM and 
depression in older adults, using the CaR-FA-X model (Williams, 2006; Williams et al., 
2007) as a theoretical framework.  
Clear evidence was found that OGM occurs in older adults in the absence of depression, 
due partly to changes in executive functioning associated with healthy aging. There is 
also suggestion that OGM in healthy older adults reflects a tendency to integrate 
memories in terms of self-relevance and a bias against retrieval of specific negative 
memories. In this respect, OGM in older adults could be considered beneficial to 
wellbeing in some circumstances, rather than a marker of emotional distress. However, 
in line with the literature in younger adults, there was strong evidence that the presence 
of depression in older adults increases OGM. This appears due in part to the effects of 
depressed mood on executive functioning, as well as possible changes in the 
relationship individuals with depression have to negative memories. However, the role 
of rumination and functional avoidance mechanisms in OGM in older adults has not 
been adequately investigated. It is also unclear to what extent OGM acts as a marker for 
recurrent depression in older adults and further research is needed.  
In terms of clinical implications, there is some support for the use of Life Review 
interventions for increasing memory specificity and improving depression symptoms. It 
would be logical for future research in this area to draw on developments in 
interventions in the working age adult literature and rumination literature. There appears 
38 
  
still to be some way to go in developing our understanding of OGM in the older adult 
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Palliative care is an approach to the treatment of terminal and life-limiting illnesses, 
which emphasises quality of life and the relief of suffering (World Health Organisation, 
2002). Hospices in the UK currently provide palliative care to around 120,000 patients 
each year (Hospice UK, 2015). Approximately 4% of all deaths annually occur in a 
hospice setting; patients most likely to receive end-of-life care from a hospice are those 
aged between 45-64, and those with a cancer diagnosis (Department of Health, 2008). 
The distress and suffering experienced by patients who are approaching the end of life is 
multidimensional. Alongside pain and other physical symptoms, suffering may be 
related to psychological factors such as depression or anxiety, spiritual and existential 
factors such as a loss of identity and meaning, and social factors such as the impact of 
illness on the family (Krikorian, Limonero, & Mate, 2012). Estimates of the prevalence 
of psychological distress in palliative care settings vary widely (Walker et al., 2013); 
however one meta-analysis suggests a prevalence of 16.5% for depression, 15.4% for 
adjustment disorders, and 9.8% for anxiety disorders (Mitchell et al., 2011). The 
presence of co-morbid depression has a substantial negative impact on health outcomes 
in various chronic illnesses (Moussavi et al., 2007), and psychological distress has been 
found to mediate the relationship between physical symptom severity and subjective 
suffering in advanced cancer (Krikorian, Limonero, Roman, Vargas, & Palacio, 2013). 
In order to provide effective palliative care and relieve suffering, it is therefore essential 
to address more than a patient’s physical health needs.  
There has been increasing attention paid to the provision of psychological support in 
cancer and palliative care services in national guidelines over the past decade. The 
NICE guidance on Improving Supportive and Palliative Care for Adults with Cancer 
(2004) made the following recommendations: 
 Psychological wellbeing of patients and carers should be explicitly assessed at 
key points in treatment.  
 All staff involved in direct patient care should provide basic emotional support, 
including good communication skills.  
 Any patients or carers identified as experiencing high psychological distress 
should be able to access specialist intervention.  
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 All staff providing psychological support should be adequately trained and 
supervised.  
 
The NICE guidance recommends developing services that provide a 4-Level model of 
psychological support. The forms of assessment and intervention provided at each level, 
and the staff groups involved in delivery, are outlined in Table 6. 
Table 6: Four Level model of psychological support in cancer services (NICE, 2004) 
Level Group Assessment Intervention 








communication and general 
psychological support 
















and diagnosis of some 
psychopathology 
 
Counselling and specific 
psychological interventions 
such as anxiety 
management and solution-
focused therapy, delivered 
according to an explicit 
theoretical framework 





Specialist psychological and 
psychiatric interventions 
such as psychotherapy, 
including cognitive 
behavioural therapy  
 
The National Cancer Action Team’s (NCAT’s) Psychological Support Measures (2010) 
built on the NICE guidance, recommending specific measures for implementing best 
practice in the planning and evaluation of services. The recommendations include that 
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staff providing Level 2 support should attend a National Advanced Communication 
Skills Training (ACST) course, as well as a regionally developed course in Level 2 
psychological skills. The Level 2 course may include training in psychological 
screening, assessment, and interventions based on Cognitive Behavioural Therapy 
(CBT) and other therapeutic approaches. The measures also advise that staff working at 
Level 2 receive regular supervision from a Level 3 or 4 practitioner; these practitioners 
therefore have a central role in providing training and supervision to other staff, as well 
as delivering specialist interventions through direct clinical work. *NCAT (2010) 
moved away from Level 4 being concerned with ‘diagnosis of psychopathology’, 
defining Level 4 as a degree of psychological screening, intervention and support that 
requires the skill-set of a clinical or counselling psychologist or consultant psychiatrist. 
 
The ACST programme has been demonstrated to significantly improve staff confidence 
in communicating sensitive information in palliative care settings (Wilkinson, Perry, 
Blanchard, & Linsell, 2008). There is also evidence that CBT-based interventions 
delivered by non-psychologist professionals who have received brief training, are an 
effective intervention for anxiety and depression in palliative care (Anderson, Watson, 
& Davidson, 2008; Moorey et al., 2009). Mannix et al. (2006) found that, following 
brief CBT training, ongoing supervision was essential for staff to maintain their skills 
and confidence.  These findings suggest that effective psychological support can be 
provided by palliative care professionals from non-psychology disciplines, when 
appropriate training and support are in place. The findings also have important 
implications for the role of Clinical Psychologists as Level 4 practitioners; to use their 
specialist knowledge to provide appropriate training and supervision to other staff.  
 
Current Project 
The purpose of the current project was to examine the psychological services being 
provided at a hospice in the South West of England. The hospice is a third sector 
organisation providing end-of-life care to people with cancer and other serious health 
conditions, and has an annual caseload of approximately 2000 patients. Since 2009, the 
hospice has employed a Clinical Psychologist for one day per week (0.2wte) to provide 




The aims of the current project were: 
1. To examine the psychological support being provided by staff at the hospice, in 
relation to NICE and NCAT recommendations. 
2. To evaluate the Clinical Psychology service at the hospice, from the perspective 
of other staff. 
3. To explore how other staff groups view the role of the Clinical Psychologist.  
4. To provide recommendations to the hospice to inform the future development of 
psychological service provision. 
 
Specific questions that the project aimed to address were: 
1. How does the psychological support provided at the hospice map onto national 
recommendations from NICE and NCAT? 
2. How confident do staff members feel at providing psychological support, and 
does training attendance increase confidence? 
3. What barriers could be addressed to improve the psychological support provided 
at the hospice? 
4. How satisfied are other staff groups with the current Clinical Psychology 
service? 






A range of methods were selected in order to address the project questions. To examine 
how the psychological support provided at the Hospice maps onto national 
recommendations (Question 1), data was collected from Clinical Psychology service 
records about the activity being conducted at Level 4, including provision of training 
and support to other staff. A staff survey was also designed, with two sections. Section 
A was designed to gather information from staff concerning service provision at Levels 
1, 2 and 3. This included asking about the psychological support being provided by staff 
members and the training and supervision they had received in relation to national 
recommendations (Question 1), as well as their confidence (Question 2), and perceived 
barriers (Question 3). Section B was designed to seek feedback on different aspects of 
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the service provided by the Clinical Psychologist (Question 4), and the staff member’s 
perception of the Clinical Psychologist’s role (Question 5). The survey method was 
chosen in order to try and gain views from as many staff as possible. Advantages of this 
method were that staff members could complete the questionnaires in their own time 
and could be assured confidentiality, which it was felt would encourage open responses 
(Barker, Pistrang, & Elliot, 2002).  
 
Following analysis of the survey data, it was then planned to conduct focus groups to 
further explore staff perceptions of the Clinical Psychologist’s role (Question 5), as well 
as to generate ideas for recommendations that might help to improve psychological 
service provision at the Hospice. A semi-structured qualitative interviewing format was 
selected in order to gain an in-depth account of the issues being explored, and the group 
format was selected to encourage participants to respond to each other’s’ ideas and 
generate a deeper exploration (Barker et al., 2002). However, if staff members were 
unable to attend a focus group for practical reasons, an individual semi-structured 
interview was arranged.  
 
 
1. Clinical Psychology Service data 
 
Data was collected from Clinical Psychology records concerning activity during the 
2013/14 financial year. This included direct clinical work provided to patients and 
carers, and indirect services provided to staff.  
 
2. Staff Survey 
 
2.1.  Participants: All hospice staff with clinical responsibility (approximately 82 
permanent and 57 bank staff) were invited to complete a survey about 
psychological service provision at the hospice. Twenty-eight responses were 
received, a response rate of 20% of all permanent and bank staff. The teams and 
professions of the respondents, compared with total permanent staff numbers as 





Table 7: Professional backgrounds and team affiliations of survey respondents, 
compared with total staff numbers 
 Respondents Total Permanent Staff 
Team 
Inpatient Unit 12  42  
Clinical Nurse Specialists 5  18  
Family Support Team  5  6  
Therapy Service 4  6  
Day Hospice 3  4  





Registered Nurse 10  34  
Clinical Nurse Specialist 5  18  
Medic
2
 4  2  
Occupational Therapist 3  4  
Social Worker 3  3  
Physiotherapist 1  2  
Dietician 1  0  
Health Care / Nursing / 
Social Work Assistants  
1  19  
Total 28 82 
1




medics included Trainee General Practitioners who were not permanent staff 
 
 
2.2. Materials: The survey was developed by the lead researcher and the Clinical 
Psychologist, in consultation with five randomly selected staff members from 
different professions. The survey included tick-box options and Likert-scale 
responses providing quantitative data, as well as free-text questions providing 
qualitative data. Items for Section A of the survey were informed by referring to 
the NICE (2004) and NCAT (2010) guidelines around the training, support and 
competencies expected for staff working at different levels. Items for Section B 
of the survey were informed by previous service evaluations, for example 
looking at referrals to clinical psychology in Hospice settings (Alexander, 2004) 
and at other professionals’ perceptions of clinical psychology services in health 
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settings (Abrahams & Udwin, 2002; Olson et al., 1988). See Appendix B for a 
copy of the survey. 
 
2.3. Procedure: Survey responses were collected between September and 
December 2013. Staff members were informed of the survey through internal 
communications and meetings arranged with team leaders. Respondents were 
assured that their responses would be confidential. 
 
2.4. Analysis: For analysis of the quantitative data, non-parametric statistics were 
used throughout due to the data being at the ordinal level. An inductive 
thematic analysis was used to analyse the qualitative responses (Braun & 
Clarke, 2006); this was performed on the data set as a whole, as responses did 
not always relate exclusively to the question asked. The data were coded and 
the codes grouped into provisional themes by the lead researcher using NVivo 




3. Focus Group and Interviews 
 
3.1. Participants: Fifteen survey respondents indicated that they would be 
interested in a follow-up interview, and were contacted during May 2014. 
Seven agreed to participate. One focus group (n=5) was conducted with 
members of the Family Support Team and Therapy Service. Individual 
interviews were conducted with a Clinical Nurse Specialist and an Inpatient 
nurse, who were unable to attend the focus group.  
 
3.2. Materials: Following preliminary analysis of the survey data, a schedule of 
open-ended questions was developed to elaborate on themes that had emerged 
(see Figure 1). These questions were used to initiate and structure the focus 
group/interview discussions. 
 
3.3. Procedure: The focus group and interviews were conducted in a semi-
structured format by the lead researcher, and were video recorded with consent 
for transcription purposes. Transcription was completed by the lead researcher 
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and transcripts were anonymised by removing potentially identifying 
information. 
 
Figure 1: Questions used to structure focus group and interviews 
 
3.4. Analysis: Inductive thematic analysis was conducted on the combined data 
from the focus group and two individual interviews (Braun & Clarke, 2006). 
Transcripts were coded and the codes grouped into provisional themes by the 
lead researcher using NVivo (QSR International, 2012). A second researcher 
independently reviewed the transcripts and identified provisional themes, which 
were then discussed and refined. The data was then reviewed again by the lead 
researcher in relation to the agreed themes, and grouped into the final themes 
and sub-themes. Throughout the analysis process, the lead researcher 
recognised her position as a Clinical Psychologist in training who was 
supervised by the Clinical Psychologist at the hospice, and who therefore might 





Clinical Psychology Service data 
The direct and indirect activity carried out by the Clinical Psychology service during the 
2013/14 financial year is summarised below. 
Direct Activity 
 If there was more Clinical Psychology time available at the Hospice, how 
could this best be used? 
 
 What do you think are the responsibilities of the Clinical Psychologist in 
providing psychological support to patient and carers, and what do you 
think are the responsibilities of other staff? 
 
 What could be done to help to build staff skills and confidence in providing 
psychological support? 
 





 64 referrals received 
 46 new patients seen 
 115 filled clinical appointments  
 
Indirect Activity 
 31 consultations  
 46 supervision slots 
 30 teaching hours 
 
Survey 
The survey data are presented below under the relevant research questions. Seven 
overarching themes were identified through the qualitative analysis; these are presented 
in summary under the relevant research question.  
 
1. How does the psychological support provided at the hospice map onto national 
recommendations from NICE and NCAT? 
 
1.1. Provision of psychological support at the 4 NICE Levels 
All respondents saw providing psychological support as part of their role. Of 27 
responses, 12 (44%) identified working at Level 1, and 15 (56%) identified working 
at Level 2. No respondents felt they were working at Level 3, however 7 (26%) felt 
they could potentially work at Level 3. 
1.2. Attendance at NCAT recommended training courses 
According to hospice records, 8 nurses had attended ACST and 16 staff members 
had attended Level 2 Psychology Skills training at the time of the survey. 
Attendance rates for survey respondents are shown in Table 8.   
Table 8: Attendance at recommended training courses 
 N ACST Level 2 
Psychology Skills  
Both 
All Respondents 27 6 (22%) 6 (22%) 3 (11%) 




Reasons given for non-attendance were: not being offered the opportunity (n=8), 
lack of course availability (n=3), being unaware of the courses (n=3), having 
equivalent training (n=3), and being new in post (n=3). Eight respondents identified 
working at Level 2 but had attended neither course; these included professionals 
who may have had equivalent training. 
1.3. Attendance at supervision with a Level 3 or 4 Practitioner 
Four of the 6 staff who had attended ACST (67%), and 5 of the 6 staff who had 
attended Level 2 Psychology Skills (83%), were accessing regular group supervision 
from the Clinical Psychologist. Of the staff who identified working at Level 2, 10 
(67%) attended group supervision. 
 
2. How confident do staff members feel at providing psychological support, and does 
training attendance increase confidence? 
 
2.1. Confidence Levels 
Respondents rated their level of confidence with six aspect of providing 
psychological support. Items were rated from 1 to 5, a higher score indicating 
greater confidence.  Table 9 summarises these responses.  
Table 9: Median staff confidence levels in providing psychological support 
Aspect of Psychological Support N Median  Range 
Recognising distress 28 4 3 to 5 
Providing supportive listening 28 4 3 to 5 
Communicating sensitive information 28 5 3 to 5 
Assessing/screening for psychological distress 28 4 1 to 5 
Using psychological techniques (e.g. problem-solving) 28 4 1 to 5 
Recognising when onward referral is needed 28 4 1 to 5 
 
Generally high levels of confidence were reported. Some staff gave low ratings for 
assessing distress and using psychological techniques; however, not all staff used 
these skills in their role. Significant positive correlations were found between the 
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frequency with which respondents performed assessments and their confidence in 
doing so (Spearman’s r=0.406, p<.05), and the frequency with which they used 
psychological techniques and their confidence in doing so (Spearman’s r=0.477, 
p<.05). Those who used these skills regularly reported greater confidence. 
2.2. Confidence and Training Attendance 
Using independent-samples Mann-Whitney U tests, confidence ratings for each of 
the six aspects of psychological support were compared between those who had 
attended recommended training courses and those who had not. No significant 
differences were found between those who had attended ACST (n=6) and those who 
had not (n=21), or between those who had attended Level 2 Psychology Skills (n=6) 
and those who had not (n=21; all p values >.05). As these courses primarily target 
nurses, the analyses were repeated using data from nurses only. No significant 
differences were found between nurses who had attended ACST (n=5) and those 
who had not (n=9), or between nurses who had attended Level 2 Psychology Skills 
(n=3) and those who had not (n=11; all p values >.05). It is important to note the 
very small sample sizes used in these analyses, which limits the conclusions that can 
be drawn.  
 
3. What barriers could be addressed to improve the psychological support provided 
at the hospice? 
 
3.1. Qualitative Theme 1: Barriers to providing Psychological Support 
Within this theme, five sub-themes were identified: Knowledge and Confidence (26 
references), Space (15 references), Environment (11 references), Time (10 
references) and Resources (9 references). 
A lack of knowledge and confidence was the most frequently expressed barrier and 
many staff reported a desire for further training. Staff identified a lack of knowledge 
as to how to identify and screen for psychological distress, and a lack of confidence 
in their ability to provide support: 
“I feel that my patients would benefit it I was able to establish psychological 
distress, as sometimes I care for people who are obviously in some difficulties 
but I do not know how to proceed.” (Respondent 5) 
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Some respondents indicated that they had knowledge and skills that were being 
underutilised in their role: 
“…there are a few staff…including myself who have qualifications in 
counselling. I would like my skills to be utilised better and to be given the 
opportunity to use them more.” (Respondent 24) 
Practical barriers were described, including a shortage of private spaces, distractions 
and interruptions, time constraints, and the pressures of meeting patients’ medical 
needs: 
“There are times when no quiet room is available to use to have these 
conversations.” (Respondent 27) 
“I feel IPU staff could help patients with psychological needs if there was more 
time (uninterrupted) to do this.” (Respondent 3) 
Finally, there were references to the need for more written resources relating to 
psychological support: 
“Literature would be a great idea for practitioners to give to patients/carers and 
to use with patients.” (Respondent 14) 
 
4. How satisfied are other staff groups with the current Clinical Psychology service? 
Respondents rated their satisfaction with various aspects of the Clinical Psychology 
service. Ratings were given only by respondents who had made use of each service. 
Median ratings were predominantly 4 (‘satisfied’) or 5 (‘very satisfied’). Table 10 
summarises these findings, and further data relating to referrals, consultation, 
supervision and training are presented below. 
Table 10: Staff satisfaction with services provided by the Clinical Psychologist 
Clinical Psychology Service N Median Range 
Referral Process 20 4 2 to 5 
Written feedback on referrals 20 4 2 to 5 
Verbal feedback on referrals 20 4 2 to 5 
Consultation  18 5 2 to 5 
Supervision 12 5 4 to 5 
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In-service training quality 11 4 2 to 5 
In-service training availability 22 3 2 to 5 
 
4.1. Referrals 
Respondents were asked to indicate the reasons for which they had referred to Clinical 
Psychology; responses are shown in Figure 2. Respondents were also asked whether 
they referred all patients or carers who they thought might require Level 3 or 4 input: 13 
(65%) said yes and 7 (35%) said no. Reasons for not referring were identified in the 
thematic analysis (see 4.1.1.). 
 
Figure 2: Reasons for referral to Clinical Psychology 
 
4.1.1. Qualitative Theme 2: Access to Clinical Psychology 
This theme comprised of four subthemes: Waiting Times (16 references), 
Process Issues (8 references), Patient Choice (6 references) and Access for 
Outpatients (5 references). 
Respondents highlighted that the Clinical Psychology service had limited 
availability and this could result in long waiting times. This was given as a 
reason for not referring, particularly when patients are very unwell:  
“Sometimes they are too poorly by the time [the Clinical Psychologist is 



























Comments made in relation to the Clinical Psychology referral process included 
that completing the referral form was time consuming, that there was a lack of 
clarity around appropriate referrals, and that feedback was not always received. 
 
It was felt that Clinical Psychology was less accessible for outpatients due to the 
need to travel. Again, this was given as a reason for not referring patients who 
might benefit: 
“Needing to come to [the Hospice] rather than home visit.” (Respondent 
9) 
Some respondents noted that they might not refer due to patient choice: 
“[I] discuss with patients first so may not refer all. Depends on what 
they want.” (Respondent 24) 
 
4.2. Consultation 
Of 18 respondents, 1 indicated that they sought consultation from the Clinical 
Psychologist weekly, 3 ‘twice per month’, 6 ‘once per month’, and 8 ‘less than once 
per month’.  
 
4.3. Supervision 
Twelve respondents (43%) indicated that they attended a supervision group with the 
Clinical Psychologist on a monthly or six-weekly basis. 
4.3.1. Qualitative Theme 3: Supervision with the Clinical Psychologist 
This theme comprised of two subthemes: Barriers to Supervision (11 references) 
and Positive Feedback (4 references).  
 
In line with the quantitative feedback, positive comments were made regarding 
the quality of supervision with the Clinical Psychologist: 
“I feel [supervision] works very well.” (Respondent 2)   
 
However, respondents raised some barriers to attending, such as a lack of other 
staff available to provide cover: 
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Twelve respondents (43%) had attended at least one in-service training event 
provided by the Clinical Psychology service. 
4.4.1. Qualitative Theme 4: In-Service Training 
This theme comprised two subthemes: Requests for Training (16 references) and 
Barriers to Training (13 references). 
A desire was clearly expressed for more psychological training generally, 
including repeating past sessions for new staff: 
“None of the [training topics] since I started working here have been 
available. More of it. More often.” (Respondent 26) 
Barriers to attending training were seen as a lack of availability, a lack of 
awareness, and that training sessions are not always accessible to all (e.g. part-
time or bank staff): 
“I don’t work on the day the psychologist is in, which is why I have poor 
attendance.” (Respondent 16) 
 
5. How do other staff groups view the role of the Clinical Psychologist in a Palliative 
Care setting? 
 
5.1. Role Importance and Service Provision 
Respondents rated how important they viewed four aspects of the Clinical 
Psychologist’s role to be, from 1 (‘not at all’) to 5 (‘extremely’). For each area, they 
also rated the current amount of service provision as to whether it was ‘not enough’, 










5.1.1. Qualitative Theme 5: Relationships with the Clinical Psychologist 
This theme comprised of two sub-themes: Positive Relationships (14 references) 
and Lack of Presence (11 references). 
Some staff commented that the Clinical Psychologist is well integrated into the 
Hospice. Positive feedback was also given about how approachable the Clinical 
Psychologist is when present: 
“[The Clinical Psychologist] is always approachable, however busy she 
is” (Respondent 11) 
 
Contrastingly, some respondents commented that they do not feel the Clinical 
Psychologist is approachable or integrated into the Hospice, due to a lack of 
presence.  
 “As I do not know the psychologist and rarely see her I would find it 
difficult to approach this service” (Respondent 5) 
 
5.1.2. Qualitative Theme 6: Clinical Psychology Hours 
The need for additional Clinical Psychology hours was a strong theme. This 
could be divided into three sub-themes: General Availability/Ambiguous (28 
references), Direct Work (22 references), and Staff Support (6 references).  
Aspect Importance Provision 









26 5 4 to 5 27 21 (78%) 6 (22%) 0 (0%) 
Consultation 26 5 3 to 5 26 15 (58%) 11 (42%) 0 (0%) 
Supervision 24 4 3 to 5 22 12 (55%) 10 (45%) 0 (0%) 
Training 26 4 3 to 5 27 16 (59%) 11 (41%) 0 (0%) 
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Some respondents were not specific about what extra Clinical Psychology time 
would be useful for: 
“The availability of a psychologist only 1 day a week feels inadequate” 
(Respondent 2) 
 
However, in line with the quantitative findings, many felt more hours were 
needed for direct clinical work: 
“I feel we need more than one clinical psychologist working one day a 
week- so many patients would value input but cannot access service” 
(Respondent 9) 
Some specifically highlighted a need for additional hours to increase staff 
support: 
“More hours to offer…more education/support to staff” (Respondent 11) 
 
5.1.3. Qualitative Theme 7: The Value of Clinical Psychology 
This final theme consisted of three sub-themes: Presence in MDT (14 
references), Value to Staff (5 references), and Value to Patients (5 references). 
Having a Clinical Psychologist as a presence in the multi-disciplinary team 
(MDT) was seen as valuable, bringing a different perspective to clinical 
discussions: 
“[Clinical Psychology] brings useful psychological focus to MDT 
meetings that can otherwise be very medical” (Respondent 17) 
The value of Clinical Psychology in providing direct clinical work was 
highlighted by several respondents, while some commented on the value in 
relation to improving staff skills and confidence: 
“It has been great to experience having a clinical psychologist in the 
team and also those in training. It has increased my awareness and 
knowledge and confidence re providing psychological support, 
something I am passionate about” (Respondent 15) 
62 
  
Focus Group and Interviews 
Five superordinate themes were identified through the thematic analysis on the 
combined data from the focus group and interviews: 1) ‘Staff Skills and Confidence’, 2) 
‘Collective Responsibility’, 3) ‘Multiple Perspectives’, 4) ‘Clinical Psychology Role’, 
and 5) ‘Clinical Psychology Presence and Hours’. Each theme is described below with 
examples. 
1. Staff Skills and Confidence 
The skills needed to provide psychological support and staff confidence in applying 
these skills was a strong theme. Within this, three subthemes were identified: Low 
Confidence (23 references), Training and Supervision (23 references), and Uniqueness 
of Palliative Care (11 references). All subthemes were identified across the focus group 
and both interviews. 
1.1.Low Confidence: It was suggested that low confidence in responding to distress can 
trigger inappropriate referrals to Clinical Psychology and means that staff may not 
take opportunities to provide support on the inpatient unit: 
 
“I kind of think sometimes people refer because someone’s really upset, it’s kind 
of in their face at the time and they…don’t know how to manage that.” (Focus 
Group Participant 1)  
“…when you’re not so confident, you sort of see [psychological distress] but 
you don’t want to go there. So it’s so easy to then get distracted and go and do 
something else…and that opportunity’s missed.” (Interview 2) 
 
1.2.Training and Supervision: Training was seen as important for helping staff to 
develop skills and confidence. Suggestions included incorporating training into staff 
inductions and running frequent skills-based sessions. Clinical supervision was also 
identified as a helpful avenue for developing skills and confidence, although 
variability in supervision between teams was noted: 
 
“…in this [Family Support Team] we have quite a lot of opportunities to reflect, 
discuss and share ideas…. Whereas for the nurses, there doesn’t seem to be 
that.” (Focus Group Participant 4) 
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1.3.Uniqueness of Palliative Care: The hospice setting was highlighted as being 
different to other healthcare environments, in terms of the skills required and the 
emotional impact of the work: 
 
“I think that we work in a unique environment, and I think that’s really 
important to recognise. It’s not a generalist environment. And that does take 
special skills…” (Focus Group Participant 5)  
“In my work in the community you’re sort of advising people who are getting 
better, and [at the Hospice] that’s not necessarily the case. You’re just trying to 
give them a better quality of life and to be able to sort of achieve their goals in 
whatever time they have got, really. It’s very different, really. It was a bit of a 
shock to me.” (Focus Group Participant 3) 
 
2. Collective Responsibility 
This theme included two subthemes, which were identified across the focus group and 
both interviews: Everyone has a Role (19 references), and Barriers (11 references).  
2.1. Everyone has a Role: Providing psychological support was strongly seen as a 
shared responsibility: 
“…it’s our responsibility, all of us, to be trying to address stuff, not thinking 
‘well that’s not ours to do, that’s the psychologist’s role’. Emotional support, 
psychological support is for us all.” (Interview 1) 
 
Staff members who have a lot of direct patient contact were seen as having an 
important role in identifying distress. There was also a suggestion that providing 
support as part of routine care can be less stigmatising than being referred to a 
specialist: 
 
“I feel that the psychology part should be done by the nurses that are on the 
unit…otherwise it becomes very clinical doesn’t it? You become- you’re ‘going 
to see the psychologist’- when I think a lot of things could be dealt with on 





2.2. Barriers: Time, the pressures of other clinical duties, and staff not prioritising 
distress screening were all raised as potential barriers to providing psychological 
support in practice. 
 
3. Multiple Perspectives  
This theme comprised three subthemes: Beyond the Medical Model (20 references 
across the focus group and interview 2), Value of Multidisciplinary Working (22 
references in the focus group only), and Professional Boundaries (29 references in 
focus group only). 
3.1. Beyond the Medical Model: Participants highlighted the importance of thinking 
broadly about a patient’s psychosocial needs rather than focusing on medical 
management, and the benefits of using distress screening tools: 
 “[It’s really good] that people are given a bit of time to [express themselves] as 
well and it’s not just about your medical symptoms. I mean it is as important to 
be able to…help someone with their psychological distress and the impact on 
their family as well.” (Focus Group Participant 1) 
“…you really find out what’s important to [patients]. And what you think might 
be important, you suddenly realise is not important at all…this is what’s 
important, like the fact they can’t drive their car anymore and stuff like that, 
which you didn’t give a second thought about.” (Interview 2) 
3.2. Value of Multidisciplinary Working: Several comments were made about the value 
of being part of a MDT in terms of hearing different perspectives on clinical issues.  
“No one person can understand loads of different layers. But what we bring as a 
collective is all those layers, you see, or a significant amount of them, which can 
help.” (Focus Group Participant 1) 
 
3.3. Professional Boundaries: It was also considered important to be aware of 
professional boundaries. A lack of clarity over distinctions between Clinical 




“Our roles are quite sort of subtle. I mean with bereavement support we say 
“we are not counsellors, we are giving bereavement support”. But quite often 
there’s very complex clients, and…there could easily be more people who could 
have input from [the Clinical Psychologist]…” (Focus Group Participant 2)  
 
4. Clinical Psychology Role 
Three subthemes related to staff’s understanding of the Clinical Psychologist’s role: 
Indirect Work (47 references across the focus group and both interviews), Role 
Information (22 reference in the focus group only) and .Direct Clinical Work (4 
references across interviews 1 and 2).  
4.1. Indirect Work: Providing training, supervision and consultation was seen as an 
important way for the Clinical Psychologist to support staff with their clinical work, 
and with the emotional impact of their work: 
 
“I don’t think it’s put all of the eggs in just direct care. It’s about training, it’s 
both. I definitely see it’s about a balance there.” (Focus Group Participant 5)  
 
“…I see [Clinical Psychology] supporting staff to get them more confident; 
more training, more role-play, that sort of thing.” (Interview 2)  
 
Supervision from the Clinical Psychologist was also identified as an avenue for 
supporting staff with the emotional impact of their work: 
“…You can talk through your own issues with patients too…as a debrief, after 
people have died, or you know, after an event, to be able to make sense of 
feelings yourself.” (Interview 1) 
 
4.2. Role Information: Comments were made regarding a lack of knowledge about the 
role of the Clinical Psychologist, and when it is appropriate to make a referral:  
 
“I do think sometimes the reason why referrals are so vague- one of the issues 
will be around people just not knowing. So a lot of people’s referring will be 
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based on…their experience of what they think a Clinical Psychologist does, 
rather than maybe based in reality.” (Focus Group Participant 1) 
 
Related to this, it was suggested that written information on the Clinical 
Psychology service would be helpful for both staff and patients. 
 
4.3. Direct Clinical Work: There was recognition that the Clinical Psychologist has a 
responsibility for working directly with clients or situations that are more complex 
than other staff might work with: 
 
“[The Clinical Psychologist’s responsibility is] the level of need that is above 
and beyond what the medical staff and the nursing staff feel that they can 
provide, and the family support team feel that they can provide, for the patients 
and the families.” (Interview 1) 
 
5. Clinical Psychology Presence and Hours 
This final theme comprised two sub-themes: Lack of Clinical Hours (22 references 
across the focus group and interview 1) and Lack of Team Presence (14 references in 
the focus group only). 
5.1. Lack of Clinical Hours: The limited hours for direct clinical work were raised as a 
concern, particularly due to long waiting times for patients who have deteriorating 
health: 
 
“I think with regard to referring patients to psychology, it’s the waiting time 
really. Because it can be a significant number of weeks, and that’s a long time 
for somebody with a limited prognosis.” (Interview 1)  
 
The lack of clinical hours was also suggested to impact on whether or not referrals are 
made to the Clinical Psychology service, highlighting that there could be unmet needs 
which are not recorded: 
 
 “I think there’s a risk when there isn’t a lot of time for people to discount 
something without even thinking about it. So we don’t know about those we 
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haven’t referred. So there’s that chunk who are “oh well, they’re going to die 
before [the Clinical Psychologist]’s around again”, therefore did that need get 
met, ever?” (Focus Group Participant 5) 
 
5.2. Lack of Team Presence: Having Clinical Psychology available one day per week 
was described as having various levels of impact on the team, for example limiting 
access to consultation and training. One concern was that the lack of presence can 
mean psychological perspectives are not always considered: 
 
“I think if you’re present in the building more often, it gets people thinking. And 
I think if you’re not at the MDT meeting for example…certain perspectives will 
be forgotten because you haven’t got anyone banging that drum.” (Focus Group 




The findings of the evaluation project are discussed below in relation to the questions 
the project aimed to address.  
 
1. How does the psychological support provided at the hospice map onto 
national recommendations from NICE and NCAT? 
The staff members who contributed to the project overwhelmingly saw psychological 
support as an aspect of their role. There was recognition of a collective responsibility, 
and that staff providing frequent direct care can be well-placed to identify psychological 
distress. The importance of thinking broadly about the person and not solely their 
medical care was also a significant theme. It must be noted that the staff members who 
participated in the evaluation were more likely to be those who saw psychological 
support as important; however the findings suggest there is an emphasis on 
psychosocial thinking across the hospice. 
In relation to the NICE (2004) Levels of psychological support, all survey respondents 
felt they were working at Level 1 or 2, although some felt they could work at a higher 
level given appropriate training and opportunity. Notably, no respondents identified 
working at Level 3 currently. A lack of Level 3 practitioners can place additional 
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pressures on Level 4 practitioners to provide this level of support, which may not be the 
most efficient use of specialist resources (Macmillan Cancer Support, 2011). 
In terms of attendance at recommended training programmes for Level 2 staff, the 
hospice could be said to be taking appropriate steps towards meeting the 
recommendations of NCAT’s (2010) Psychological Support measures, with scope for 
improvement. There were eight staff members who identified working at Level 2 but 
who had not attended either ACST or Level 2 Psychological Skills training. Five of 
these staff were doctors or social workers, who may have received equivalent training as 
part of their professional qualifications. However, only 20% of the staff working at 
Level 2 had attended both training courses, with a lack of opportunity and availability 
being cited as the main reasons. In terms of supervision, two-thirds of those working at 
Level 2 were attending group supervision with the Clinical Psychologist on a monthly 
or six-weekly basis. NCAT’s (2010) Psychological Support measures suggest that Level 
2 practitioners should receive one hour of clinical supervision per month with a Level 3 
or 4 practitioner, but does not stipulate whether this is in group or individual format. 
Given the limited capacity at Level 4, providing supervision in groups is likely to be the 
only feasible option for the Hospice, however the survey indicates a need for increased 
availability and frequency in order to meet the recommended standards. Since the 
distribution of the survey, further Level 2 Psychology Skills courses and additional 
supervision groups have been provided by the Clinical Psychology service, which will 
help to improve the hospice’s Level 2 provision.  
Offering additional training and supervision hours means that the Clinical Psychologist 
dedicates more time to indirect work, at the cost of direct work. A lack of Level 4 
clinical hours emerged as a serious concern through the survey and interviews. 
Importantly, it was suggested that poor availability means staff might not consider 
referral to Clinical Psychology as an option; therefore, referral rates are unlikely to 
reflect the true level of need. NICE (2004) guidance suggests that 10-15% of people 
with advanced stage illness are likely to require specialist psychological or psychiatric 
services. The hospice currently supports approximately 2000 patients per year. Given 
these figures, it could be expected that between 200-300 patients attending the hospice 
annually might benefit from access to Clinical Psychology; however during 2013/14, 64 
referrals were made and only 46 new patients accessed the service. This supports the 
staff perception that there is a substantial shortfall in the direct clinical provision at 




2. How confident do staff members feel at providing psychological support, 
and does training attendance increase confidence?  
Staff confidence levels were good for basic skills such listening and communicating, 
which NICE (2004) suggests all staff in clinical roles should be able to demonstrate. 
Confidence in more specialist skills such as assessing distress and delivering 
psychological interventions was good for staff who identified using these skills in their 
role. The qualitative data suggested that a lack of confidence can be a barrier to 
providing psychological support, with training from Clinical Psychology being 
proposed as one way to improve this.  
No significant differences were found in confidence levels between survey respondents 
who had attended the ACST or Level 2 Psychology Skills training and those who had 
not. However, very small sample sizes were involved in these analyses; therefore no 
conclusions can be drawn about the relationship between training attendance and 
confidence from this evaluation. There is an established evidence base that suggests 
such training courses do have a positive effect on confidence levels (e.g. Wilkinson et 
al., 2008).  
 
3. What barriers could be addressed to improve the psychological support 
provided at the Hospice? 
The main barrier identified was a lack of knowledge and confidence, with a clear desire 
expressed for increased access to training. Additional barriers were mainly practical in 
nature and linked to the challenges of working in a busy clinical setting, such as access 
to quiet spaces and having time aside from other core duties. A lack of resources (e.g. 
information leaflets) regarding psychological support and the Clinical Psychology 
service was a practical barrier that could be readily addressed.  
 
4. How satisfied are other staff groups with the current Clinical Psychology 
service? 
The feedback from staff on the Clinical Psychology service was extremely positive, 
particularly for consultations and supervision. However, lower levels of satisfaction 
were expressed with the availability of training and the accessibility of clinical services. 
The amount of provision across all aspects of the service was highlighted as feeling 
insufficient to meet needs.  
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The rate that survey respondents reported seeking consultations would suggest a much 
higher frequency per year than the number recorded by the Clinical Psychologist (31). It 
is possible that staff classify different types of discussion (e.g. brief informal chats) as 
consultations, whereas the Clinical Psychologist only recorded more formal discussions. 
The extent of the indirect work delivered by the Clinical Psychologist could potentially 
be underestimated using documented figures alone. 
 
5. How do other staff groups view the role of the Clinical Psychologist in 
palliative care? 
Staff appeared to have a broad view of the role of the Clinical Psychologist, recognising 
that it encompasses direct work at a ‘complex’ level, indirect work through other staff 
and staff support. Clear themes emerged from both the survey and interviews regarding 
the value that having a Clinical Psychologist adds to MDT working; bringing an 
important psychosocial perspective to clinical discussions that can otherwise be 




A report on the findings of this project was presented to the Patient Services Director at 
the hospice in November 2014. The following recommendations were made: 
1. To produce written information leaflets and resources about the Clinical Psychology 
service, to better inform staff and patients/carers.  
2. To continue efforts to increase access to training in psychological skills for all 
clinical staff, and consider the inclusion of psychological skills training as part of 
clinical staff inductions.  
3. To look at ways to increase the provision of Level 3 psychological support, for 
example, by enabling any staff who have existing qualifications in psychological 
therapies, and who wish to do so, to have allocated time for this in their roles.  
4. To increase the time available to Clinical Psychology, in order that the service can 
continue to deliver staff training, supervision and support, and enable adequate and 




During a meeting between the researcher, the Patient Services Director and Clinical 
Psychologist, provisional action plans were developed to address each of these 
recommendations: 
In the short term (during the remainder of the 2014/15 financial year), the Patient 
Services Director committed to allocating additional funding (<0.1wte) to Clinical 
Psychology on a temporary basis, to support the development of service information 
leaflets and resources for common psychological difficulties. It was also agreed to 
develop a Level 1 Psychological Skills course that will be mandatory for all clinical and 
non-clinical staff who have not received training at Level 2 or higher, with the aim of 
improving skills and confidence. This was planned to be delivered to existing staff as a 
baseline by the end of 2014/15, then on a quarterly basis as part of the induction 
programme for new staff.  
Longer-term, the Patient Service Director recognised the need to develop service 
provision at Levels 3 and 4, and expressed commitment to using the report to 
prospectively plan services. A plan was developed to identify staff with existing 
qualifications that would allow them to work at Level 3, and to monitor referrals to 
establish the need at this level. To better meet need at Level 4, it was planned to put 
forward a proposal to trial an increase in Clinical Psychology hours to between 0.4-
0.5wte through a fixed-term Band 7 post, with a timescale of two years to re-evaluate.   
The results and outcome of the project were fed back to hospice staff through a 
lunchtime presentation and discussion. This was attended by around 12 staff members, 




Through an evaluation of one palliative care setting, this project has demonstrated some 
of the challenges of implementing national guidelines in practice. The provision of 
psychosocial support was clearly seen as very important by staff, suggesting that the 
palliative care principle of relieving distress in all domains was well embedded into the 
hospice culture. Although there was scope for improvement, staff confidence in 
providing psychological support was fair, as was access to the recommended training 
and supervision for Level 2 staff. Even with these factors in place, staff working at 
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Levels 1 and 2 may find it difficult to prioritise psychological screening and support due 
to practical barriers associated with the demands of their role.  
Level 4 practitioners have a central role in providing training and supervision under 
national guidelines; however providing these services when limited time is funded can 
compromise capacity for direct clinical work. As highlighted by Macmillan (2011), a 
lack of trained Level 3 practitioners nationally is a problem in being able to deliver the 
NICE (2004) recommended levels of psychological support, and can place additional 
pressures on Level 4 practitioners such as Clinical Psychologists.  
The findings of this project suggest that Clinical Psychology is viewed by other 
professionals as a valuable addition to the palliative care team, helping to ensure that 
patients’ and carers’ psychological needs are thought about and appropriately addressed. 
It is essential that Clinical Psychologists in palliative care find ways to monitor and 
document the impact of their work, in order to demonstrate the value that they bring and 
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1.1.Chronic Fatigue Syndrome 
CFS is estimated to affect between 2 and 4 people per 1000 in the UK (National 
Institute for Health and Clinical Excellence, 2007). The International Consensus 
Criteria proposed to define the illness (ICC; Carruthers et al., 2011) outline the primary 
clinical feature as a marked loss of energy and prolonged recovery period following 
mental or physical exertion. Sleep disturbance is a common feature of CFS and is said 
to take two main forms. These are: a) a disrupted sleep pattern, which may include 
insomnia and frequent night-time awakenings and/or prolonged sleep and daytime 
napping, and b) unrefreshing sleep, including excessive sleepiness and exhaustion 
regardless of sleep duration (Carruthers et al., 2011). 
 
1.2. Sleep Disturbance in CFS  
Researchers have investigated sleep disturbance in CFS using polysomnography, 
actigraphy and electro-encephalogram (EEG) recordings (for reviews, see Jackson & 
Bruck, 2012; Mariman, Vogelaers, et al., 2013). Although as many as 87-95% of 
patients with CFS report having poor quality, non-restorative sleep (Mariman, 
Vogelaers, et al., 2013), there is no consistent evidence that their sleep structure (e.g. 
sleep onset latency, number of awakenings) is different to that of healthy controls. 
Several authors have therefore concluded that there is a misperception of sleep quality 
in CFS (e.g. Majer et al., 2007; Reeves et al., 2006; Watson et al., 2003), which may be 
driven by psychological factors (Mariman, Vogelaers, et al., 2013).  
There are some findings from EEG studies that patients with CFS have impaired sleep 
homeostasis, the ability to regulate the intensity of sleep by adjusting the amount of 
slow-wave sleep and delta activity according to need (Armitage et al., 2007; Decker, 
Tabassum, Lin, & Reeves, 2009), although evidence for this is mixed (Jackson & 
Bruck, 2012). There is also emerging evidence that patients with CFS have greater 
levels of physiological arousal during sleep than healthy controls, as indicated by a 
higher rate of cyclical alternating pattern (CAP; Guilleminault et al., 2006) and reduced 
heart-rate variability (e.g. Boneva et al., 2007). These findings may suggest a state of 
hypervigilance during sleep (Jackson & Bruck, 2012).  
It has been suggested that the apparent misperception of sleep quality in CFS may be in 
part due to a misattribution of fatigue symptoms as reflecting poor sleep, as patients 
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expect that sleep should reduce their fatigue (Westcombe & O'Dowd, 2012). If an 
individual experiences fatigue on waking, it is understandable for them to perceive they 
have not slept well (Mariman, Vogelaers, et al., 2013). However, while sleep reduces 
sleepiness, it does not necessarily reduce fatigue (associated with a lack of muscle 
strength, low energy levels and neurocognitive complaints), which may have other 
causes. Although both sleepiness and fatigue are forms of ‘tiredness’, there is evidence 
that they are different constructs and do not necessarily correlate closely (Hossain et al., 
2005).  
In a recent qualitative study of the experience of sleep in CFS, Gotts, Newton, Ellis, and 
Deary (in press) identified sleep as a significant part of the illness. Themes that emerged 
from their interviews with CFS patients included that poor sleep is seen as having a 
significant impact on daytime functioning, quality of life, and the severity of fatigue 
symptoms. It is therefore clear that, whether or not sleep is objectively disturbed in 
CFS, the subjective experience of poor sleep can have a significant impact on wellbeing 
and functioning.  
 
1.3. Sleep Disturbance in Insomnia 
Similarly to patients with CFS, the phenomenon of misperceiving sleep quality is a 
consistent finding in patients reporting insomnia as their primary concern, or co-morbid 
with other health conditions (for a review, see Harvey & Tang, 2012). People with 
insomnia commonly report poor quality non-restorative sleep, in the absence of 
objective markers of sleep disturbance. Like in CFS, patients with primary insomnia 
have been found to have a tendency to misattribute fatigue to poor sleep (see Harris & 
Carney, 2012). People with primary insomnia also show an elevated CAP rate as found 
in patients with CFS (Parrino, Milioli, De Paolis, Grassi, & Terzano, 2009), which these 
authors suggest may be a physiological marker of cognitive processes (such as anxiety) 
underlying insomnia.  
These findings raise interesting questions regarding the similarities and differences in 
the sleep disturbances of people with CFS and insomnia. A recent study was the first to 
directly compare sleep in patients with CFS and primary insomnia (Neu, Mairesse, 
Verbanck, & Le Bon, in press). This study found that both groups were comparable to 
healthy controls on objectively recorded sleep variables, except that both patient groups 
had similarly elevated micro-arousals. They also found support for previous findings of 
impaired sleep homeostasis in CFS patients. Both groups self-reported poorer sleep 
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quality and similarly elevated levels of fatigue, depression and anxiety compared to 
controls (Neu et al., in press). This study indicates comparable levels of misperception 
about actual sleep in CFS and insomnia. Such findings suggest that both CFS and 
insomnia might share an underlying aetiology (Mariman, Vogelaers, et al., 2013). 
 
1.4. Cognitive-Behavioural Models 
Cognitive-behavioural models have implicated a number of factors in the vulnerability 
to and maintenance of both CFS and insomnia. In terms of vulnerability, Surawy, 
Hackmann, Hawton, and Sharpe (1995) proposed that beliefs about the importance of 
maintaining high standards and beliefs about the importance of psychological resilience 
are central to CFS. These characteristics may contribute to a tendency to overestimate 
the impact of fatigue on performance, and to prefer somatic rather than emotional 
explanations for symptoms (Surawy et al., 1995). Research has supported the 
suggestion of elevated levels of perfectionism (e.g. Kempke et al., 2011) and negative 
beliefs about emotions (see Rimes & Chalder, 2010) in CFS. Vulnerability factors for 
insomnia are also thought to include perfectionism, with findings of elevated 
perfectionistic thinking styles, such as high personal standards and concerns about 
making mistakes (Lundh, Broman, Hetta, & Saboonchi, 1994; Vincent & Walker, 
2000), although this relationship may be mediated by emotional distress (Jansson-
Frojmark & Linton, 2007). 
Common cognitive-behavioural maintenance factors that have emerged from the CFS 
literature are: an enduring tendency to attribute symptoms to physical causes; negative 
beliefs about the consequences of activity and fatigue (such as that exercise will lead to 
worsened symptoms, and that fatigue will negatively affect performance); and an 
attentional bias to signs of fatigue (for a review, see Knoop, Prins, Moss-Morris, & 
Bleijenberg, 2010). Factors commonly identified as maintaining insomnia include: 
having unwanted repetitive thoughts (i.e. worrying or ruminating) while trying to fall 
asleep; holding unhelpful beliefs about the importance of sleep and consequences of not 
sleeping; and an attentional bias to signs of tiredness. These factors have been well-
supported by insomnia research (see Carney, Harris, Moss, & Edinger, 2010; Espie, 







There are clear similarities between the research findings relating to patterns of sleep 
disturbance in CFS and in insomnia. Both groups commonly report tiredness and 
subjectively disturbed sleep. The similarities make sense theoretically, given the overlap 
between the cognitive-behavioural formulations of each disorder in terms of 
vulnerability factors such as perfectionism, and maintaining factors such as unhelpful 
beliefs or misattributions about symptoms. This leaves the important question of where 
the differences might lie. To the best of our knowledge, only one study has directly 
compared disturbed sleep in CFS and insomnia, and this study has a primary focus on 
objectively measured sleep characteristics (Neu et al., in press). Cognitive factors 
relating to sleep and fatigue have not previously been compared in these groups.   
The current study aimed to address this gap in the literature by comparing participants 
with primary insomnia and patients with CFS in terms of their self-reported sleep, 
fatigue, and psychological characteristics. Of primary interest was to establish whether 
there are differences in the levels of fatigue, sleepiness and sleep disturbance reported 
by the two groups. A secondary aim was to look at how the groups differ in terms of 
cognitions about fatigue and sleep. Finally, key factors considered significant to the 
cognitive-behavioural models of CFS and insomnia were compared, to look at the 





A cross-sectional between groups design was used, comparing 1) patients with a clinical 
diagnosis of CFS, 2) people with a primary complaint of insomnia, and 3) healthy 
community controls. It was originally planned to subdivide the CFS sample into two 
groups according to whether or not they reported a clinical level of insomnia, however 
due to the size of the final sample this was not feasible. Patients with CFS were 
recruited through two specialist NHS services in the South West. In the absence of an 
accessible sleep clinic population, the Insomnia and Healthy Control groups were 
community samples recruited via social media. The study protocol was approved by the 
University of Bath Department of Psychology Ethics Committee, the East Midlands 
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Research Ethics Committee (REC Reference 14/EM/1297), and by the relevant NHS 
Trust Research & Development departments.  
 
2.2. Participants  
Inclusion criteria for all groups were: 1) aged 18 or above, 2) sufficient English 
language ability to complete the questionnaires, 3) no known diagnosis of a sleep 
disorder other than insomnia (e.g. narcolepsy, sleep apnoea, restless leg syndrome), and 
4) not having received individual CBT for insomnia or fatigue in the past two years. 
Participants taking medications for sleep, depression, or other conditions were included. 
Figure 3 shows a CONSORT flow diagram for all groups. Demographic information is 
presented in Table 12.  
 
Power calculations were performed based on between group differences in fatigue 
severity on the Chalder Fatigue Scale (ChalderFS; Chalder et al., 1993). Cella and 
Chalder (2010) found a large effect size (Cohen’s d= 1.94) between CFS patients and a 
community sample on the ChalderFS. Using a different fatigue measure, Neu et al. 
(2008) also found a large effect size (Cohen’s d= 2.29) between CFS patients and 
patients with sleep disorders (sleep apnoea/hypopnoea). The total sample required to 
detect a large effect size (using effect size convention f=0.4) with .8 power, for a one-
way ANOVA between three groups, was calculated using G*power (Faul, Erdfelder, 
Lang, & Buchner, 2007). This indicated a sample of 22 participants per group. 
 
 
2.2.1. CFS Group 
Patients with CFS were invited to participate either by their clinician during routine 
appointments or by the lead researcher during psycho-educational groups. Potential 
participants were contacted by telephone and screened against the eligibility criteria. 
In addition to the above criteria, CFS participants were required to have a clinical 
diagnosis of CFS and no other significant physical or mental health conditions that 
might account for their fatigue. To reflect the clinical population, participants with a 
co-morbid diagnosis of Fibromyalgia (n=4) were included, as were participants who 
reported mild mental health problems that were being managed in primary care (e.g. 
depression or anxiety; n=9). After confirming eligibility, participants were asked to 
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complete a consent form and return the questionnaire pack, either by post or online. 
The final CFS sample consisted of 18 participants.  
 
2.2.2. Insomnia Group and Healthy Control Group  
For the Insomnia and Healthy Control groups, participants were asked to confirm 
that they met the study’s core eligibility criteria, and additionally to confirm they 
did not have any significant physical or mental health problems. Participants were 
then invited to complete an online consent form and directed to the relevant survey. 
Participants were directed to complete the ‘Insomnia’ survey if they experienced 
problems falling asleep, staying asleep or waking early which impacted on their 
daily life, or to complete the ‘Healthy Control’ survey if they considered themselves 
to have no problems with their sleep.  
 
The presence or absence of insomnia was corroborated using the Insomnia Severity 
Index (ISI; Bastien, Vallières, & Morin, 2001). A cut-off of 10 on this measure 
suggests insomnia in community samples (Morin, Belleville, Bélanger, & Ivers, 
2011), therefore participants who self-selected into the Insomnia group but scored 
below 10 were excluded (n=3). Participants who completed the Healthy Control 
survey but scored 10 or above were reallocated to the Insomnia group (n=2). One 
participant completed the Insomnia survey twice (as identified by contact details), 
therefore the data set with the greatest number of missing items was excluded. The 
final Insomnia sample consisted of 18 participants, and the final Healthy Control 









Self-report questionnaires were used to assess the psychological wellbeing and 
subjective sleep characteristics of the groups, and to asses various cognitive factors 
associated with CFS and insomnia. The measures were completed independently by 
participants in their own time. All measures used (with the exception of the Beliefs 
Referred to study (n=39) 
 By clinician (n=14) 
 By self (n=25) 
Screened for eligibility 
(n=27) 





 Declined (2) 
 Unable to contact (n=10) 
Excluded (n=6) 
 Withdrew interest (n=1) 
 Unable to contact to consent (n=2) 
 Did not meet criteria: 
o Complex mental health history 
(n=1) 
o Restless leg syndrome (n=1)  
o CBT for fatigue (n=1) 
 
Questionnaires not returned (n=3) 
Completed online Insomnia 
survey (n=20) 
Completed online Healthy 
Control survey (n=21) 
Excluded (n=4) 
 Duplication (n=1) 
 ISI score <10 (n=3) 
ISI score ≥10 (n=2) 
 






































































about Fatigue Scale, see below) were previous validated, with good internal 
consistencies and established cut-offs.  
 
2.3.1. General Psychological Characteristics 
General psychological wellbeing was assessed using the 14-item Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983), a widely used measure for 
screening depression (HADS-D) and anxiety (HADS-A) in medical settings. Both 
subscales have adequate test-retest reliability (both r>0.7; see Herrmann, 1996) and 
good internal consistency (mean α=0.83 for depression, α=0.82 for anxiety; see 
Bjelland, Dahl, Haug, & Neckelmann, 2002). McCue, Martin, Buchanan, Rodgers, and 
Scholey (2003) found good internal reliability for the anxiety (α=0.86) and depression 
(α=0.81) subscales in a sample with CFS. In the CFS and Insomnia groups only, 
participants’ functional impairment was assessed using the 5-item Work and Social 
Adjustment Scale (WSAS; Mundt, 2002). The WSAS has demonstrated excellent 
internal consistency (α=0.91) and test-retest reliability (r=0.99) in a clinical sample with 
insomnia, with a cut-off of ≥17 discriminating sub-clinical from clinical insomnia (88% 
sensitivity and 78% specificity; Jansson-Fröjmark, 2014). The WSAS has also 
demonstrated good internal consistency in CFS samples (Cella, White, Sharpe, & 
Chalder, 2013). 
 
The 15-item Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & 
Borkovec, 1990) was used to evaluate participants’ tendency to worry generally (e.g. “I 
am always worrying about something”). The measure has good internal consistency 
(α=0.93) and test-retest reliability (r=0.92; Meyer et al., 1990). The PSWQ has been 
used in previous insomnia research and has been found to differentiate primary 
insomnia from pain-related insomnia (Tang, Goodchild, Hester, & Salkovskis, 2012). 
The 14-item Short Health Anxiety Inventory (SHAI; Salkovskis, Rimes, Warwick, & 
Clark, 2002) was used to evaluate anxiety surrounding illness and somatic symptoms. A 
recent meta-analysis concluded that the SHAI demonstrates good internal consistency, 
(α=0.74-0.96) and adequate test-retest reliability (r=0.87; Alberts, Hadjistavropoulos, 
Jones, & Sharpe, 2013). Elevated scores on the SHAI have been identified across 






2.3.2. Sleep and Fatigue Symptoms 
The presence of insomnia was screened using the Insomnia Severity Index (ISI; Bastien 
et al., 2001), a brief 7-item scale validated against diagnostic criteria for clinical 
insomnia. The ISI has been extensively used in insomnia research, including groups 
with insomnia secondary to physical health conditions (see Omachi, 2011). It has good 
internal consistency (Cronbach’s α= 0.74-0.78), and concurrent validity with other 
insomnia measures. Morin et al. (2011) suggest that a cut-off of ≥10 is optimal for 
identifying insomnia in community samples with 86.1% sensitivity and 87.7% 
specificity. The ISI was used to define the Insomnia and Healthy Control groups and to 
compare insomnia severity between all groups. 
Fatigue severity was assessed using the 11-item Chalder Fatigue Scale (ChalderFS; 
Chalder et al., 1993), This is a reliable measure of fatigue with high internal consistency 
(Chalder et al., 1993), which is commonly used in clinical practice and has been 
validated in a CFS population (Morriss, Wearden, & Mullis, 1998). Items include, for 
example, “do you need to rest more [than usual]?” and “do you have less strength in 
your muscles [than usual]?”. Daytime levels of sleepiness were assessed using the 8-
item Epworth Sleepiness Scale (ESS; Johns, 1991, 1992), a valid and reliable measure 
of fatigue that has been extensively used in research with both insomnia and CFS 
populations (e.g. Neu et al., 2008). This scale asks respondents to indicate how likely 
they would be to fall asleep in different situations, such as “watching television” and 
“sitting and talking to someone”. 
 
The 18-item Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds, Monk, Berman, 
& Kupfer, 1989) was used to provide a more detailed comparison of perceived sleep 
quality between groups than the ISI, with seven component scores including sleep onset 
latency, sleep efficiency and sleep disturbance. The scale has good internal consistency 
(α=0.83) and test-retest reliability (r=0.85). The PSQI has been widely used to assess 
sleep quality in populations with physical health conditions, including CFS (e.g. Neu et 
al., 2007). 
 
2.3.3. Cognitions related to Sleep and Fatigue  
The widely used 16-item Dysfunctional Beliefs and Attitudes about Sleep scale 
(DBAS-16; Morin, Vallières, & Ivers, 2007) was used to evaluate sleep-related 
cognitions known to maintain insomnia. The DBAS-16 has adequate internal 
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consistency (α=0.77-0.79) and test-retest reliability (r=0.83; Morin et al., 2007), and has 
been found to be reliable and valid across a range of insomnia groups (Carney, Edinger, 
et al., 2010). The scale asks respondents to indicate the extent to which they agree with 
statements relating to unhelpful beliefs about sleep and negative consequences of poor 
sleep, such as “I need 8 hours of sleep to feel refreshed and function well during the 
day”.  
No previously validated measures could be identified that evaluate fatigue-related 
cognitions. Therefore a 15-item Beliefs about Fatigue Scale (BAFS; see Appendix C) 
was developed for the present study, using the same response format as the DBAS-16. 
Items on the BAFS were derived from themes identified in qualitative literature on 
fatigue-related beliefs in CFS patients (see Deale, Chalder, & Wessely, 1998; Surawy et 
al., 1995), and adapted items from the DBAS-16. Consistent with cognitive behavioural 
theory of the maintenance of CFS, items related to potentially unhelpful beliefs about 
the negative consequences of activity and fatigue, and somatic attributions for fatigue, 
for example “doing less activity than usual helps to improve my fatigue”, and “I avoid 
or cancel plans when my fatigue is bad”. 
The 10-item Anxiety and Preoccupation about Sleep Questionnaire (APSQ; Tang & 
Harvey, 2004) was used to evaluate sleep-related worry (e.g. “I worry about my loss of 
control over sleep”). This scale has been found to have good internal consistency 
(α=0.86-0.93) and to discriminate well between good sleepers, poor sleepers, and 
people with insomnia (Jansson-Frojmark, Harvey, Lundh, Norell-Clarke, & Linton, 
2011). The 10-item Sleep Anticipatory Anxiety Questionnaire (SAAQ; Bootzin, 
Shoham, & Kuo, 1994) was used to evaluate pre-sleep cognitions (e.g., “I worry that I 
won’t be able to fall asleep”) and pre-sleep somatic experiences (e.g. “I become short 
of breath”). This scale has high reliability and differentiates people with insomnia from 
the general population. 
 
2.3.4. Additional measures related to CFS and Insomnia: 
Selected subscales from the Frost Multidimensional Perfectionism Scale (Frost, 
Marten, Lahart, & Rosenblate, 1990) were used to form a 20-item scale; the 9-item 
Concern over Mistakes subscale (e.g. “People will probably think less of me if I make a 
mistake”), 4-item Doubts about Actions subscale (e.g. “It takes me a long time to do 
something ‘right’”) and 7-item Personal Standards subscale (e.g. “It is important to me 
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that I be thorough and competent in everything that I do”). All three subscales have 
adequate internal consistency (α=0.77-0.88; Frost et al., 1990). Finally, the 12-item 
Beliefs about Emotions Scale (BES; Rimes & Chalder, 2010) was used to evaluate 
unhelpful beliefs about emotional experiences (e.g. “To be acceptable to others, I must 
keep any difficulties or negative feelings to myself”). This measure has good internal 
consistency (α=0.91). The BES has been found to differentiate patients with CFS from 
healthy controls and to be sensitive to change following CBT intervention (Rimes & 
Chalder, 2010). 
 
2.4. Data Analysis 
Missing data items (n=13) were discussed with the two academic supervisors, who were 
blind to group allocation. It was agreed to impute missing values with subscale modes 
for the PSQI (n=1), HADS (n=1) and SAAQ (n=3), and with scale modes for the ESS 
(n=2), HAI (n=3), DBAS-16 (n=1), APSQ (n=1) and BAE (n=1).  
The three groups were compared for demographic characteristics using a one-way 
ANOVA for age and Chi-Square analyses or Fisher’s Exact test for categorical variables 
(sex, ethnicity, marital status, employment status, household income, and medication 
use). Between-group analyses were also conducted on the measures of general 
psychological characteristics: depression (HAD-D), anxiety (HADS-A), worry (PSWQ) 
and health anxiety (HAI), and functional impairment (WSAS). 
The primary analysis focussed on whether sleep disturbance and fatigue symptoms were 
comparable between CFS and insomnia. This was evaluated by group comparisons of 
mean scores on the ISI, PSQI, ChalderFS, and ESS, using one-way ANOVAs. The 
secondary analysis was of cognitions about sleep and fatigue, with one way ANOVAS 
on the DBAS-16, BAFS, APSQ and SAAQ. Additionally, mixed ANOVAs were used 
to test for any group x belief (DBAS vs. BAFS) interaction, and any group x SAAQ 
subscale (somatic vs. cognitive) interaction. The relationships between beliefs about 
sleep/fatigue and the severity of fatigue (ChalderFS) or insomnia (ISI) were looked at 
using Pearson’s correlations. Additional analyses were conducted to compare groups in 
terms of vulnerability factors previously identified in CFS and insomnia (i.e. 
Perfectionism, BAE). Throughout, post-hoc analyses were performed using Fisher’s 
Least Significant Difference (LSD) test where homogeneity of variance assumptions 





Demographic characteristics of the groups are presented in Table 12. There were no 
significant differences between groups in terms of age, sex, ethnicity or marital status. 
However, significant differences were apparent in employment status, household 
income, education level and medication use. The CFS group were less likely to be in 
full-time employment and more likely to report a low household income. A majority of 
the Insomnia and Healthy Control participants were educated to university degree level, 
compared to half of the CFS group. All participants reported at least secondary school 
qualifications. Regular medication use was more frequent in the CFS group, followed 
by the Insomnia group then Healthy Controls.  
 











Fisher’s Exact Test 
(FET) 
Age M  41.94  
SD 10.61 
M  37.89  
SD 12.40 
M  37.16  
SD 12.23 
F(2,52)=0.87, p>.05 
Sex (% female) 88.9 83.3 84.2 FET: p>.05 
Ethnicity (% white) 94.5 94.1 100 FET: p>.05 
Marital Status  
(% married) 
72.2 66.7 94.7 χ2 (2, N=55)=3.37, p>.05 
Employment status  
(% full-time) 
16.7 66.7 78.9 χ2(2, N=55)=16.05, p<.001 
Household income  
(% ≥£25,000) 
50.0 93.8 94.4 FET: p<.01 
Education level  
(% university degree) 
50.0 83.3 100.0 FET: p<.001 
Regular medication 
use (% yes) 





3.2.General Psychological Characteristics 
Using one-way ANOVAs, significant main effects were found between groups on the 
HADS-D (F(2,52)= 34.06, p<.001), HADS-A (F(2,52)=8.47, p<.05), PSWQ (F(2,52)=6.96, 
p<.01) and HAI (F(2,52)=9.28, p<.001). Homogeneity of variance assumptions were met 
for the PSWQ but not the HADS-D, HADS-A or HAI.  
Mean scores and standard deviations are presented in Table 13. No significant 
differences were found between the CFS and Insomnia groups in terms of depression 
(HADS-D), general anxiety (HADS-A), worry (PSWQ) or health anxiety (HAI; all 
p>.05). The Healthy Control group had significantly lower HADS-D score compared to 
both the CFS and Insomnia groups (both p<.001). Similarly, on the HADS-A and 
PSWQ, the Healthy Control group scored significantly lower than the CFS (both p<.01) 
and Insomnia (both p<.05) groups. On the HAI, the Healthy Control group scored 
significantly lower than the CFS group (p<.001), but not the Insomnia groups (p>.05). 
An independent samples t-test was used to compare mean scores on the WSAS between 
the Insomnia and CFS groups. The CFS group showed significantly higher work and 
social impairment than the Insomnia group (t(32)=6.24, p<.001).  
 







HADS-D 9.33 (3.22)a 6.39 (3.94)a 1.21 (1.48)b 
HADS-A 9.44 (4.68)a 7.94 (4.68)a 4.05 (2.78)b 
PSWQ 55.72 (15.19)a 54.06 (15.10)a 39.58 (13.31)b 
HAI 16.26 (5.70)a 11.78 (7.87)ab 7.68 (4.14)b 
WSAS 29.58 (5.99)a 16.94 (5.79)b NA 
a,b 
Values with the same superscript are not significantly different 
 
3.3. Primary Analyses: Sleep and Fatigue Symptoms 
Mean scores on sleep and fatigue measures are presented in Table 14. From one-way 
ANOVAs, significant main effects were found for the ISI (F(2,52)=42.41, p<.001), 
ChalderFS (F(2,52)=46.88, p<.001) and ESS (F(2,52)=10.64, p<.001). Homogeneity of 












ISI1 13.67 (7.11)a 15.56 (3.29)a 2.53 (2.22)b 
Chalder FS 27.78 (4.94)a 20.06 (4.65)b 13.11 (4.23)c 
ESS 12.28 (6.01)a 8.78 (5.29)a 4.68 (3.40)b 
PSQI 
Component 
Sleep Duration 1.06 (1.16)a 1.72 (1.18)a 0.26 (0.56)b 
Sleep Latency 2.06 (1.00)a 1.67 (1.33)a 0.68 (0.82)b 
Sleep Efficiency 1.78 (1.22)a 2.06 (1.16)a 0.21 (0.42)b 
Sleep Disturbance 1.67 (0.49)a 1.50 (0.51)a 1.11 (0.32)b 
Medication Use 1.22 (1.48)a 0.44 (0.78)ab 0.11 (0.46)b 
Daytime 
Dysfunction 
1.89 (0.83)a 1.83 (0.79)a 0.74 (0.73)b 
Subjective Sleep 
Quality 
1.78 (1.06)a 2.06 (0.41)a 0.47 (0.51)b 
PSQI Total 11.44 (4.41)a 11.28 (3.82)a 3.58 (2.46)b 
1
72% of the CFS sample scored above clinical cut-off for insomnia on the ISI (≥10). 
a,b,c 
Values with the same superscript are not significantly different 
 
No significant differences were found between the Insomnia and CFS groups in terms 
of insomnia (ISI) or sleepiness severity (ESS; both p>.05). Insomnia severity on the ISI 
was significantly lower in the Healthy Control group than the CFS group (p<.001) and 
Insomnia group (p<.001). Similarly, Healthy Controls scored significantly lower than 
both the CFS (p<.001) and Insomnia (p<.05) groups on the ESS. As anticipated, the 
CFS group had significantly higher fatigue scores on the ChalderFS than the Insomnia 
group (p<.001), who in turn reported significantly higher fatigue than Healthy Controls 
(p<.001).  
To further investigate self-reported sleep characteristics, one-way ANOVAs were used 
to test for between-group differences on the mean total PSQI score and each of the 
seven component scores (see Table 10). Higher scores on all variables indicate greater 
dysfunction or dissatisfaction. Due to multiple comparisons being made using this 
measure, a Bonferroni correction was used, indicating a significance level of α=.006. 
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Significant main effects were found for all PSQI variables: sleep duration (F(2,52)=9.84, 
p<.001), sleep latency (F(2,52)=8.18, p<.006), sleep efficiency (F(2,52)=18.73, p<.001), 
sleep disturbance (F(2,52)=7.81, p<.006), medication use (F(2,52)=6.10, p<.006), daytime 
dysfunction (F(2,52)=12.81, p<.001), subjective sleep quality (F(2,52)=25.80, p<.001) and 
total PSQI score (F(2,52)=28.53, p<.001).  
Homogeneity assumptions were not met for the majority of PSQI variables, therefore 
Dunnett’s T3 was used for post-hoc analyses. No significant differences were found 
between the CFS and Insomnia groups on any of the PSQI variables (all p>.05). Both 
groups scored significantly higher than Healthy Controls on all PSQI variables (all 
p<.05), with the exception of medication use, for which only the CFS groups was 
significantly higher than Controls (p<.05). 
 
3.4. Secondary Analyses: Cognitions related to Sleep and Fatigue  
 
3.4.1. Beliefs about Sleep and Fatigue 
As it was a newly developed measure, the BAFS was analysed for reliability using the 
data from the whole sample (N=55). The internal consistency of the scale was found to 
be excellent (Cronbach’s α=0.94).   
A repeated measures ANOVA was performed with ‘group’ as a between subjects factor 
and belief measure (DBAS-16 and BAFS) as a within-subjects factor. There was no 
main effect of belief (F(1,52)=0.36, p>.05), indicating no overall differences between 
levels of dysfunctional beliefs about sleep and fatigue across the sample as a whole. A 
main effect of group was found (F(2,52)=35.22, p<.001), and there was evidence of a 





Figure 4: Group x Belief interaction 
 
One-way ANOVAs were then used as simple main effects analyses of the group 
differences on the DBAS-16 and BAFS separately. Homogeneity of variance 
assumptions were met. Significant main effects were found for both the DBAS-16 
(F(2,52)=14.98, p<.001) and BAFS (F(2, 52)=50.84, p<.001). Post-hoc analyses showed no 
significant difference in DBAS-16 scores between the CFS group and Insomnia group 
(CFS: M=5.64, SD=1.38; Insomnia: M=4.96, SD=1.74; p>.05), though both were higher 
than Healthy Controls (M=3.11, SD=1.23; both p<.001)
1
. On the BAFS, significant 
differences were found between all groups. The CFS group reported higher mean beliefs 
about fatigue compared to the Insomnia group (CFS: M=7.16, SD=1.24; Insomnia: 
                                                 
1
 Due to an error in administration of the DBAS-16, responses were recorded on a 1-10 scale instead of 
the usual 0-10 scale. To facilitate comparison with other studies, rescaled mean scores for each group 
are presented below, calculated using the formula (x-1)*1.111: 
 CFS: M=5.16 
 Insomnia: M=4.40 
 Healthy Control: M=2.34 
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M=3.93; SD=1.82; p<.001) and Healthy Controls (M=2.52, SD=1.16; p<.001). The 
Insomnia group also scored significantly higher than Healthy Controls (p<.01).  
Paired-samples t-tests were used to look at the pattern of group differences in sleep and 
fatigue beliefs. In the CFS group, the mean BAFS score was significantly higher than 
the mean DBAS score (t(17)=-4.95, p<.001). By contrast, the mean DBAS score was 
significantly higher than the mean BAFS score in both the Insomnia (t(17)=2.81, p<.05) 
and Healthy Control (t(18)=3.08, p<.01) groups. 
 
3.4.2. Relationships between Cognitive Measures and Sleep and Fatigue 
Pearson’s correlations were used to look at relationships between fatigue and insomnia 
symptom severity and scores on the DBAS-16 and BAFS, for the CFS and Insomnia 
groups separately. In the CFS group, significant positive correlations were found 
between insomnia severity (ISI score) and DBAS-16 score (r(16)=.517, p<.05), and 
between fatigue severity (ChalderFS score) and DBAS-16 scores (r(16)=.614, p<.01). No 
relationships were found between either insomnia or fatigue severity and beliefs about 
fatigue (BAFS). In the Insomnia group, a significant positive relationship was found 
between insomnia severity and DBAS-16 scores (r(16)=.470, p<.05). No relationships 
were found between fatigue severity and the DBAS-16, or between fatigue or insomnia 
severity and the BAFS. Having dysfunctional beliefs about sleep was associated with 
higher insomnia severity in both the CFS and Insomnia groups, and with higher fatigue 
severity in the CFS group only.  
 
3.4.3. Sleep-Related Anxiety  
A one-way ANOVA revealed a significant between-group effect on the Anxiety and 
Preoccupation about Sleep Questionnaire (APSQ; F(2,52)=18.38, p<.001). The 
homogeneity of variance assumption was met. There was no significant difference 
between the CFS and Insomnia groups (CFS/MS: M=64.61, SD=22.18; Insomnia: 
M=53.22, SD=23.24, p>.05). Both groups reported significantly higher anxious 
cognitions about sleep than Healthy Controls (M=23.63, SD=18.27, both p<.001). 
A repeated measures ANOVA was used to look at differences in the cognitive and 
somatic subscales of the Sleep Anticipatory Anxiety Questionnaire (SAAQ) between 
groups. This revealed a significant main effect of subscale (F(1,52)=62.97, p<.001), a 
significant main effect of group (F(2,52)=16.72, p<.001) and a significant subscale x 





Figure 5: Group x SAAQ subscale interaction 
 
One-way ANOVAs were used to conduct simple main effects analyses of the group 
differences in pre-sleep cognitive and somatic signs of anxiety. These revealed 
significant between-group differences in cognitive (F(2,52)=11.71, p<.001) and somatic 
(F(2,52)=18.37, p<.001) subscales. The homogeneity of variance assumption was met for 
the cognitive subscale but not the somatic subscale.  
For the cognitive subscale, there was no significant difference between the CFS group 
and Insomnia group (CFS: M=9.61, SD=3.84; Insomnia: M=7.67, SD=4.56; p>.05). 
Both groups reported equally elevated levels of cognition about sleep during the pre-
sleep period, which were higher than reported by Healthy Controls (M=3.37, SD=3.63; 
both p<.01). For the somatic subscale, the CFS group scored significantly higher than 
the Insomnia group (CFS: M=6.33, SD=3.43; Insomnia: M=2.61, SD=2.30; p<.01) and 
the Healthy Control group (M=1.21, SD=2.15; p<.001). No significant difference was 
found between the Insomnia and Healthy Control groups (p>.05), therefore the CFS 
group alone reported elevated pre-sleep somatic experiences. 
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3.5. Additional measures related to CFS and Insomnia 
One-way ANOVAs were used to compare mean scores between groups on the beliefs 
about emotions (BAE) scale and 20-item Perfectionism scale. Homogeneity of variance 
assumptions were met. Significant main effects were found between groups for both 
BAE (F(2,52)=5.61, p<.01) and Perfectionism (F(2,52)=4.50, p<.05). 
Post-hoc analyses indicated that there was no significant difference in BAE between the 
CFS and Insomnia groups (CFS: M=40.56, SD=14.57; Insomnia: M=36.72, SD=15.61; 
p>.05). Both the CFS (p<.01) and Insomnia (p<.05) groups scored significantly higher 
than Healthy Controls (M=24.85, SD=14.61). Similarly, no significant difference in 
perfectionism was found between the CFS and Insomnia groups (CFS: M=63.44, 
SD=15.16; Insomnia: M=64.67, SD=11.87; p>.05), but both CFS (p<.05) and Insomnia 





The aim of the present study was to directly compare the subjective sleep experiences of 
those with CFS versus insomnia, including self-report of sleep and fatigue symptoms, as 
well as cognitions related to these processes. While they differed from healthy controls, 
these two groups were comparable on most variables assessed, including depression, 
anxiety, sleepiness, insomnia severity and cognitions about sleep. The CFS and 
insomnia groups differed only in terms of functional impairment, fatigue severity, 
cognitions about fatigue and somatic symptoms in the pre-sleep period, with the CFS 
group scoring higher.  
 
4.2.Similarities between CFS and Insomnia 
In line with previous research, the findings of the present study suggest that self-
reported disturbed sleep is a significant problem in the CFS population (Jackson & 
Bruck, 2012; Mariman, Delesie, et al., 2013; Mariman, Vogelaers, et al., 2013). By 
directly comparing CFS and insomnia samples we found that levels of self-reported 
insomnia symptoms are comparable in those with CFS versus insomnia. The findings 
further suggest similarities in key cognitive processes that are known to maintain poor 
sleep and insomnia (see Carney et al., 2010; Espie et al., 2006; Harvey, 2002; Harvey et 
al., 2005). These included comparably elevated levels of unhelpful repetitive thinking in 
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the pre-sleep period, and unhelpful beliefs about sleep and the consequences of not 
sleeping (e.g. “Without an adequate night's sleep, I can hardly function the next day”). 
In both the insomnia and CFS groups, elevated levels of dysfunctional beliefs about 
sleep were associated with increased insomnia severity, suggesting that the relationship 
between sleep-related cognitions and sleep disturbance is similar in both populations.  
While it was anticipated that perfectionism would be elevated in both groups due to 
previous findings (Kempke et al., 2011; Lundh et al., 1994; Vincent & Walker, 2000), 
research had yet to directly compare whether this feature would be more problematic in 
either CFS or insomnia. The current findings suggested that perfectionistic traits were 
equally, although only slightly, elevated in both groups compared to controls. An 
unexpected finding was that people with CFS and people with insomnia did not differ in 
terms of unhelpful beliefs about emotions. Given the importance placed on this 
characteristic in cognitive-behavioural models of CFS, it was anticipated that it would 
show greater specificity in differentiating the groups. However, both groups reported 
stronger beliefs about emotions compared to controls, suggesting this trait may be 
equally relevant in insomnia.   
 
4.3.Differences between CFS and Insomnia 
Some notable differences between the CFS and insomnia groups were observed. CFS 
patients were found to have higher levels of health anxiety than healthy controls, a 
pattern that was not found with the insomnia group. Those with CFS were also more 
impaired in their daily functioning than the insomnia group. As might be anticipated, as 
well as being ‘sleepy’, CFS patients reported higher levels of fatigue than those with 
insomnia, and had stronger beliefs about the negative consequences of fatigue and 
activity. Finally, CFS patients reported higher levels of somatic anxiety symptoms in 
the pre-sleep period compared to people with insomnia, possibly indicating a greater 
attentional bias to physical changes when trying to initiate sleep. These findings are in 
line with the cognitive-behavioural theory of CFS (see Knoop et al., 2010), suggesting 
that people with this condition hold potentially unhelpful beliefs about the consequences 
of fatigue and activity, and may attend to somatic signs of fatigue and tiredness.  
It was interesting to find that fatigue severity in the CFS groups was associated with 
dysfunctional beliefs about sleep, but not with beliefs about fatigue. The relationship 
between sleep-related cognitions and fatigue was not found in the insomnia group. This 
finding could be interpreted in light of the suggestion that individuals with CFS 
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misinterpret the connection between sleep and fatigue, expecting sleep to improve their 
fatigue levels (Westcombe & O'Dowd, 2012). Those who experience more severe 
fatigue might therefore develop stronger beliefs about the importance of sleep and 
greater anxiety about the consequences of not sleeping. Alternatively, those with 
stronger dysfunctional beliefs about sleep might be more attentive to signs of tiredness 
following a poor night’s sleep, resulting in a perception of worsened fatigue. The 
direction of this relationship can only be hypothesised from the current findings, and 
warrants further investigation.   
 
4.4.Limitations and Future Direction 
Some limitations of the present study in terms of the sample are important to note. The 
study was slightly underpowered, as power analysis indicated a sample size of 22 
participants per group. Replication with a larger sample would therefore be beneficial. 
Also, the insomnia sample was recruited through community channels. Although a 
clinical cut-off on a well-validated standardised measure of insomnia was used to define 
the sample, this does not guarantee that the results would be the same for individuals 
with insomnia who seek treatment. Replication is therefore needed with a clinical 
insomnia sample. 
The Beliefs About Fatigue Scale (BAFS) was a previously unvalidated measure created 
for this research, as no measures were identified targeting dysfunctional beliefs about 
fatigue. The measure was designed based on items from the DBAS-16 and the existing 
qualitative literature, and showed good internal consistency in the current sample. 
However there is a need for replication and further testing of the psychometric 
properties of the BAFS using larger samples, particularly as in the current study this 
measure was not found to relate to fatigue severity. Further psychometric analysis will 
need to examine the test-retest reliability of the BAFS when re-administered at different 
time points, and look at the validity of the construct of unhelpful beliefs about fatigue 
by seeing how this measure relates to other variables; for example, does having 
unhelpful beliefs about fatigue predict behavioural maintenance factors for CFS, such as 
activity avoidance? It would also be interesting to conduct a factor analysis to identify 
whether the BAFS captures more than one construct (Barker, Pistrang, & Elliot, 2002). 
A further limitation of the present study was the use of self-report measures only. 
Objective measures of sleep such as polysomnography would have provided an 
indication of whether there were actual differences in sleep quality between the groups. 
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That said, this line of research has recently been investigated by other researchers (Neu 
et al., in press), and the focus of our research was specifically the subjective sleep 
experience and associated psychological factors. To expand on the current findings, 
future research could conduct more in-depth comparisons of behavioural maintaining 
factors for insomnia and CFS (e.g. activity avoidance), as the current study primarily 
investigated cognitive maintaining factors.  
 
4.5.Summary and Clinical Implications 
To our knowledge, this is the first study to directly compare cognitive processes related 
to the subjective sleep and fatigue experiences of those with CFS and insomnia. 
Similarities were found in self-reported insomnia symptoms and cognitions known to 
maintain insomnia, including dysfunctional beliefs about sleep and pre-sleep cognitive 
arousal. Of note, such cognitions are those that are typically targeted in cognitive-
behavioural treatment for insomnia (CBT-I). The current results therefore suggest that it 
may be appropriate to use a transdiagnostic approach to addressing sleep problems in 
CFS. Recent trials have looked at the use of CBT-I approaches for sleep in different 
physical health conditions, such as chronic pain (Tang, Goodchild, & Salkovskis, 2012) 
and fibromyalgia (Martínez et al., 2014), with promising outcomes. It is therefore hoped 
that the current findings may contribute to similar developments in the field of CFS. 
The present study also found, as expected, that fatigue levels, negative beliefs about 
fatigue and somatic complaints were elevated in CFS compared to insomnia. Therefore 
it is important for clinicians to remain cognisant of the presence of these types of 
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Psychological factors associated with self-reported sleep disturbance in Chronic 
Fatigue Syndrome and Insomnia 
 
Background 
Sleep disturbances are a common feature of Chronic Fatigue Syndrome (CFS) and 
patients often report feeling unrefreshed on waking. However, research that has looked 
at the sleep patterns of people with CFS using objective recording methods has not 
found evidence for a problem with sleep. Similar findings occur in people who have 
insomnia; they report poor quality sleep, but the objective evidence does not confirm 
this. Therefore there seems to be a misperception about sleep quality in both conditions. 
Psychological models of both CFS and insomnia include some of the same vulnerability 
factors (e.g. perfectionism) and some similar maintaining factors such as unhelpful 
cognitive (thinking) processes. People with insomnia tend to pay attention to signs of 
tiredness, have unhelpful repetitive thoughts while trying to fall asleep (e.g. worrying 
about not sleeping), and hold unhelpful beliefs about their sleep (e.g. “Without an 
adequate night's sleep, I can hardly function the next day”). People with CFS tend to 
pay attention to physical symptoms and to hold negative beliefs about their fatigue (e.g. 
that fatigue will negatively affect performance). 
Although there are common features, psychological factors relating to sleep and fatigue 
in people with CFS versus insomnia have not been compared before. This research 
study looked at what the similarities and differences are between people with CFS and 
people with insomnia, in terms of their self-reported sleep and fatigue symptoms, their 
thoughts about sleep and fatigue, and other psychological factors.  
 
What we did 
Patients with CFS (n=18) were recruited through specialist NHS services. People with 
insomnia (n=18) and healthy volunteers (n=19) were recruited via the internet. All of 
the participants gave informed consent to take part in the study and then completed a set 
of questionnaires. These asked about: depression and anxiety; sleep quality; sleepiness 
and fatigue symptoms; cognitive processes relating to sleep and fatigue; perfectionism 
(e.g. “It is important to me that I be thorough and competent in everything that I do”) 
and unhelpful beliefs about emotions (e.g. “To be acceptable to others, I must keep any 
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difficulties or negative feelings to myself”). Statistical tests (ANOVAs) were used to see 
if there were significant differences between the three groups on each of the measures.  
 
What we found 
The CFS and Insomnia participants reported similar scores on most of the measures. No 
significant differences were found in depression, anxiety, worry, insomnia severity, 
sleep quality, sleepiness, cognitions relating to sleep, perfectionism, or beliefs about 
emotions. On all of these measures, both groups scored significantly higher than the 
healthy volunteers. The CFS participants (but not the Insomnia participants) also 
reported higher levels of anxiety about their health than healthy volunteers. As 
expected, the CFS group reported higher levels of impairment in their day-to-day lives, 
worse fatigue symptoms, and stronger beliefs about fatigue (e.g. “doing less activity 
than usual helps to improve my fatigue”) compared to the other groups. Patients with 
CFS also reported more physical signs of anxiety when trying to fall asleep (e.g. “I 
become short of breath”) compared to both of the other groups.  
 
Conclusion 
The study found evidence that the self-reported sleep disturbances in CFS are 
comparable to those found in people with insomnia as their main problem. Both groups 
report similar levels of insomnia symptoms, sleep quality and sleepiness. The findings 
also suggest that the same thinking processes that are known to maintain insomnia are 
also found in people with CFS. These thinking processes are targeted during cognitive-
behavioural therapy for insomnia (CBT-I), therefore our findings suggest that this 
treatment approach might be helpful for treating sleep disturbances in CFS. We also 
found some important differences between the groups. Compared to people with 
insomnia, people with CFS appear more likely to be aware of physical sensations while 
trying to fall asleep, be anxious about their health, and hold potentially unhelpful beliefs 
about their fatigue symptoms. It is therefore important for clinicians working with CFS 
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Through the course of Clinical Psychology training, I have had opportunities to develop 
a wide range of research skills and to gain experience of the full research process, from 
the initial brainstorming of ideas to disseminating my findings. This connecting 
narrative draws together my reflections on these experiences, in relation to the 
following pieces of work: 
 Literature Review:  Overgeneral autobiographical memory and depressive 
symptoms in older adults: An evaluative review 
 Service Improvement Project (SIP): An evaluation of psychological service 
provision in a palliative care setting 
 Main Research Project: Psychological factors associated with self-reported 
sleep disturbance in Chronic Fatigue Syndrome/M.E. and insomnia 
 Case Study 1: Health anxiety in the context of co-morbid anxiety and trauma 
 Case Study 2: A cognitive behavioural intervention for adjustment to late-onset 
multiple sclerosis (MS) 
 Case Study 3: Cognitive behavioural intervention for anxiety in a client with 
mild intellectual disabilities: What adaptations may be needed to the therapeutic 
process? 
 Case Study 4: Engaging an adolescent with chronic selective mutism in a 
behavioural intervention programme 
 Case Study 5: Enhanced cognitive behaviour therapy (CBT-E) for bulimia 
nervosa in a client with co-morbid obesity 
My topic choices for each of these projects and case studies have been guided by my 
areas of clinical interest. I have a particular interest in Clinical Health Psychology, 
which was established prior to training and has remained a long-term focus for my 
career. As such, physical health is a strong theme that connects my Service 
Improvement Project, Main Research Project, and case studies 1, 2 and 5. In order for 
research to remain clinically relevant, I believe it is important to evaluate established 
cognitive behavioural models and treatment approaches in the context of different client 
groups and unusual or complex presentations. In line with this interest, cognitive-
behavioural theory and transdiagnostic approaches connect my Literature Review, Main 






Choice of Topic 
I found it difficult to choose a subject for my Literature Review, as the potential scope 
was so wide. At the time of needing to decide on a topic, we were in our Older Adult 
teaching block and I thought about potential ideas relating to our lectures. Initially I was 
drawn to an idea around attachment and depression in older adults, however after 
meeting my supervisor, Dr James Gregory, and discussing current lines of research in 
depression, it was agreed to look at rumination and overgeneral memory in older adults 
with depression. I was pleased with this choice of topic as it matched well with my 
interest in transdiagnostic cognitive processes. 
 
Research Process 
Conducting literature searches and screening papers took considerably longer than I had 
anticipated. I had never previously completed a review on this scale and, although it was 
an evaluative review, it felt important to me to be thorough and systematic in my 
methods. In retrospect, this process may have been facilitated by more clearly defining 
my inclusion and exclusion criteria from the outset. This became more of an iterative 
process, based on the nature and number of search results I found. Towards the end of 
screening, it was clear that the number of papers identified was too large to be feasible. 
After discussing options with my supervisor, I decided to exclude rumination and 
instead focus the review on overgeneral memory.  
From the point of deciding on the final set of included articles, the review progressed 
more quickly. I enjoyed the opportunity to spend time reading in depth on one topic, 
and to see patterns of findings emerging across the different studies. Writing up the 
paper also progressed quickly, facilitated by my supervisor agreeing clear deadlines 
with me for sections to be written and reviewed.  
 
Outcome 
Overall, I felt pleased with the finished result. My review drew together some quite 
disparate pieces of literature under the same theoretical framework, and provided some 
clear directions for future research and clinical practice. I feel that I also learned 
valuable skills in terms of literature review methodology, and have a much better 




Service Improvement Project 
 
Choice of Topic 
My choice of Service Improvement Project (SIP) was made quite quickly in the first 
term of training. Dr Anna Lagerdahl contacted our cohort offering the opportunity to 
conduct a SIP around the clinical psychology service at the Hospice. I was immediately 
keen to take up this opportunity. I had interests in oncology and palliative care, however 
for personal reasons felt it would be challenging to work clinically in this area. 
Conducting my SIP in this field enabled me to gain some experience and knowledge of 
palliative care practice, while also contributing to improving services for staff and 
patients. At a first meeting, Anna and I discussed the project as being focused on 
evaluating the Clinical Psychology service. After further discussion and reading the 
literature and relevant policies, I expanded the scope to include an evaluation of the 
wider psychological service being provided by all staff at the hospice and relating this 
to national guidelines.  
 
Ethical Approval 
As it was not an NHS service and I was not collecting data from patients or carers, 
approval from the Hospice was a simple process of obtaining agreement from the 
Hospice board. Ethical approval was also required from the University Department of 
Psychology Ethics Committee. Unfortunately, I was unaware that the Committee did 
not meet during the summer months. I had hoped to complete data collection during the 
summer between my first and second years, however this was delayed until the autumn 
term of my second year while awaiting approval. The Committee asked me to submit 
final versions of the staff survey and the interview/focus group question schedule. As it 
was planned to develop the question schedule from the outcome of the questionnaire, it 
was necessary to submit one application for the questionnaire element of the study, and 
a later application for the interviews/focus group. This was a useful learning experience 
in terms of understanding ethical review procedures. 
 
Research Process 
Collecting the survey and interview data for my SIP was challenging due to not being 
physically based within the service and having limited research time. I was therefore 
quite reliant on my field supervisor for facilitating communication with team leaders, 
although I was able to arrange and attend meetings to promote the project to different 
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staff groups. The response rate for the survey was not as high as hoped, possibly due to 
the difficulties in promoting the project and the relatively short space of time for data 
collection.  
 
My SIP was the first time I had conducted qualitative research. Transcribing the 
interviews and focus group took considerably longer than I expected, however I enjoyed 
this as it allowed me to immerse myself in the data and to think about themes that were 
emerging. Identifying the final themes was challenging as there were so many potential 
ways to group the data and interconnections between different themes. Having my 
internal supervisor, Dr Cathy Dysch, to read the transcripts and discuss themes with was 
extremely helpful and gave me confidence to make these decisions. I learned that while 
there is a degree of subjectivity in interpreting qualitative data, this is acceptable as long 
as you acknowledge and hold an awareness of your position and apply structured 
methods. I feel that I gained a much better appreciation of qualitative analysis through 
this project.  
 
Outcome 
The response I received when feeding back my findings to the Patient Services Director 
was very positive. I had not expected the Hospice to make firm plans to implement my 
recommendations immediately, and felt proud that the hard work I had put into the 
project was recognised. I received feedback from the Hospice that they felt I had really 
understood their service, despite not working there, and had made recommendations 
that were very realistic and relevant. This outcome was extremely rewarding and 




Main Research Project 
 
Choice of Topic 
On starting training, I had no preconceived ideas about my main research topic, other 
than wanting this to be in a Clinical Health Psychology field. I had hoped to develop an 
idea through the Research Fair in our first term. However, the Fair was disappointing as 
it was poorly attended by regional supervisors. I arranged some discussions with 
regional supervisors about potential projects, however nothing emerged from this. I 
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therefore arranged a meeting with Professor Paul Salkovskis to brainstorm ideas. 
Through considering my interests in physical health and transdiagnostic research, the 
idea for my final project emerged. Paul had previously been involved in research on 
insomnia in chronic pain, and raised the suggestion of taking a similar approach to CFS. 
This topic appealed for personal reasons, as a close friend has experienced severe CFS 
for many years. I felt I therefore had some insight into the condition and would be 
motivated to work towards contributing to the evidence-base in this field. Meeting with 
regional Clinical Psychologists who worked in CFS helped to encourage me that the 
idea would be very relevant to clinical practice. My regional supervisor, Dr Hazel 
O’Dowd also put me in contact with a service-user, who provided very useful feedback 
on the proposed study and documentation and how this might be received by patients.  
 
Ethical Approval 
The process of gaining approvals for my Main Research Project was probably the most 
challenging aspect of my training. Developing an initial outline of a project into a 
detailed protocol to meet the requirements of an NHS Research Ethics Committee and 
two different NHS Trusts involved numerous drafts, emails and meetings, with delays 
waiting for responses at every stage. I had thought I was prepared for this due to my 
previous role as a Clinical Studies Officer, which involved local site set-up for different 
NHS research projects. However, it proved more challenging than expected, particularly 
given the limited research time available during the second year of training. Due to the 
demands on his time as Programme Director, I was not always able to meet with Paul 
when needed, therefore Dr Rachel Hiller agreed to act as a second internal supervisor at 
the end of my second year. Having this additional input to review study documents was 
extremely helpful.  
 
One of the NHS services asked for a number of revisions to the study documentation. 
As I was keen to have two recruitment sites, I chose to wait for this service to confirm 
they were happy with the documents before submitting my REC application. In 
retrospect, it would have been preferable to have sought REC approval earlier on the 
basis of one recruitment site, and to make amendments later if necessary. The actual 
process of obtaining REC approval after submitting my application was, fortunately, 
quite quick as this passed through proportionate review with only minor changes. The 
Trust R&D processes were relatively smooth for one site, but required some additional 





Due to the time taken to set up the study, I had only around three months to recruit 
participants. For the Healthy Control and Insomnia samples, I recruited using social 
media, and was able to achieve a reasonable sample size quite quickly. For the clinical 
sample, one of my main sources of recruitment was through attending group 
programmes run by the North Bristol NHS Trust. This also provided me with 
opportunities to learn more about clinical approaches to CFS and gain insight into the 
realities of living with the condition. I was also dependent on referrals from clinicians in 
the recruiting teams, which was challenging due to not working clinically at these sites. 
As a clinician, I understand that being asked to recruit for research is an added demand 
on pressured clinical time, and is not likely to be a high priority. It was therefore 
difficult to balance my need to drive forward recruitment with not wanting to appear too 
pushy or demanding. I found that regular email reminders of the approaching deadlines 
encouraged clinicians to refer, as well as engaging service leads to send out reminders 
on my behalf.  
 
Due to the short recruitment period, I was unable to obtain the clinical sample I had 
hoped for. It was originally planned to divide the CFS sample into two groups based on 
insomnia severity, to enable comparison of cognitive factors between individuals with 
CFS with and without clinical insomnia. However, only one group was possible. 
Despite this change, I feel the design at it stands is strong and revealed some interesting 
findings. Conducting the data analysis was initially overwhelming due to the number of 
measures used. It was tempting to just start comparing everything! However my 
supervisors encouraged me to form a clear plan as to the questions we wanted to 
address, so that the analyses we ran were targeted. Having opportunities to discuss the 
findings with my supervisors was really helpful to clarify my thinking and shape the 
final write-up.  
 
Outcome 
Due to the nature of my Main Research Project, I had no strong expectations about what 
the findings might show; whether or not there were differences between the CFS and 
insomnia groups, the outcome would have been interesting. The final outcome fits well 
with the existing literature and leads to some interesting research and clinical 
implications about the nature of the sleep problems reported in CFS. I have not yet had 
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the opportunity to disseminate the findings to the clinical services involved or to 
patients, but I look forward to seeing how these are received. While extremely stressful 
at the time, the difficulties experienced in conducting this project have provided me 
with useful knowledge about the challenges of conducting NHS-based research, which 




Choice of Topics 
For each of my case studies, I have chosen cases that have an interesting point of 
difference. As so many clients seen in clinical practice do not precisely ‘fit’ into 
evidence-based models, I believe it is important to test the generalisability of 
psychological treatments by evaluating their use with clients with slightly different 
presentations. This fits with current movements in Clinical Psychology towards 
transdiagnostic and lifespan approaches to treatment. All of my case studies have 
therefore included some element of co-morbidity that complicates treatment, or have 
focused on a client with an unusual presentation for their age group.  
 
Research Process 
While identifying suitable cases has been straightforward, I have always felt anxious 
about approaching clients with the request to write a case report about our work, as I 
worry they will feel it to be intrusive. I have been surprised at how willing clients have 
been to consent to this. Once I had decided on a case to write up, I was conscious of the 
potential for this to impact on my clinical work, for example using additional outcome 
measures or trying techniques I might not otherwise have used, driven by my research 
needs rather than clinical need. However, rather than compromising clinical practice, I 
think that the process of writing a case report has led to higher quality pieces of clinical 
work, due to the additional reading I have done around the subject and detailed 
discussions in supervision.   
 
Outcome 
I have found producing detailed written accounts of my clinical work to be one of the 
most useful elements of training. It has provided a direct link between my placement 
experience and the research and academic aspects of the course. Opening my clinical 
practice to the scrutiny of course tutors has felt exposing, however I have generally 
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received very positive feedback. Writing case studies has also encouraged me to apply 
more rigorous methods to evaluating my clinical work generally and to think more 
carefully about the evidence-base and rationale for my treatment decisions. This is 
something I will carry into my wider clinical practice. 
 
 
Reflections and Future Research Plans 
 
My experience of research throughout the programme has been mixed. Some aspects 
have been quite stressful and led to a lot of uncertainty, particularly the process of 
setting up my Main Research Project. It was also very challenging to identify topics for 
my Main Research Project and Literature Review, as there was some pressure to think 
of ideas quickly at the beginning of training, when I had relatively little clinical 
experience and academic knowledge to draw these ideas from. However, other aspects 
of conducting my research have been really interesting and enjoyable, and I have felt a 
real sense of reward from the final outcome of all of my projects. After three years of 
teaching and clinical placements, I have come to see that potential ideas for research are 
everywhere. 
 
In terms of research skills, training has given me a broad range of experiences to draw 
on. This has included conducting research in NHS and third sector organisations, using 
quantitative and qualitative methodologies, conducting literature reviews and single-
case experimental designs. I have a better awareness of some of the challenges and 
obstacles to conducting clinical research, such as the delays inherent in obtaining 
approvals, and juggling research with competing clinical demands. I understand the 
importance of negotiating protected time for research and service development activities 
if I wish to do this as part of a clinical role.  
 
By the end of training, I plan to submit some of my research work for publication to 
gain experience of the peer-review process and the exposure of disseminating my work 
more widely. While I envisage my career being primarily clinical rather than academic, 
I plan to continue to use my research skills in the context of my clinical work. I will 
seek opportunities to lead on service evaluation and development, and hope to be able to 
contribute to the evidence base by publishing examples of my clinical practice and 
small-scale service related projects. Long-term, I will be keen to have ongoing 
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involvement in research being conducted on the Bath Programme by acting as a 
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Appendix A: Study quality checklist- Literature Review 
Critical Appraisal Journal Article Review Form 
Please tick one column for each item to indicate how well you think it has been addressed. 





    
Design and 
methodology 




    
Analysis of data     
Presentation of 
tables and figures 
    
Discussion of 
results 
    
Conclusions and 
implications 
    
Summary/Abstract     
Referencing     
Clarity of style and 
expression 




    
Ethical 
acceptibility 
    
Theoretical 
importance 
    
Contribution to 
knowledge 
    
Breadth of interest 
 




Appendix B: Staff survey- Service Improvement Project  
 
Evaluation of Psychological Service Provision at the XXX Hospice 
Staff Questionnaire 
Please read the enclosed Information Sheet and read and sign the Consent Form before 
completing this questionnaire. If you have any queries, please contact Flora Wilson (Clinical 
Psychologist in Training) at fclw20@bath.ac.uk.  
The questionnaire is divided into two sections. Section A comprises questions about any 
psychological support that you currently provide to patients and carers in your role at the XXX 
Hospice. Section B asks for your views regarding the Clinical Psychology service provided at the 





About you  
 
1. What is your professional background? 
Doctor 




Healthcare Assistant/Nursing Assistant 
Other (please specify)……………………………………………………………….. 
 
 
2. Which part of the Hospice do you work in? 
Day Hospice 
Inpatient Unit 
Family Support Team 
Therapy Team 
Community/Hospice at Home 
Other (please specify)……………………………………………………………….. 
 
3. Do you have any formal qualifications in psychological therapies or counselling?  
 
No 








4.  The National Institute for Clinical Excellence (NICE) recommends a four-level model 
of psychological assessment and intervention in Palliative Care.  
 
Please read the descriptions of the four levels and answer the questions below: 
 
Level Group Assessment Intervention 





Effective information giving, 
compassionate 
communication and general 
psychological support 















psychological distress and 
diagnosis of some 
psychopathology 
 
Counselling and specific 
psychological interventions 
such as anxiety management 
and solution-focused therapy, 
delivered according to an 
explicit theoretical framework 





Specialist psychological and 
psychiatric interventions such 
as psychotherapy, including 
cognitive behavioural therapy  
Guidance on Cancer Services: Improving Supportive and Palliative Care for Patients with Cancer (NICE, 2004) 
 
 
a. At which level would you identify yourself as working currently? …………………… 
 
b. At which level do you consider you could be working in your role? …………………… 
 






5. How large a part of your role is the delivery of psychological support and/or 
intervention?  
It is a main focus of my role 
It is an integrated part of my routine interactions with patients/carers 
It is not a part of my role 
 
If delivering psychological support and/or intervention is part of your role, please give 







6. a. Have you attended the following training courses? Please tick all that apply. 
National Advanced Communication Skills training 
Level 2 Psychological Skills (4 half-day sessions) 
If not, why is this?  
………………………………………………………………………………………………………………………………………………… 
 
b. If you have attended the above training, approximately how often do you access 
supervision with a Level 4 Practitioner (psychologist or psychiatrist)? 
Not applicable (not attended the training) 
Never 
Monthly 
Every 6 weeks 
Every 2 months 
Other (please specify)……………………………………………………………….. 
 
 
7. The following statements relate to how confident you feel at identifying and 
responding to psychological distress. Please circle a number to indicate your level of 
agreement with each statement. 
 
a) I am confident in my ability to recognise when a patient/carer is experiencing 
psychological distress. 









b) I am confident in my ability to provide supportive listening when a patient/carer 
expresses psychological distress. 










c) I am confident in my ability to communicate information to patients/carers in a 
sensitive manner. 










d) I am confident in my ability to conduct assessments to screen patients/carers for 
psychological distress. 














Approximately how often do you perform this task? 
Daily 
Several times per week 
Weekly 
1-2 times per month 
Never 
Other (please specify)......................................................... 
 
 
e) I am confident at using psychological techniques to support patients/carers who are 
experiencing distress (e.g. problem-solving). 










Approximately how often do you perform this task? 
Daily 
Several times per week 
Weekly 
1-2 times per month 
Never 
Other (please specify)......................................................... 
 
 
f) I am confident at recognising when a patient/carer requires referral for more specialist 
psychological support or intervention. 











Hospice Facilities  
 
8. In what setting(s) do you provide psychological support to Hospice patients/carers?  
Tick all that apply.  
Not applicable 
At the Hospice 
At patient/carer’s home 
Over the telephone 
Other (please specify)…………………………………………………………………………………………… 
 
 
9. Please rate the current facilities at the Hospice in each of the following areas: 
 
a) Availability of quiet spaces to talk to patients/carers who are distressed. 
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1 2 3 4 5  
Very poor Poor Neutral Good Very good Not aware 
 
 
b) Availability of information and resources to give to patients/carers about psychological 
support that they can access. 
1 2 3 4 5  
Very poor Poor Neutral Good Very good Not aware 
 
 
c) Availability of appropriate levels of psychological support to refer/signpost to. 
1 2 3 4 5  
Very poor Poor Neutral Good Very good Not aware 
 
10. How conducive do you feel the overall environment at the Hospice is to providing 
psychological support? Please add any comments below. 
1 2 3 4 5 







11. Are there any factors that you feel act as barriers to you being able to provide 






12. Are there any other facilities or resources that you think would improve the 










Throughout this section, please give your answers in relation to the service currently being 
provided by the Clinical Psychologist working at the XXX Hospice.  
1. Referrals 
 
a. Have you made, or prompted, any referrals to the Clinical Psychologist?  
Yes - Please complete the rest of Questions 1 and 2 
No - Please skip to Question 3: Consultation (p9) 
 
b. Approximately how many referrals have you made to the Clinical Psychologist during 
the past 3 months? 
…………………… 
c. Do you refer all patients/carers who you think might require Level 3 or Level 4 
psychological support? 
Yes 
No - Please give details of the reasons why not below (e.g. waiting times, availability, 








d. What concerns do you most frequently refer patients/carers to the Clinical 
Psychologist for? Please rank the items that apply, rating the most frequent as ‘1’ and 
the next most frequent as ‘2’, and so on. 
 




Physical problems (e.g. pain) 
Cognitive problems (e.g. confusion, memory) 
Family/carer issues. 
Bereavement 
Other (please specify)……………………………………………………………………… 
 
 
e. Do you feel that the process for making referrals to the Clinical Psychologist is clear? 
1 2 3 4 5 











2. Feedback  
 
a. How satisfied are you with any written feedback received from the Clinical 
Psychologist following a referral? 
1 2 3 4 5 
Very 
Dissatisfied  





b. How satisfied are you with any verbal feedback received from the Clinical 
Psychologist following a referral? 
1 2 3 4 5  
Very 
Dissatisfied  











3. Consultation  
 
a. Have you ever sought consultation from the Clinical Psychologist (asked for their 
professional opinion or advice regarding a patient or carer)?  
Yes - Please complete the rest of Question 3 
No - Please skip to Question 4: Supervision with the Clinical Psychologist (p9, below) 
 
b. Approximately how often do you seek consultation from the Clinical Psychologist?
  
Once per week 
Twice per month 
Once per month 
Less than once per month (please specify)……………………………………………………………….. 
 




1 2 3 4 5 
Very 
Dissatisfied  











4. Supervision with the Clinical Psychologist  
  
a. Do you attend supervision with the Clinical Psychologist?  
 
Yes - Please complete the rest of Question 4 
No - Please skip to Question 5: Training (p10) 
 
b. Please tick to indicate the type of supervision, and frequency with which you 
attend.  
Group:  
Family Support Team  
Group:  
Level 2 Psychological Skills 
Individual 
Monthly 
Every 6 weeks 
Every 2 months 




Every 6 weeks 
Every 2 months 




Every 6 weeks 
Every 2 months 





c. Are there any barriers to being able to attend supervision sessions with the Clinical 







d. How satisfied are you with the supervision you have received from the Clinical 
Psychologist? 
1 2 3 4 5 
Very Dissatisfied  Dissatisfied Neutral Satisfied Very Satisfied 
 









5. Training  
  
a. Have you attended any of the following in-service training sessions delivered by 
Clinical Psychologists at the Hospice since 2009? Please tick all that apply. 
Distress thermometer 
Family Work from a Psychological Perspective 
Hallucinations and Paranoia 
Clinical Psychology with Hospice IPU Settings. 
Making Connections with Patients  
Recognising and Responding to Emotional Distress  
The Personal and Professional Impact of Working in Palliative Care  
Recognising and Responding to Emotional Distress in Palliative Care Patients  
None of the above 
 
b. How satisfied are you with the quality of the in-service psychology training you have 
received? 
1 2 3 4 5 
Very 
Dissatisfied  





c. How satisfied are you with the availability of in-service psychology training? 
1 2 3 4 5 
Very Dissatisfied  Dissatisfied Neutral Satisfied Very Satisfied 
 







e. Do you have any suggestions for future training sessions related to psychological 









6. General  
 
a. How would you rate the general approachability of the Clinical Psychology service?  
Please add any additional comments below. 
1 2 3 4 5 







b. How would you rate the general availability of the Clinical Psychology service? 
 Please add any additional comments below. 
1 2 3 4 5 







c. To what extent do you feel that the Clinical Psychologist is an integrated member of 
the multidisciplinary team at the Hospice?   
Please add any additional comments below. 
1 2 3 4 5 









d. How important do you feel each of the following roles of the Clinical Psychologist are 
to the Hospice? 
Consultation with staff: 
1 2 3 4 5 










1 2 3 4 5 










1 2 3 4 5 






Very important Extremely 
important 
 
Direct clinical work with patients/carers: 
1 2 3 4 5 










e. How would you rate the current amount of Clinical Psychology service provision in 
each of the following areas? 
 
Consultation with staff: 
1 2 3 
Not enough About right Too much 
 
Supervision: 
1 2 3 








1 2 3 
Not enough About right Too much 
 
Direct clinical work with patients/carers: 
1 2 3 
Not enough About right Too much 
 
 













Thank you for your time in completing this questionnaire. 
 
Please return your completed questionnaire to Flora Wilson in the 





Appendix C: Beliefs about Fatigue Scale- Main Research Project 
 
Please indicate to what extent you personally agree or disagree with each statement by 
circling a number on the scale. 
 
1. My fatigue can be caused by over-activity: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
2. It is important to avoid exercise when I feel tired: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
3. I believe that my fatigue is caused by a virus or infection: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
4. Doing less activity than usual helps to improve my fatigue: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
5. My fatigue can be caused by failing to get enough rest: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
6. Doing exercise is harmful to me: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
7. My fatigue can be caused by stress: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
8. I am worried that I may lose control over my fatigue: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 




1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
10. I have little ability to manage my fatigue: 
Strongly 
Disagree 





11. I feel my fatigue is ruining my ability to enjoy life: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
12. I can’t predict how bad my fatigue will be from one day to the next:  
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
13. When I feel irritable, depressed or anxious, it is mostly because of my fatigue: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
14. My fatigue prevents me from doing what I want: 
Strongly 
Disagree 
1 2 3 4 5 6 7 8 9 10 
Strongly 
Agree 
15. I avoid or cancel plans when my fatigue is bad: 
Strongly 
Disagree 






Appendix D: Instructions to authors for Aging and Mental Health 
 
 
This journal uses ScholarOne Manuscripts (previously Manuscript Central) to peer 
review manuscript submissions. Please read the guide for ScholarOne authors before 
making a submission. Complete guidelines for preparing and submitting your 
manuscript to this journal are provided below.  
Aging & Mental Health has a new editorial e-mail address: amh@ucl.ac.uk. General 
enquiries can be sent to m.orrell@ucl.ac.uk. 
  
Use these instructions if you are preparing a manuscript to submit to Aging & Mental 
Health. To explore our journals portfolio, visit http://www.tandfonline.com, and for 
more author resources, visit our Author Services website. 
  
Aging & Mental Health is an international peer-reviewed journal publishing high-
quality, original research. All submitted manuscripts are subject to initial appraisal by 
the Editor and if found suitable for further consideration, to peer-review by independent 
anonymous expert referees. All peer review is double blind and submission is online via 
ScholarOne Manuscripts. We encourage the submission of timely review articles that 
summarize emerging trends in an area of mental health or aging, or which address 
issues which have been overlooked in the field. Reviews should be conceptual and 
address theory and methodology as appropriate. 
 
Aging & Mental Health considers all manuscripts on the strict condition that 
 the manuscript is your own original work, and does not duplicate any other 
previously published work, including your own previously published work. 
 the manuscript is not currently under consideration or peer review or accepted 
for publication or in press or published elsewhere. 
 the manuscript contains nothing that is abusive, defamatory, libellous, obscene, 
fraudulent, or illegal. 
Please note that Aging & Mental Health uses CrossCheck™ software to screen 
manuscripts for unoriginal material. By submitting your manuscript to Aging & Mental 
Health you are agreeing to any necessary originality checks your manuscript may have 
to undergo during the peer-review and production processes. 
Any author who fails to adhere to the above conditions will be charged with costs which 
Aging & Mental Health incurs for their manuscript at the discretion of Aging & Mental 
Health’s Editors and Taylor & Francis, and their manuscript will be rejected. 
 
This journal is compliant with the Research Councils UK OA policy. Please see the 
licence options and embargo periods here.  
  
Manuscript Preparation 
1. General guidelines 
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 Manuscripts are accepted only in English. Any consistent spelling and 
punctuation styles may be used. Please use single quotation marks, except where 
‘a quotation is “within” a quotation’. Long quotations of 40 words or more 
should be indented without quotation marks. 
 Manuscripts may be in the form of (i) regular articles not usually exceeding 
5,000 words (under special circumstances, the Editors will consider articles up 
to 10,000 words), or (ii) short reports not exceeding 2,000 words. These word 
limits exclude references and tables. Manuscripts that greatly exceed this will be 
critically reviewed with respect to length. Authors should include a word count 
with their manuscript. 
 Manuscripts should be compiled in the following order: title page (including 
Acknowledgments as well as Funding and grant-awarding bodies); abstract; 
keywords; main text; references; appendices (as appropriate); table(s) with 
caption(s) (on individual pages); figure caption(s) (as a list).  
Please supply all details required by any funding and grant-awarding bodies as 
an Acknowledgement on the title page of the manuscript, in a separate 
Funding paragraph, as follows:  
For single agency grants:  
This work was supported by the <Funding Agency> under Grant <number 
xxxx>.  
For multiple agency grants:  
This work was supported by the <Funding Agency #1> under Grant <number 
xxxx>; <Funding Agency #2> under Grant <number xxxx>; and <Funding 
Agency #3> under Grant <number xxxx>.  
 Structured Abstracts of not more than 250 words are required for all manuscripts 
submitted. The abstract should be arranged as follows: Title of manuscript; 
name of journal; abstract text containing the following headings: Objectives, 
Method, Results, and Conclusion. 
 Each manuscript should have 3 to 5 keywords.   
 Search engine optimization (SEO) is a means of making your article more 
visible to anyone who might be looking for it. Please consult our guidance here. 
 Section headings should be concise. The text should normally be divided into 
sections with the headings Introduction, Methods, Results, and Discussion. Long 
articles may need subheadings within some sections to clarify their content.   
 All authors of a manuscript should include their full names, affiliations, postal 
addresses, telephone numbers and email addresses on the cover page of the 
manuscript. One author should be identified as the corresponding author. Please 
give the affiliation where the research was conducted. If any of the named co-
authors moves affiliation during the peer review process, the new affiliation can 
be given as a footnote. Please note that no changes to affiliation can be made 
after the manuscript is accepted. Please note that the email address of the 
corresponding author will normally be displayed in the article PDF (depending 
on the journal style) and the online article. 
 All persons who have a reasonable claim to authorship must be named in the 
manuscript as co-authors; the corresponding author must be authorized by all co-
authors to act as an agent on their behalf in all matters pertaining to publication 
of the manuscript, and the order of names should be agreed by all authors. 
 Biographical notes on contributors are not required for this journal. 
 Authors must also incorporate a Disclosure Statement which will acknowledge 




 For all manuscripts non-discriminatory language is mandatory. Sexist or racist 
terms must not be used. 
 Authors must adhere to SI units. Units are not italicised. 
 When using a word which is or is asserted to be a proprietary term or trade 
mark, authors must use the symbol ® or TM. 
 Authors must not embed equations or image files within their manuscript. 
2. Style guidelines 
 Description of the Journal’s article style.  
 Description of the Journal’s reference style.  
 Guide to using mathematical scripts and equations.  
 Word templates are available for this journal. If you are not able to use the 
template via the links or if you have any other template queries, please contact 
authortemplate@tandf.co.uk. 
3. Figures 
 Please provide the highest quality figure format possible. Please be sure that all 
imported scanned material is scanned at the appropriate resolution: 1200 dpi for 
line art, 600 dpi for grayscale and 300 dpi for colour. 
 Figures must be saved separate to text. Please do not embed figures in the 
manuscript file. 
 Files should be saved as one of the following formats: TIFF (tagged image file 
format), PostScript or EPS (encapsulated PostScript), and should contain all the 
necessary font information and the source file of the application (e.g. 
CorelDraw/Mac, CorelDraw/PC). 
 All figures must be numbered in the order in which they appear in the 
manuscript (e.g. Figure 1, Figure 2). In multi-part figures, each part should be 
labelled (e.g. Figure 1(a), Figure 1(b)). 
 Figure captions must be saved separately, as part of the file containing the 
complete text of the manuscript, and numbered correspondingly. The captions 
should include keys to symbols, and should make interpretation possible without 
reference to the text. 
 The filename for a graphic should be descriptive of the graphic, e.g. Figure1, 
Figure2a. 
4. Publication charges 
Submission fee  
There is no submission fee for Aging & Mental Health. 
Page charges  
There are no page charges for Aging & Mental Health. 
Colour charges  
Colour figures will be reproduced in colour in the online edition of the journal free of 
charge. If it is necessary for the figures to be reproduced in colour in the print version, a 
charge will apply. Charges for colour figures in print are £250 per figure ($395 US 
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Dollars; $385 Australian Dollars; 315 Euros). For more than 4 colour figures, figures 5 
and above will be charged at £50 per figure ($80 US Dollars; $75 Australian Dollars; 63 
Euros). 
Depending on your location, these charges may be subject to Value Added Tax. 
5. Reproduction of copyright material 
If you wish to include any material in your manuscript in which you do not hold 
copyright, you must obtain written permission from the copyright owner, prior to 
submission. Such material may be in the form of text, data, table, illustration, 
photograph, line drawing, audio clip, video clip, film still, and screenshot, and any 
supplemental material you propose to include. This applies to direct (verbatim or 
facsimile) reproduction as well as “derivative reproduction” (where you have created a 
new figure or table which derives substantially from a copyrighted source). 
You must ensure appropriate acknowledgement is given to the permission granted to 
you for reuse by the copyright holder in each figure or table caption. You are solely 
responsible for any fees which the copyright holder may charge for reuse. 
The reproduction of short extracts of text, excluding poetry and song lyrics, for the 
purposes of criticism may be possible without formal permission on the basis that the 
quotation is reproduced accurately and full attribution is given. 
For further information and FAQs on the reproduction of copyright material, please 
consult our Guide. 
 
6. Supplemental online material  
Authors are encouraged to submit animations, movie files, sound files or any additional 
information for online publication. 
 Information about supplemental online material  
  
Manuscript submission 
All submissions should be made online at the Aging & Mental Health ScholarOne 
Manuscripts website. New users should first create an account. Once logged on to the 
site, submissions should be made via the Author Centre. Online user guides and access 
to a helpdesk are available on this website. 
Manuscripts may be submitted in any standard editable format, including Word and 
EndNote. These files will be automatically converted into a PDF file for the review 
process. LaTeX files should be converted to PDF prior to submission because 
ScholarOne Manuscripts is not able to convert LaTeX files into PDFs directly. All 
LaTeX source files should be uploaded alongside the PDF.  
Authors should prepare and upload two versions of their manuscript. One should be a 
complete text, while in the second all document information identifying the author 
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Appendix E: Instructions to authors for Palliative Medicine 
SAGE 
Manuscript Submission Guidelines: Palliative Medicine  
Palliative Medicine is a highly ranked, peer reviewed scholarly journal dedicated to 
improving knowledge and clinical practice in the palliative care of patients with far 
advanced disease. It reflects the multi-disciplinary and multi-professional approach that 
is the hallmark of effective palliative care. Papers are selected for publication based on 
their scientific excellence, contribution to knowledge, and their importance to 
contemporary palliative care. We welcome papers relating to palliative care clinical 
practice, policy, theory and methodological knowledge. 
Palliative Medicine is an international journal, and is the official research journal of the 
European Association for Palliative Care and a journal of the Association of Palliative 
Medicine. Whilst we acknowledge that many papers will focus on palliative care issues 
within particular countries, it is important to our readers that authors reflect on how 
these issues might be relevant to a wider audience, present the study in the context of 
the existing international research on the topic, and discuss how this knowledge 
contributes to the international knowledge base. 
1. Peer review policy 
Palliative Medicine operates a conventional single blind reviewing policy in which the 
reviewer's name is always concealed from the submitting authors. All submitted 
manuscripts undergo a two stage review process. The initial review is undertaken by 
three editors and a decision is made either to send the paper for external review or to 
reject it without review. We undertake to make the decision whether or not to send for 
external review within three weeks of submission. In this initial review the editors 
ensure that only those papers that meet the scientific and editorial standards of the 
journal and fit within the aims and scope of the journal will be sent for external review. 
Within 10 weeks of sending the paper out to external review we will make a final 
decision. Papers accepted for publication following external review usually require 
some modification before final acceptance. Generally, due to the high volume of 
submissions, we are able to accept only about 30% of papers submitted to us.  
2. Article types 
Palliative Medicine publishes original research and review articles on all aspects of 
palliative care. The Journal considers the following kinds of article for publication: 
1. Review Articles – 5,000 words.  The reviews we publish are usually systematically 
constructed reviews, clearly following the relevant publication guidelines (such as 
PRISMA) for the particular review style chosen. We are happy to consider a range of 
review types (systematic reviews, meta- analysis, meta-ethnography, realist review for 
example) for publication, but they must be methodologically clear and rigorously 
conducted.   
2. Original Articles – 3,000 words with up to six tables or figures. For papers reporting 
qualitative methods participants' quotations may be excluded from the word count. We 
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still prefer, however, that these quotations are succinct and carefully chosen – it is rare 
that more than one quote is required to illustrate the point being made.  All research 
papers should follow relevant reporting guidelines such as CONSORT for trials, 
COREQ for qualitative research etc. Please see http://www.equator-
network.org/resource-centre/library-of-health-research-reporting/ for up to date 
information on reporting guidelines, and fuller instructions below on constructing 
different aspects of the paper. 
3. Short reports – 1,000-1,400 words. These should report research, but are usually 
small scale survey/pilot/feasibility studies etc, which would not warrant a full original 
research paper 
4. Case reports – 1,000-1,400 words with one table or figure. We have specific and 
explicit requirements for case report abstracts and the construction of the report (see 
below) which must be followed.  Case reports must be used to generate future research 
questions. 
5. Audit and Service Evaluation. 1 000- 1,400 words. We do accept audit and service 
evaluation reports, but these should be of exceptional quality and interest. These should 
be robustly reported – we expect audits to discuss the audit cycle and feedback, and 
service evaluations to report sufficient contextual information on the service being 
evaluated. They should be used to raise future research questions. Full details of all 
relevant permissions and consents should be reported.  
6. Research letters. We occasionally publish short research letters (750 words, no 
abstract required, no more than 3 references). These are usually offered as a publication 
type to authors submitting original papers or short reports which we feel should be 
disseminated, but in a more succinct form.  
7. Letters to the editors. We welcome correspondence relating to issues of general 
interest to our readership, or in response to a publication. Such letters should be 
succinct, and generally no more than 500 – 750 words.  
NB: word count excludes references, tables and figures references  
2.1 Structured abstracts 
Reviews, original articles, short reports, case reports, audits and service evaluations 
should be  accompanied by a structured abstract. Full details are given below of the 
format we expect for these:  
Research Paper/Short Report/Audit/Service Evaluation:  
Abstracts should have clear headings, which should generally follow the structure 
below when reporting research, but may vary depending on the requirements of the 
reporting guidelines followed. There is some flexibility for audit/service evaluation as it 
is important that these are not presented as research.  
 
Background: Identify the issue to be addressed, current knowledge on the topic and 




Aim: A clear statement of the main research aim(s), research question (s) or hypotheses 
to be tested. 
Design: A statement about the research strategy adopted. For intervention studies, a 
clear statement of the intervention is required. For clinical trials, the trial number should 
be given.  
Setting/participants: Indicate the type of setting(s) the research was conducted in (i.e. 
primary/secondary care), the number of centres, and who participated including brief 
indication of inclusion/exclusion criteria, numbers of participants and any relevant 
characteristics. 
Results: Report the main outcomes(s) findings of the study. If appropriate, report levels 
of statistical significance and confidence intervals. 
Conclusions: Identify how the aims have been met, and the relevance of the findings 
for clinical practice, theory or research methodology. Suggestions for further research. 
Review Paper 
These should generally follow the structure below, with reference to relevant review 
reporting guidelines such as PRISMA. 
Background: Identify the issue to be addressed, current knowledge on the topic and 
some indication of its relevance and importance to clinical practice, theory or research 
methodology. 
Aim: A clear statement of the review aim(s). 
Design: A statement about the review strategy/methods adopted  
Data sources: State the data sources used (including years searched). Include a 
statement about eligibility criteria for selecting studies and study quality appraisal 
Results: Report the main outcomes(s) /findings of the review. 
Conclusions: Identify how the aims have been met, and the relevance of the findings 
for clinical practice, theory or research methodology. 
Case Report 
This format differs from our structured abstracts for research or reviews, so please 
ensure you follow the correct format or your paper will be returned without review. 
Case report abstracts should be 200 words in length. 
Background: Identify the issue the case report addresses, why this case is important, 
current knowledge on the topic, and some indication of the case relevance to practice 
and research. 
Case Presentation: Presenting features of the case(s) and working/differential 
diagnoses. Brief summary of case(s) history, examinations and investigations etc. 
Case Management: Details of any treatment given and a description of the course of 
the clinical issue(s) being reported. 
Case Outcome: Description of case(s) outcome. Details of any outcome measures used. 
Conclusions: Identify how the aims have been met, and the relevance of the findings 
for clinical practice, theory or research methodology. Suggestions for further research.  
2.2 General instructions to authors relevant to all paper types 
We wish papers published by Palliative Medicine to adhere to the highest publishing 
standards possible. We want to ensure that the key messages for our readers are 
explicitly articulated. We also want you to consider the following issues: authorship; 




Palliative Medicine has a system where all papers are required to clearly state what is 
already known about the topic, what their paper adds, and implications for practice, 
theory, or policy. You are required to give these at the start of the manuscript. Please 
use these three specific headings (see below), with 1-3 separate bullet points for each 
heading. Please use clear, succinct, separate bullet points rather than complex or 
multiple sentences.  Each bullet point should be one sentence only.   
What is already known about the topic? 
 Short statement(s) here about state of knowledge in this area. 
 You may highlight both what is known and what is not known. 
 Be specific rather than broad or sweeping statements. Avoid statements 
such as 'Little is known about ... x or y' in favour of statements 
specifying exactly what is known. 
What this paper adds? 
 Short specific statement(s) here about what this paper adds.  
 These should be styled in terms of outcomes where possible (This study 
demonstrates that x intervention has a (specific) impact on y outcome) 
rather than study aims or process. (This study considers whether x 
intervention has an impact of y outcome). 
 Be as specific as possible please here. Avoid broad statements such as 
'New Knowledge is added about ... ' but rather be specific about exactly 
what this knowledge is. So for example rather than 'We add to the 
knowledge base on x' we would prefer the specific such as 'x variable 
was found to increase the experience of y outcome (by z amount)'. 
 Ensure that these statements clearly relate to the findings of the study. 
Implications for practice, theory or policy? 
 Short specific statement(s) here on the implications of this paper for 
practice, theory or policy. These should clearly draw from the findings of 
the study, without over stating their importance. 
 Where possible please make these internationally relevant. 
Authorship: 
Palliative Medicine adheres to the guidelines from the International Committee of 
Medical Journal Editors in ascribing authorship. These state that authorship credit 
should be based on 1) substantial contributions to conception and design, acquisition of 
data, or analysis and interpretation of data; 2) drafting the article or revising it critically 
for important intellectual content; and 3) final approval of the version to be published. 
Authors should meet conditions 1, 2, and 3. A statement regarding authorship should be 
included in your covering letter to the editor. Full details of the ICMJE regarding 
authorship can be found here http://www.icmje.org/ethical_1author.html.  
Multiple publications:  
We want our readers to be aware of other published or in-press accounts of any studies 
published in Palliative Medicine. For this reason we ask that all published and in-press 
accounts of the study from which data in your paper are taken must be explicitly 
142 
  
referred to in your paper. Please make it clear in your manuscript that you are referring 
to data/publications from the same study. If you have other publications from the same 
study in preparation or under review please refer to this in your letter to the editor. If 
you are successful in your submission to Palliative Medicine we ask that where possible 




We expect all studies that we publish to be conducted to high ethical standards which 
adhere to local ethical regulations and standards. We recommend that studies follow the 
recommendations of the International Committee of Medical Journal Editors. 
http://www.icmje.org/ethical_6protection.html.  
When reporting experiments on human subjects, authors should indicate whether the 
procedures followed were in accordance with the ethical standards of the responsible 
committee on human experimentation (institutional and national) and with the Helsinki 
Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was 
conducted in accordance with the Helsinki Declaration, the authors must explain the 
rationale for their approach and demonstrate that the institutional review body explicitly 
approved the doubtful aspects of the study. When reporting experiments on animals, 
authors should indicate whether the institutional and national guide for the care and use 
of laboratory animals was followed. 
Manuscripts reporting research studies must state at an appropriate point how such local 
regulations and standards have been met. Where applicable the approving body and 
approval number should be given.  
Research design/reporting issues 
 
Research reports frequently omit important information. Palliative Medicine 
recommends that authors use, where possible, reporting guidelines to assist them in 
providing all the relevant information required by our readers. Reporting guidelines are 
statements that provide advice on how to report research methods and findings. Usually 
in the form of a checklist, flow diagram or explicit text, they specify a minimum set of 
items required for a clear and transparent account of what was done and what was found 
in a research study, reflecting in particular issues that might introduce bias into the 
research. Most widely recognised guidelines are based on the available evidence and 
reflect consensus opinion of experts in a particular field, including research 
methodologists and journal editors.  
Palliative Medicine asks that guidelines are followed relevant to the research design 
used. Not being able to meet all of the requirements of a guideline is not necessarily a 
barrier to publishing your manuscript, but all essential requirements of the research 
design should be met. You can, if you wish, submit a checklist with your manuscript as 
a guide to the editors and reviewers of the paper. The Equator Network is a useful 
resource, with links to many widely used guidelines: http://www.equator-
network.org/resource-centre/library-of-health-research-reporting/reporting-guidelines/ 
Examples of guidelines the editors would expect to be used include:  
The CONSORT guidelines for Randomised Controlled Trials (http://www.consort-
statement.org). In addition Palliative Medicine has adopted the proposal from the 
International Committee of Medical Journal Editors (ICMJE) which requires, as a 
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condition of consideration for publication of clinical trials, registration in a public trials 
registry. Trials must register at or before the onset of patient enrolment. The clinical 
trial registration number should be included at the end of the abstract of the article. For 
this purpose, a clinical trial is defined as any research project that prospectively assigns 
human subjects to intervention or comparison groups to study the cause-and-effect 
relationship between a medical intervention and a health outcome. Studies designed for 
other purposes, such as to study pharmacokinetics or major toxicity (e.g. phase I trials), 
would be exempt. Further information can be found at www.icmje.org.  
The STARD guidelines for studies of diagnostic accuracy http://www.stard-
statement.org 
The PRISMA or MOOSE guidelines for systematic reviews and meta-analyses 
http://www.equator-network.org/resource-centre/library-of-health-research-
reporting/reporting-guidelines/systematic-reviews-and-meta-analysis/ 
The STROBE guidelines for observational studies in epidemiology http://www.strobe-
statement.org 




Although Palliative Medicine does not require structured discussions, we would like 
you to bear in mind the typical content for a structured discussion when writing your 
paper. This would typically be a statement of the principal findings of the study, a 
discussion of the strengths and weaknesses of the study/review with reference to other 
studies or reviews in the area, a discussion of what is already known about this topic 
and what this research/review adds, and a discussion of the implications of the 
research/review for clinical practice, theory or methods in this area. You may wish to 
raise further research or review questions.  
2.3 Case report instructions for Palliative Medicine 
The purpose of our case reports: We are interested in publishing unusual clinical 
presentations or novel approaches to care. As a research focused journal, we publish 
case reports to highlight issues of clinical interest which help readers to pose research 
questions for future further study, and so we want these research focused learning points 
to be explicit within the report.  
Case report length: Case reports should be succinct and focused. They should be 
between 1000 and 1400 words in length. The aim is description of the case, without 
undue speculation.  
Case report instructions: Case report authors should also read our general instructions to 
authors regarding title, keywords, article retrievability, authorship and other general 
formatting issues. Case reports should include the words ‘case report’ or ‘case series’ as 
appropriate in the title and keywords. Please do not use ‘case study’ as this leads to 
confusion with the research strategy of the same name.  
2.3.1 Case report format:The format for the written case report should, where 
possible, follow the same structured format as for the abstract, but in greater detail.  
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Background: Identify the issue the case report addresses, why this case is important, 
current knowledge on the topic, and some indication of the case relevance to practice 
and research. The case should be placed in context, remembering that Palliative 
Medicine is an international journal and readers are unlikely to be familiar with the 
particular context in which this case(s) occurred. You should briefly make reference to 
any similar published cases, and related research findings.  
Case presentation:  Presenting features of the case(s) and working/differential 
diagnoses. Brief summary of case(s) history, examinations and investigations etc. Cases 
presented in Palliative Medicine should be anonymised. Sufficient detail should be 
given so that the case is informative to the reader, but the patient should not be able to 
be identified from the case information.  Details should be given in this section or in a 
final ‘consent’ section of the permissions the patient(s) gave for their case(s) to be 
written for publication. Where possible patients should sign an informed consent form 
which is submitted as a supplementary file to the case report, and this should be noted in 
the report. We do expect written informed consent for most of the case reports we 
publish, however we acknowledge that this can be challenging in the field of palliative 
care with potentially rapidly deteriorating patients. If the patient has died, as a next step 
we would expect the authors to request permission from a relative, and make this clear 
on the consent form and in the report. If no written consent is possible from either 
patient or relative we will carefully consider the utility of the case against the likelihood 
of identification or potential distress. To reduce the possibility of identification then it is 
likely that in this position more information will have to be removed from the case, and 
this will have to be made clear in the report.  
Case management:  Details of any treatment given and a description of the course of 
the clinical issue(s) being reported. Drug names should be generic not proprietary. 
Details of management should be specific and described to be understandable by those 
who may follow different protocols in different contexts. A rationale should be given 
for any changes in management. An indication of timescale should be included.  
Case outcome: Description of case(s) outcome. Details of any outcome measures used. 
Conclusions: Indication of novelty of this case(s) with reference to other published 
cases and any existing research. Description of lessons learnt from the case(s) and 
implications for future research. It is particularly important that these learning points 
from the case are clearly spelt out. In particular, as a research journal, we expect a clear 
statement of the research questions or areas that could be investigated that follow from 
this case(s). 
Case reports should usually have no more than 8 references and include no more than 1 
table or figures.  
 
3. How to submit your manuscript 
Before submitting your manuscript, please ensure you carefully read and adhere to all 
the guidelines and instructions to authors provided below. Manuscripts not conforming 
to these guidelines may be returned. 
Palliative Medicine is hosted on SAGE track - a web based online submission and peer 
review system powered by ScholarOne Manuscripts. Please read the Manuscript 
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Submission guidelines below, and then simply visit 
http://mc.manuscriptcentral.com/palliative-medicine to login and submit your article 
online.  
IMPORTANT: Please check whether you already have an account in the system before 
trying to create a new one. If you have reviewed or authored for the journal in the past 
year it is likely that you will have had an account created.Â For further guidance on 
submitting your manuscript online please visit ScholarOne  
All papers must be submitted via the online system. If you would like to discuss your 
paper prior to submission, please contact the journal by e-mail to Debbie Ashby 
[Debbie.Ashby@bristol.ac.uk]. 
 
4. Journal contributor’s publishing agreement     
Before publication SAGE requires the author as the rights holder to sign a Journal 
Contributor's Publishing Agreement. SAGE's Journal Contributor's Publishing 
Agreement is a exclusive licence agreement which means that the author retains 
copyright in the work but grants SAGE the sole and exclusive right and licence to 
publish for the full legal term of copyright. Exceptions may exist where an assignment 
of copyright is required or preferred by a proprietor other than SAGE. In this case 
copyright in the work will be assigned from the author to the society. For more 
information please visit our Frequently Asked Questions on the SAGE Journal Author 
Gateway. 
4.1 SAGE Choice 
If you wish your article to be freely available online immediately upon publication (as 
some funding bodies now require), you can opt for it to be included in SAGE Choice 
subject to payment of a publication fee. The manuscript submission and peer reviewing 
procedure is unchanged. On acceptance of your article, you will be asked to let SAGE 
know directly if you are choosing SAGE Choice. For further information, please visit 
SAGE Choice. 
  
5. Declaration of conflicting interests                    
Within your Journal Contributor's Publishing Agreement you will be required to make a 
certification with respect to a declaration of conflicting interests. It is the policy of 
Palliative Medicine to require a declaration of conflicting interests from all authors 
enabling a statement to be carried within the paginated pages of all published articles.  
Please include any declaration at the end of your manuscript after any 
acknowledgements and prior to the references, under a heading 'Conflict of Interest 
Statement'. If no declaration is made the following will be printed under this heading in 
your article: 'None Declared'. Alternatively, you may wish to state that 'The Author(s) 
declare(s) that there is no conflict of interest'. 
When making a declaration the disclosure information must be specific and include any 
financial relationship that all authors of the article has with any sponsoring organization 
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and the for-profit interests the organization represents, and with any for-profit product 
discussed or implied in the text of the article.  
Any commercial or financial involvements that might represent an appearance of a 
conflict of interest need to be additionally disclosed in the covering letter accompanying 
your article to assist the Editor in evaluating whether sufficient disclosure has been 
made within the Conflict of Interest statement provided in the article. 
For more information please visit the SAGE Journal Author Gateway. 
  
6. Other conventions 
None. 
  
7. Acknowledgements                                                           
Any acknowledgements should appear first at the end of your article prior to your 
Declaration of Conflicting Interests (if applicable), any notes and your References. 
All contributors who do not meet the criteria for authorship should be listed in an 
`Acknowledgements’ section. Examples of those who might be acknowledged include a 
person who provided purely technical help, writing assistance, or a department chair 
who provided only general support. Authors should disclose whether they had any 
writing assistance and identify the entity that paid for this assistance. 
7.1 Funding Acknowledgement 
To compile with the guidance for Research Funders, Authors and Publishers issued by 
the Research Information Network (RIN), Palliative Medicine additionally requires all 
Authors to acknowledge their funding in a consistent fashion under a separate heading. 
All research articles should have a funding acknowledgement in the form of a sentence 
as follows, with the funding agency written out in full, followed by the grant number in 
square brackets: 
This work was supported by the Medical Research Council [grant number xxx]. 
Multiple grant numbers should be separated by comma and space. Where the research 
was supported by more than one agency, the different agencies should be separated by 
semi-colon, with and before the final funder. Thus: 
This work was supported by the Wellcome Trust [grant numbers xxxx, yyyy]; the 
Natural Environment Research Council [grant number zzzz]; and the Economic and 
Social Research Council [grant number aaaa]. 
In some cases, research is not funded by a specific project grant, but rather from the 
block grant and other resources available to a university, college or other research 
institution. Where no specific funding has been provided for the research we ask that 
corresponding authors use the following sentence: 
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This research received no specific grant from any funding agency in the public, 
commercial, or not-for-profit sectors. 
Please include this information under a separate heading entitled 'Funding' directly after 
any other Acknowledgements prior to your 'Declaration of Conflicting Interests' (if 
applicable), any Notes and your References. For more information on the guidance for 




Authors are responsible for obtaining permission from copyright holders for 
reproducing any illustrations, tables, figures or lengthy quotations previously published 
elsewhere. For further information including guidance on fair dealing for criticism and 
review, please visit our Frequently Asked Questions on the SAGE Journal Author 
Gateway.. 
  
9. Manuscript style 
9.1 File types 
Only electronic files conforming to the journal's guidelines will be accepted. Preferred 
formats for the text and tables of your manuscript are Word DOC, RTF, XLS. LaTeX 
files are also accepted.Â Please also refer to additional guideline on submitting artwork 
below. 
9.2 Journal Style 
Palliative Medicine conforms to the SAGE house style.Â Click here to review 
guidelines on SAGE UK House Style. 
9.3 Reference Style 
Palliative Medicine operates a SAGE Vancouver reference style. Click here to review 
the guidelines on SAGE Vancouver to ensure your manuscript conforms to this 
reference style 
9.4. Manuscript Preparation 
The text should be double-spaced throughout and with a minimum of 3cm for left and 
right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point. 
9.4.1 Your Title, Keywords and Abstracts: Helping readers find your article online 
The title, keywords and abstract are key to ensuring readers find your article online 
through online search engines such as Google. Please refer to the information and 
guidance on how best to title your article, write your abstract and select your keywords 
by visiting SAGE’s Journal Author Gateway Guidelines on How to Help Readers Find 
Your Article Online. 
Palliative Medicine requires authors to list between 4 and 6 key words that are also 
Medical Subject Headings (MESH headings). These key words should be closely 
related to the papers subject, purpose, method and focus. Details of MESH headings can 
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be found here http://www.nlm.nih.gov/mesh/. If authors submit keywords that are not 
MESH headings Palliative Medicine reserves the right to submit alternative keywords. 
Abstracts for Palliative Medicine should be structured and no more than 250 words. 
They should not include references or abbreviations. Please refer to section 2 above. 
9.4.2 Corresponding Author Contact details 
Provide full contact details for the corresponding author including email, mailing 
address and telephone numbers. Academic affiliations are required for all co-authors. 
These details should be presented separately to the main text of the article to facilitate 
anonymous peer review. 
9.4.3 Guidelines for submitting artwork, figures and other graphics 
For guidance on the preparation of illustrations, pictures and graphs in electronic 
format, please visit SAGE's Manuscript Submission Guidelines.  
Figures supplied in colour will appear in colour online regardless of whether or not 
these illustrations are reproduced in colour in the printed version. For specifically 
requested colour reproduction in print, you will receive information regarding the costs 
from SAGE after receipt of your accepted article. 
9.4.4 Guidelines for submitting supplemental files 
This journal is able to host approved supplemental materials online, alongside the full-
text of articles. Supplemental files will be subjected to peer-review alongside the article. 
For more information please refer to SAGE's Guidelines for Authors on Supplemental 
Files. 
 
9.4.5 English Language Editing services 
Non-English speaking authors who would like to refine their use of language in their 
manuscripts might consider using a professional editing service. Visit 
http://www.uk.sagepub.com/journalgateway/msg.htm for further information. 
  
10. After acceptance             
10.1 Proofs 
We will email a PDF of the proofs to the corresponding author. Any corrections should 
be sent to the editors within two weeks of receipt. 
10.2 E-Prints 
SAGE provides authors with access to a PDF of their final article. For further 
information please visit Offprints and Reprints on our Journal Author Gateway.  
10.3 SAGE Production 
At SAGE we place an extremely strong emphasis on the highest production standards 
possible. We attach high importance to our quality service levels in copy-editing, 
typesetting, printing, and online publication (http://online.sagepub.com/). We also seek 
to uphold excellent author relations throughout the publication process. 
We value your feedback to ensure we continue to improve our author service levels. On 
publication all corresponding authors will receive a brief survey questionnaire on your 
experience of publishing in Palliative Medicine with SAGE. 
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10.4 OnlineFirst Publication 
Palliative Medicine benefits from OnlineFirst, a feature offered through SAGE's 
electronic journal platform, SAGE Journals Online. It allows final revision articles 
(completed articles in queue for assignment to an upcoming issue) to be hosted online 
prior to their inclusion in a final print and online journal issue which significantly 
reduces the lead time between submission and publication. For more information please 
visit our OnlineFirst Fact Sheet 
  
11. Further information 
Any correspondence, queries or additional requests for information on the Manuscript 













Your Paper Your Way  
 
We now differentiate between the requirements for new and revised submissions. You 
may choose to submit your manuscript as a single Word or PDF file to be used in the 
refereeing process. Only when your paper is at the revision stage, will you be requested 
to put your paper in to a 'correct format' for acceptance and provide the items required 
for the publication of your article. 
To find out more, please visit the Preparation section below. 
 
Types of article  
Full Length Papers  
Full length research papers will not normally be more than 4000 words in length 
(Introduction through Discussion) and will preferably be shorter. Submission of a paper 
to the Journal of Psychosomatic Research will be held to imply that it represents 
original research not previously published (except in the form of an abstract or 
preliminary report), that it is not being considered for publication elsewhere, and that if 
accepted by the Journal of Psychosomatic Research it will not be published elsewhere in 
the same form in any language without the consent of the Publisher. Major papers of 
topical content will be given priority in publication. Please note that this journal does 
not publish animal studies. 
Short Reports  
The journal welcomes short reports, which may be either preliminary communications 
or brief accounts of original research. Short Reports must not exceed 1500 words and 
should include no more than 2 tables and 30 references. The journal does not publish 
case reports. 
Editorials  
The Editors welcome suggestions for editorials which give personal and topical views 
on subjects within the journal's area of interest. They should not normally exceed 1500 
words, excluding references and should have no more than 20 references. 
Review Articles  
Review papers are normally 4000-5000 words (Introduction through Discussion). 
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Authors are advised to consult one of the Editors with an outline before submitting a 
review. 
Letters to the Editors  
These normally refer to articles previously published in the journal. The Editors are also 
willing to consider letters on subjects of direct relevance to the journal's interest, 
including research letters. Letters should not exceed 1000 words, including references. 
Where appropriate, they should begin with a reference to the published article that is the 
subject of the letter. Research letters should be submitted as 'Letters to the Editors' 
Book Reviews  
These are normally submitted by the Book Review Editor. In addition we welcome 
suggestions of books for review. 
Special Articles  
These may be invited by an editor or submitted after discussion with an editor. Special 
articles are designed to provide an analysis of a topic of particular interest to readers of 
the journal and are more extensive in scope than an editorial. They should not primarily 
be a commentary on an article previously published in the journal, which would be 
better addressed in a letter or editorial. 
Other Papers  
The Editors welcome suggestions for other types of papers, such as conference reports, 
accounts of major research in progress and interviews with senior research workers. 
These should not be submitted without prior consultation with an editor. 
European Association for Consultation-Liaison Psychiatry and Psychosomatics 
(EALCPP) Contributions  
These should not exceed 1000 words, excluding references Contributions are not meant 
to publish results of specific disease-related research; topics covered should be of 
general interest, stem from countries participating in the EACLPP or refer to EACLPP 
activities. EACLPP contributors are not peer-reviewed but subject to editorial approval. 
In case of doubt about the suitability of a subject, please contact 
jpsychores@elsevier.com 
Contact details for submission  




Ethics in publishing  
 
For information on Ethics in publishing and Ethical guidelines for journal publication 
see http://www.elsevier.com/publishingethics and http://www.elsevier.com/journal-
authors/ethics. 
Human and animal rights  
 
If the work involves the use of animal or human subjects, the author should ensure that 
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the work described has been carried out in accordance with The Code of Ethics of the 
World Medical Association (Declaration of Helsinki) for experiments involving humans 
http://www.wma.net/en/30publications/10policies/b3/index.html; EU Directive 
2010/63/EU for animal experiments 
http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; Uniform 
Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. 
Authors should include a statement in the manuscript that informed consent was 
obtained for experimentation with human subjects. The privacy rights of human 
subjects must always be observed. 
Conflict of interest  
 
All authors are requested to disclose any actual or potential conflict of interest including 
any financial, personal or other relationships with other people or organizations within 
three years of beginning the submitted work that could inappropriately influence, or be 
perceived to influence, their work. See also http://www.elsevier.com/conflictsofinterest. 
Further information and an example of a Conflict of Interest form can be found at: 
http://help.elsevier.com/app/answers/detail/a_id/286/p/7923. 
Submission declaration  
 
Submission of an article implies that the work described has not been published 
previously (except in the form of an abstract or as part of a published lecture or 
academic thesis or as an electronic preprint, see 
http://www.elsevier.com/sharingpolicy), that it is not under consideration for 
publication elsewhere, that its publication is approved by all authors and tacitly or 
explicitly by the responsible authorities where the work was carried out, and that, if 
accepted, it will not be published elsewhere including electronically in the same form, 
in English or in any other language, without the written consent of the copyright-holder. 
Changes to authorship  
 
This policy concerns the addition, deletion, or rearrangement of author names in the 
authorship of accepted manuscripts: 
Before the accepted manuscript is published in an online issue: Requests to add or 
remove an author, or to rearrange the author names, must be sent to the Journal 
Manager from the corresponding author of the accepted manuscript and must include: 
(a) the reason the name should be added or removed, or the author names rearranged 
and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the 
addition, removal or rearrangement. In the case of addition or removal of authors, this 
includes confirmation from the author being added or removed. Requests that are not 
sent by the corresponding author will be forwarded by the Journal Manager to the 
corresponding author, who must follow the procedure as described above. Note that: (1) 
Journal Managers will inform the Journal Editors of any such requests and (2) 
publication of the accepted manuscript in an online issue is suspended until authorship 
has been agreed. 
After the accepted manuscript is published in an online issue: Any requests to add, 
delete, or rearrange author names in an article published in an online issue will follow 
the same policies as noted above and result in a corrigendum. 
Reporting clinical trials  
All reports on clinical trials submitted for publication should include a completed 
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Consolidated Standards of Reporting Trials (CONSORT) flow chart. Please refer to the 
CONSORT statement website at http://www.consort-statement.org for more 
information. This journal has adopted guidelines on clinical trial registration of the 
International Committee of Medical Journal Editors (ICMJE) which require, as a 
condition of consideration for publication of clinical trials, registration in a public trials 
registry. Trials must register at or before the onset of patient enrolment. The clinical 
trial registration number should be included at the end of the abstract of the article. For 
this purpose, a clinical trial is defined as any research study that prospectively assigns 
human participants or groups of humans to one or more health-related interventions to 
evaluate the effects of health outcomes. Health-related interventions include any 
intervention used to modify a biomedical or health-related outcome (for example drugs, 
surgical procedures, devices, behavioural treatments, dietary interventions, and process-
of-care changes). Health outcomes include any biomedical or health-related measures 
obtained in patients or participants, including pharmacokinetic measures and adverse 
events. Further information can be found at http://www.icmje.org. 
Reporting on other types of research studies  
It is also recommended that authors submitting other types of articles (non-trials) follow 
the appropriate reporting guidelines for the type of study being reported 
(http://www.equator-network.org/resource-centre/library-of-health-research-
reporting/reporting-guidelines/).  
 Systematic reviews and meta-analyses of randomized trials and other evaluation 
studies: PRISMA  
 Systematic reviews and meta-analyses of observational studies: MOOSE 
 Studies of diagnostic accuracy: STARD  
 Observational studies: STROBE 
Copyright  
 
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing 
Agreement' (for more information on this and copyright, see 
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Please write your text in good English (American or British usage is accepted, but not a 
mixture of these). Authors who feel their English language manuscript may require 
editing to eliminate possible grammatical or spelling errors and to conform to correct 
scientific English may wish to use the English Language Editing service available from 
Elsevier's WebShop (http://webshop.elsevier.com/languageediting/) or visit our 
customer support site (http://support.elsevier.com) for more information. 
Submissions  
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instructions are available on the Web site. 
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review within 90 days of submission. Approximately 25% of submitted manuscripts are 
ultimately accepted for publication. 
 
 
Manuscripts should conform to the uniform requirements known as the 'Vancouver 
style' (International Committee of Medical Journal Editors. Uniform requirements for 
manuscripts submitted to biomedical journals. N Engl J Med 1997; 336:309-315). The 
Editors and Referees attach considerable importance to a succinct and lucid prose style 
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'Vancouver style' (International Committee of Medical Journal Editors. Uniform 
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There are no strict requirements on reference formatting at submission. References can 
be in any style or format as long as the style is consistent. Where applicable, author(s) 
name(s), journal title/book title, chapter title/article title, year of publication, volume 
number/book chapter and the pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted 
article by Elsevier at the proof stage. Note that missing data will be highlighted at proof 
stage for the author to correct. 
Formatting requirements  
 
There are no strict formatting requirements but all manuscripts must contain the 
essential elements needed to convey your manuscript, for example Abstract, Keywords, 
Introduction, Materials and Methods, Results, Conclusions, Artwork and Tables with 
Captions. 
If your article includes any Videos and/or other Supplementary material, this should be 
included in your initial submission for peer review purposes. 
Divide the article into clearly defined sections. 
Figures and tables embedded in text  
Please ensure the figures and the tables included in the single file are placed next to the 
relevant text in the manuscript, rather than at the bottom or the top of the file. 
REVISED SUBMISSIONS  
Use of word processing software  
Regardless of the file format of the original submission, at revision you must provide us 
with an editable file of the entire article. Keep the layout of the text as simple as 
possible. Most formatting codes will be removed and replaced on processing the article. 
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manuscripts (see also the Guide to Publishing with Elsevier: 
http://www.elsevier.com/guidepublication). See also the section on Electronic artwork.  
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 
'grammar-check' functions of your word processor. 
Cover letter  
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description of the article being submitted and its relevance to likely readers of the 
journal, the Cover Letter should include a statement that (1)authors of this article had 
access to all study data, are responsible for all contents of the article, and had authority 
over manuscript preparation and the decision to submit the manuscript for publication, 
(2) that all listed authors have approved of the submission of the manuscript to the 
journal, and (3) an explanation of the relationship of the submitted paper to any other 
published, submitted or proposed papers reporting the same or overlapping data. You 
may submit the completed letter online. 
Title Page  
This should contain (a) the title of the article; (b) a short running head; (c) name of 
department where the work was conducted; (d) names of the each author with highest 
academic degree; (e) name, address, phone and fax of author responsible for 
correspondence and to whom requests for reprints should be addressed. 
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Structured Abstract  
This should be subdivided under the headings Objective, Methods, Results, and 
Conclusion and should not exceed 250 words. 
Keywords  
Up to six keywords should be listed in alphabetical order after the abstract. These terms 
should optimally characterize the paper to facilitate choice of peer reviewers. 
Article Structure  
The text should be divided into sections with main headings: Introduction, Method, 
Results and Discussion and, in total, these sections should not normally be greater than 
4000 words in length. 
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Collate acknowledgements in a separate section at the end of the article before the 
references and do not, therefore, include them on the title page, as a footnote to the title 
or otherwise. Acknowledgements must include mention of any source of funding 
outside the basic funding of the host institution (see Role of the funding source above). 
List here those individuals who provided help during the research (e.g., providing 
language help, writing assistance or proof reading the article, etc.). 
Tables  
Number tables consecutively in accordance with their appearance in the text. Place 
footnotes to tables below the table body and indicate them with superscript lowercase 
letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data 
presented in tables do not duplicate results described elsewhere in the article.Each 
should be on a separate sheet, numbered consecutively in Roman numerals. 
Figures  
Each should be on a separate sheet, and numbered consecutively. Captions should be on 
a separate sheet. The number of illustrations should be kept to a minimum. Colour 
illustrations are not normally acceptable. Authors may be asked to support the costs of 
colour reproduction. 
Competing Interest Statement  
All manuscripts should include a competing interests declaration that should be in the 
following format: 
'All authors have completed the Unified Competing Interest form at 
http://www.icmje.org/coi_disclosure.pdf and declare that(1)[authors] received support 
from [name of company or other competing interest] for the submitted 
work;(2)[authors] have [specify relationships] with [name of companies or other 
competing interests] in the past three years that could be perceived to constitute a 
conflict of interest;(3)spouses, partners, or children of [authors] have [specified] 
financial relationships that may be relevant to the submitted work; and(4)[authors] have 
[specify type of relationship] non-financial interests that may be relevant to the 
submitted work. 'If there are no competing interests to report, the authors should state, 
'The authors have no competing interests to report'. 
Appendices  
If there is more than one appendix, they should be identified as A, B, etc. Formulae and 
equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; 
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in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table 
A.1; Fig. A.1, etc. 
Graphical abstract  
 
Although a graphical abstract is optional, its use is encouraged as it draws more 
attention to the online article. The graphical abstract should summarize the contents of 
the article in a concise, pictorial form designed to capture the attention of a wide 
readership. Graphical abstracts should be submitted as a separate file in the online 
submission system. Image size: Please provide an image with a minimum of 531 × 1328 
pixels (h × w) or proportionally more. The image should be readable at a size of 5 × 13 
cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or 
MS Office files. See http://www.elsevier.com/graphicalabstracts for examples.  
Authors can make use of Elsevier's Illustration and Enhancement service to ensure the 




Highlights are mandatory for this journal. They consist of a short collection of bullet 
points that convey the core findings of the article and should be submitted in a separate 
editable file in the online submission system. Please use 'Highlights' in the file name 
and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet 
point). See http://www.elsevier.com/highlights for examples. 
Abbreviations  
Keep abbreviations to a minimum and avoid their use in the abstract. Spell out each 
abbreviation in the text the first time that it is used. Ensure consistency of abbreviations 
throughout the article. 
Footnotes  
 
Footnotes should be used sparingly. Number them consecutively throughout the article. 
Many word processors build footnotes into the text, and this feature may be used. 
Should this not be the case, indicate the position of footnotes in the text and present the 
footnotes themselves separately at the end of the article. 
Electronic artwork  
General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, Courier.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Indicate per figure if it is a single, 1.5 or 2-column fitting image.  
• For Word submissions only, you may still provide figures and their captions, and 
tables within a single file at the revision stage.  
• Please note that individual figure files larger than 10 MB must be provided in separate 
source files.  
A detailed guide on electronic artwork is available on our website:  
http://www.elsevier.com/artworkinstructions. 
You are urged to visit this site; some excerpts from the detailed information are 




Regardless of the application used, when your electronic artwork is finalized, please 
'save as' or convert the images to one of the following formats (note the resolution 
requirements for line drawings, halftones, and line/halftone combinations given below):  
EPS (or PDF): Vector drawings. Embed the font or save the text as 'graphics'.  
TIFF (or JPG): Color or grayscale photographs (halftones): always use a minimum of 
300 dpi.  
TIFF (or JPG): Bitmapped line drawings: use a minimum of 1000 dpi.  
TIFF (or JPG): Combinations bitmapped line/half-tone (color or grayscale): a minimum 
of 500 dpi is required.  
Please do not:  
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); the 
resolution is too low.  
• Supply files that are too low in resolution.  
• Submit graphics that are disproportionately large for the content. 
Color artwork  
Submit color illustrations as original photographs, high-quality computer prints or 
transparencies, close to the size expected in publication, or as 35 mm slides. Please 
make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF) 
or MS Office files) and with the correct resolution. If, together with your accepted 
article, you submit usable color figures then Elsevier will ensure, at no additional 
charge, that these figures will appear in color online (e.g., ScienceDirect and other sites) 
regardless of whether or not these illustrations are reproduced in color in the printed 
version. For color reproduction in print, you will receive information regarding the 
costs from Elsevier after receipt of your accepted article. Please indicate your 
preference for color: in print or online only. For further information on the preparation 
of electronic artwork, please see http://www.elsevier.com/artworkinstructions.  
Please note: Because of technical complications that can arise by converting color 
figures to 'gray scale'(for the printed version should you not opt for color in print) please 
submit in addition usable black and white versions of all the color illustrations. 
Illustration services  
 
Elsevier's WebShop (http://webshop.elsevier.com/illustrationservices) offers Illustration 
Services to authors preparing to submit a manuscript but concerned about the quality of 
the images accompanying their article. Elsevier's expert illustrators can produce 
scientific, technical and medical-style images, as well as a full range of charts, tables 
and graphs. Image 'polishing' is also available, where our illustrators take your image(s) 
and improve them to a professional standard. Please visit the website to find out more. 
Figure captions  
Ensure that each illustration has a caption. A caption should comprise a brief title (not 
on the figure itself) and a description of the illustration. Keep text in the illustrations 
themselves to a minimum but explain all symbols and abbreviations used. 
References  
These should be numbered consecutively in the text in the order in which they are first 
mentioned and be so denoted in the list. Their form should be that adopted by the US 
National Library of Medicine, as used in the Index Medicus and as recommended in 
Huth EJ, Medical Style and Format. 
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Reference links  
Increased discoverability of research and high quality peer review are ensured by online 
links to the sources cited. In order to allow us to create links to abstracting and indexing 
services, such as Scopus, CrossRef and PubMed, please ensure that data provided in the 
references are correct. Please note that incorrect surnames, journal/book titles, 
publication year and pagination may prevent link creation. When copying references, 
please be careful as they may already contain errors. Use of the DOI is encouraged. 
Web references  
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a 
source publication, etc.), should also be given. Web references can be listed separately 
(e.g., after the reference list) under a different heading if desired, or can be included in 
the reference list. 
Reference management software  
Most Elsevier journals have a standard template available in key reference management 
packages. This covers packages using the Citation Style Language, such as Mendeley 
(http://www.mendeley.com/features/reference-manager) and also others like EndNote 
(http://www.endnote.com/support/enstyles.asp) and Reference Manager 
(http://refman.com/support/rmstyles.asp). Using plug-ins to word processing packages 
which are available from the above sites, authors only need to select the appropriate 
journal template when preparing their article and the list of references and citations to 
these will be formatted according to the journal style as described in this Guide. The 
process of including templates in these packages is constantly ongoing. If the journal 
you are looking for does not have a template available yet, please see the list of sample 
references and citations provided in this Guide to help you format these according to the 
journal style. 
 
If you manage your research with Mendeley Desktop, you can easily install the 
reference style for this journal by clicking the link below: 
http://open.mendeley.com/use-citation-style/journal-of-psychosomatic-research 
When preparing your manuscript, you will then be able to select this style using the 
Mendeley plug-ins for Microsoft Word or LibreOffice. For more information about the 
Citation Style Language, visit http://citationstyles.org. 
Reference formatting  
There are no strict requirements on reference formatting at submission. References can 
be in any style or format as long as the style is consistent. Where applicable, author(s) 
name(s), journal title/book title, chapter title/article title, year of publication, volume 
number/book chapter and the pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted 
article by Elsevier at the proof stage. Note that missing data will be highlighted at proof 
stage for the author to correct. If you do wish to format the references yourself they 
should be arranged according to the following examples: 
Reference style  
Text: Indicate references by number(s) in square brackets in line with the text. The 
actual authors can be referred to, but the reference number(s) must always be given.  
List: Number the references (numbers in square brackets) in the list in the order in 




Reference to a journal publication:  
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J 
Sci Commun 2010;163:51–9.  
Reference to a book:  
[2] Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000.  
Reference to a chapter in an edited book:  
[3] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: 
Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-
Publishing Inc; 2009, p. 281–304.  
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors 
the first 6 should be listed followed by 'et al.' For further details you are referred to 
'Uniform Requirements for Manuscripts submitted to Biomedical Journals' (J Am Med 
Assoc 1997;277:927–34) (see also 
http://www.nlm.nih.gov/bsd/uniform_requirements.html). 
Journal abbreviations source  
Journal names should be abbreviated according to the List of Title Word Abbreviations: 
http://www.issn.org/services/online-services/access-to-the-ltwa/. 
Video data  
 
Elsevier accepts video material and animation sequences to support and enhance your 
scientific research. Authors who have video or animation files that they wish to submit 
with their article are strongly encouraged to include links to these within the body of the 
article. This can be done in the same way as a figure or table by referring to the video or 
animation content and noting in the body text where it should be placed. All submitted 
files should be properly labeled so that they directly relate to the video file's content. In 
order to ensure that your video or animation material is directly usable, please provide 
the files in one of our recommended file formats with a preferred maximum size of 150 
MB. Video and animation files supplied will be published online in the electronic 
version of your article in Elsevier Web products, including ScienceDirect: 
http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose any 
frame from the video or animation or make a separate image. These will be used instead 
of standard icons and will personalize the link to your video data. For more detailed 
instructions please visit our video instruction pages at 
http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot 
be embedded in the print version of the journal, please provide text for both the 
electronic and the print version for the portions of the article that refer to this content. 
AudioSlides  
 
The journal encourages authors to create an AudioSlides presentation with their 
published article. AudioSlides are brief, webinar-style presentations that are shown next 
to the online article on ScienceDirect. This gives authors the opportunity to summarize 
their research in their own words and to help readers understand what the paper is about. 
More information and examples are available at http://www.elsevier.com/audioslides. 
Authors of this journal will automatically receive an invitation e-mail to create an 
AudioSlides presentation after acceptance of their paper. 
Supplementary material  
 
Elsevier accepts electronic supplementary material to support and enhance your 
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scientific research. Supplementary files offer the author additional possibilities to 
publish supporting applications, high-resolution images, background datasets, sound 
clips and more. Supplementary files supplied will be published online alongside the 
electronic version of your article in Elsevier Web products, including ScienceDirect: 
http://www.sciencedirect.com. In order to ensure that your submitted material is directly 
usable, please provide the data in one of our recommended file formats. Authors should 
submit the material in electronic format together with the article and supply a concise 
and descriptive caption for each file. For more detailed instructions please visit our 
artwork instruction pages at http://www.elsevier.com/artworkinstructions. 
Submission checklist  
 
The following list will be useful during the final checking of an article prior to sending 
it to the journal for review. Please consult this Guide for Authors for further details of 
any item.  
Ensure that the following items are present:  
One author has been designated as the corresponding author with contact details:  
• E-mail address  
• Full postal address  
All necessary files have been uploaded, and contain:  
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been 'spell-checked' and 'grammar-checked'  
• All references mentioned in the Reference list are cited in the text, and vice versa  
• Permission has been obtained for use of copyrighted material from other sources 
(including the Internet)  
Printed version of figures (if applicable) in color or black-and-white  
• Indicate clearly whether or not color or black-and-white in print is required.  
• For reproduction in black-and-white, please supply black-and-white versions of the 
figures for printing purposes.  
For any further information please visit our customer support site at 
http://support.elsevier.com. 
 
Use of the Digital Object Identifier  
 
The Digital Object Identifier (DOI) may be used to cite and link to electronic 
documents. The DOI consists of a unique alpha-numeric character string which is 
assigned to a document by the publisher upon the initial electronic publication. The 
assigned DOI never changes. Therefore, it is an ideal medium for citing a document, 
particularly 'Articles in press' because they have not yet received their full bibliographic 
information. Example of a correctly given DOI (in URL format; here an article in the 
journal Physics Letters B):  
http://dx.doi.org/10.1016/j.physletb.2010.09.059 
When you use a DOI to create links to documents on the web, the DOIs are guaranteed 
never to change. 
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Online proof correction  
 
Corresponding authors will receive an e-mail with a link to our online proofing system, 
allowing annotation and correction of proofs online. The environment is similar to MS 
Word: in addition to editing text, you can also comment on figures/tables and answer 
questions from the Copy Editor. Web-based proofing provides a faster and less error-
prone process by allowing you to directly type your corrections, eliminating the 
potential introduction of errors. 
If preferred, you can still choose to annotate and upload your edits on the PDF version. 
All instructions for proofing will be given in the e-mail we send to authors, including 
alternative methods to the online version and PDF. 
We will do everything possible to get your article published quickly and accurately. 
Please use this proof only for checking the typesetting, editing, completeness and 
correctness of the text, tables and figures. Significant changes to the article as accepted 
for publication will only be considered at this stage with permission from the Editor. It 
is important to ensure that all corrections are sent back to us in one communication. 
Please check carefully before replying, as inclusion of any subsequent corrections 
cannot be guaranteed. Proofreading is solely your responsibility. 
Offprints  
 
The corresponding author, at no cost, will be provided with a personalized link 
providing 50 days free access to the final published version of the article on 
ScienceDirect. This link can also be used for sharing via email and social networks. For 
an extra charge, paper offprints can be ordered via the offprint order form which is sent 
once the article is accepted for publication. Both corresponding and co-authors may 
order offprints at any time via Elsevier's WebShop 
(http://webshop.elsevier.com/myarticleservices/offprints). Authors requiring printed 
copies of multiple articles may use Elsevier WebShop's 'Create Your Own Book' service 
to collate multiple articles within a single cover 
(http://webshop.elsevier.com/myarticleservices/booklets). 
Additional information  
 
 
You can track your submitted article at http://www.elsevier.com/track-submission. You 
can track your accepted article at http://www.elsevier.com/trackarticle. You are also 





Appendix G: Department of Psychology Ethical Approval for SIP 
Questionnaire (13-129) and Focus Group/Interviews (14-015) 
 
 
Date: Wed, 03 Jul 2013 16:30:09 +0100 
From: Jeffrey Gavin <J.Gavin@bath.ac.uk> 
To: Flora Wilson <F.C.L.Wilson@bath.ac.uk>, Caroline Ransford 
<C.A.Ransford@bath.ac.uk> 
Subject: ethics ref 13-129 
 
 
Dear Flora Wilson 
 
Reference Number 13-129 
 
The ethics committee have considered your application for the study entitled 'An 
evaluation of psychological service provision at the [X] Hospice' and have given it 
conditional ethical approval. 
 
The committee have raised the following points which they would like you to attend to 
before giving the study full ethical approval: 
 
- The survey that is included is identified as a draft, and it is stated that it will be 
developed further. However, it is not clear when or how this will be done and what the 
final version will be. We need to see this prior to it being sent to participants. 
 
- There is no interview schedule included. This needs to be looked at before approval is 
given. It is also not clear what the follow up interview will add to the overall study 
questions or the information gained from the questionnaire. 
 
Please send the revised document to Caroline Ransford - you can do this by email. 
 




Dr Jeff Gavin 
Acting Chair of Psychology Ethics Committee 
--------- 
Dr Jeff Gavin 
Department of Psychology 
University of Bath, 
Bath BA2 7AY, England 
 
ph: +44 1225 386591 









Date: Wed, 04 Sep 2013 16:40:49 +0100 
From: Psychology-Ethics <psychology-ethics@bath.ac.uk> 
To: fclw20@bath.ac.uk, Caroline Ransford <C.A.Ransford@bath.ac.uk> 





Reference Number 13-129 
 
Thank you for satisfactorily attending to the amendments. I can now confirm that you 
have full ethical approval for your study. 
 
Best wishes with your research. 
 
-- 
Dept of Psychology Ethics Committee 





Date: Mon, 10 Feb 2014 14:54:48 +0000 
From: Psychology Ethics Committee <psychology-ethics@bath.ac.uk> 
To: Flora Wilson <F.C.L.Wilson@bath.ac.uk> 
Subject: Ethics 14-015 
 
 
Dear Flora Wilson 
 
Reference Number 14-015 
 
The ethics committee have considered your ethics proposal for the study entitled 'An 
evaluation of psychological service provision at the [X] Hospice: part 2' and have given 
it full ethical approval. 
 
Best wishes with your research. 
 
Dr Helen Lucey 
Chair Psychology Ethics Committee 
University of Bath  
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RE: North Bristol NHS Trust Full R&D approval: [Psychological factors in CFS/ME 
and Insomnia v1], R&I [3414]  
Smith Rebecca (NORTH BRISTOL NHS TRUST)  
Sent:  13 February 2015 16:06  
To:  hazel.o'dowd@nbt.nhs.uk  
Cc:  
Wilson Flora (TAUNTON AND SOMERSET NHS FOUNDATION TRUST); 
Williams Nicola (NORTH BRISTOL NHS TRUST); Helen.Lewis@nbt.nhs.uk; 
stacey.mcgarry@nbt.nhs.uk; annette.clarke@nbt.nhs.uk; 






Title:   Psychological factors associated with self-reported sleep disturbance in Chronic 
Fatigue Syndrome/Myalgic Encephalomyelitis and Insomnia 
CI:                            Flora Wilson 
IRAS number:        156785 
REC number:         14/EM/1297 
R&D Reference:     3414 
Start Date:              13.02.2015 
End Date:                30.09.2015 
 
I am pleased to confirm North Bristol NHS Trust (NBT) NHS permission for the above 
study. 
 
FULL R&D APPROVAL 
 
You have permission to begin recruitment 
 
I understand that the University of Bath will act as sponsor for this study. 
 
Permission is based on the NHS REC favourable opinion given on 16.12.2014 date and 
amendment submitted on 18.12.2014. 
 
Please notify us of the date of your first patient first visit. If you experience any 
problems recruiting, please contact the R&I office for advice and support. 
 
We wish you every success with your study. We are keen to support good research at 
North Bristol NHS Trust and are pleased that you have decided to conduct your project 
here. 
 
The lead Research Facilitator for this study is Mary, who will remain your ongoing 
main point of contact. They can be reached at the following email address: 
research@nbt.nhs.uk<mailto:research@nbt.nhs.uk>. 
 
Approval is given on the understanding that this project be carried out according to 
Good Clinical Practice and UK Statutory Instrument, and within the guidelines of the 
NHS Research Governance Framework for Health and Social Care, and NHS Trust 
policies, procedures, and SOPs which are available online at 
http://www.nbt.nhs.uk/research. 
 




-  Ensuring that, all participants sign informed consent (whenever applicable) 
-  Adhering to the protocol as agreed by the Research Ethics Committee and ensuring 
your co-workers do the same. 
-  Adhering to National Research Ethics Service and other applicable regulatory (e.g. 
MHRA) reporting requirements. 
-  Ensuring all recruitment figures are uploaded to the Edge database on a weekly basis. 
-  Providing us with information about any amendments to the protocol, changes in 
funding, personnel or end date. Amendments should be submitted in accordance with 
guidance in IRAS. 
-  Informing us of any research-related adverse events. 
-  Ensuring that any staff working on this study at this site have been issued with a 
contract with NBT (honorary, substantive or bank) or a letter of access before they 
commence work on the study at this site. 
-  Maintenance of an Investigator Site File and/or Trial Master Files* 
 
Researchers who hold substantive or honorary contracts with North Bristol NHS Trust 
(NBT) will be covered against claims of negligence by patients of NBT under the 
Clinical Negligence Scheme for Trusts (CNST). This scheme does not cover ‘no fault’ 
compensation and the Trust is precluded from taking out separate insurance to cover 
this. Any patient or volunteer taking part in the study is entitled to know that if they 
suffered injury as a result of participating in the study they would first have to prove 
negligence in a court of law before they could gain compensation. If the study involves 
patients of any other Trust or healthcare organisation, you will need to confirm the 
indemnity arrangements with that organisation. 
 
In addition, other information may be requested from time to time and lay summary of 
the results will be requested from you at the end of the study. 
 
This full R&D approval document will need to be filed in your Investigator Site File 
and/or Trial Master Files. 
 
In accordance with the NBT Research Monitoring and Audit policy, this study is subject 
to audit by the R&I Office. We will contact the Principal Investigator to make 




Dr Nicola Williams 
Deputy Director 
Research & Innovation 
North Bristol NHS Trust 
 
Tel: 0117 323 6468 
Fax: 0117 323 6192 
http://www.nbt.nhs.uk/research 
 
